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Abstract 
Intervertebral disc degeneration-associated low back pain is a debilitating 
condition with no current treatments directed towards halting or reversing the 
degenerative cascade at a cellular level. The lack of such treatments is in part due to 
an incomplete knowledge of the molecular mechanisms that govern IVD function in 
health and degeneration. Due to the unique location and role of the IVD within the 
spine, many factors contribute to the microenvironment that cells reside within. The 
survival and function of cells has been irrefutably linked to their ability to adapt to 
the microenvironment in which they live. However, it is not completely understood 
how IVD cells have been able to survive and adapt to their environment. 
The intervertebral disc is a highly hydrated tissue; the rich proteoglycan 
matrix imbibes water, enabling the disc to withstand compressive loads. During 
ageing and degeneration increased matrix degradation leads to dehydration and loss 
of function. Aquaporins are a family of transmembrane channel proteins that 
selectively allow the passage of water in and out of cells and are responsible for 
maintaining water homeostasis in many tissues; hence many AQPs are potentially 
expressed by cells within the intervertebral disc to enable their adaptation to this 
highly hydrated tissue. 
The aim of this thesis was to investigate the expression, regulation and 
function of AQP transmembrane water channels within the IVD and how they 
potentially contribute to the adaptation of cells to their environment. Results have 
highlighted NP cells express many AQP water channels in vivo, whose expression may 
be altered between disc development and degeneration. AQP1 and 5 were found to 
be upregulated by TonEBP in hyperosmotic conditions, a transcription factor 
controlling osmotic adaptation and matrix expression, which may implicate them in 
the adaptation of NP cells to their environment, which becomes unachievable when 
AQP1 and 5 are decreased during degeneration. AQP4 and TRPV4 function in NP cells 
was required for fundamental cellular processes such as cell volume regulation and 
water permeability, enabling adaptation to their osmotically fluxing environment. 
Finally, it was identified that other microenvironmental factors also contribute to 
AQP expression in NP cells, indicating the regulation and function of these water 
channels is potentially very complex. 
Together, investigations presented in this thesis have demonstrated many 
AQPs are expressed by the intervertebral disc and enable NP cells to respond and 
adapt to their environment, ultimately contributing to the overall function of the 
tissue. Their regulation by multiple environmental factors may signify that AQPs have 
diverse roles within the IVD, which remain to be elucidated. Importantly, this body 
of work has contributed novel findings, increased knowledge and opened new 
avenues of research in the field of IVD and spine biology. 
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Chapter 1: Introduction 
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1.1 The Spine 
 The vertebral column consists of 24 articulating vertebrae, separated by 23 
intervertebral discs (IVD), and 10 fused vertebrae. This is the main structural element 
of the spine which functions to provide support to the human body and allows 
rotation and bending with the contiguous IVDs, whilst also encasing and protecting 
the spinal cord within the vertebral foramen. The vertebral column is divided into 5 
anatomical regions from superior to inferior (Figure 1.1). 
 The cervical spine contains the topmost 7 vertebrae (C1-C7). C1 and C2 (atlas 
and axis) enable the attachment and movement of the skull. The 12 thoracic 
vertebrae (T1-T12) are larger than the cervical vertebrae, contain large spinous 
processes and enable attachment and movement of the ribs to protect the lungs and 
heart. The 5 lumbar vertebrae (L1-L5) are the largest and increase in size and 
robustness from L1 to L5. The lumbar spine has an inward curve which forms the 
characteristic concavity of the lower back. The lumber vertebrae allow considerably 
more movement than the thoracic vertebrae; permitting a range of movements such 
as flexion and extension whilst also supporting weight bearing activities. The sacrum 
is attached inferiorly to the lumbar vertebrae at L5 by an IVD and contains 5 (S1-S5) 
fused vertebrae that integrate the two halves of the pelvis. The coccyx is the most 
inferior part of the spine and contains 3-5 fused bones. IVDs are not present between 
the fused bones of the sacrum or coccyx (Figure 1.1). 
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Figure 1.1. Anatomy of the human spine. (A) The spine contains a total of 34 
vertebrae, 24 separated by IVDs and 8-10 fused. (B) A motion segment comprised of 
2 adjacent vertebrae separated by an IVD. (B) The IVD is composed of the outer 
annulus fibrosus with lamellar fibrocartilaginous structure and the inner gelatinous 
nucleus pulposus. IVDs are attached to adjacent vertebrae via cartilaginous 
endplates. B and C show the posterior spinous processes and the spinal cord which 
travels protected through the vertebral foramen. Adapted from (Medline, 2018) 
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1.2 The intervertebral disc 
 The IVD is a fibrocartilaginous structure positioned between each of the 24 
movable vertebrae. The main function of the IVD is mechanical; it enables the 
movement of the head and spine and accommodates the applied loading of the body. 
The IVD is comprised of 3 distinct regions; cartilaginous endplates (CEP), annulus 
fibrosus (AF) and nucleus pulposus (NP) (Figure 1.1). These regions within the IVD all 
work in unison to withstand mechanical loading and disperse energy evenly 
throughout the spine. 
1.2.1 Cartilaginous endplates 
 Both the superior and inferior ends of the IVD are covered by a thin layer of 
hyaline cartilage. The cartilaginous endplate (CEP) has maximal thickness at birth 
which thins during aging, in adults it is approximately 0.5 – 1mm in width. They act 
as an interface between the internal IVD structures and the vertebral bone and 
prevent pressure being applied directly between both. Chondrocytes reside within 
the CEP embedded into an aggrecan and collagen type II rich matrix, which gives the 
CEP a structure similar to articular cartilage. The central region of the CEP contains 
the highest density of cells throughout the IVD, with approximately 18 x 106 cells/cm3 
in the young adult, these cells do not undergo osteochondral differentiation (Johnson 
et al., 2006; Liebscher et al., 2011). The CEP transitions into bone through a layer of 
calcified cartilage. The CEP is permeable to small molecules and thus also plays a role 
in the viability and metabolism of cells within the IVD, as it facilitates the diffusion of 
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nutrients and oxygen between the subchondral vertebral bone and the internal 
structures of the IVD which are avascular, except for the outer AF. The mechanical 
properties of the CEP may be altered due to weakening or mineralisation of the 
cartilage, which can lead to fractures and cause NP tissue to be exuded into the bone 
(Wu, Morrison and Schweitzer, 2006). These phenomena are called Schmorl’s nodes. 
1.2.2 Annulus fibrosus 
 The AF can be divided into 2 regions; the outer and inner AF. The outer AF is 
composed of bundled collagen type I fibres that are orientated into long parallel 
lamellae. The collagen fibres within each lamella run in parallel at a 65° angle to the 
adjacent lamellae. The fibres of the outer AF are anchored to the vertebral bone 
(Figure 1.2). This structural formation provides the outer AF with the ability to resist 
tensile forces from bending and twisting of the spine. The inner AF serves as a 
transition zone between the highly ordered outer AF and the disorganised NP, and 
characteristics of both tissues are observed. Aggrecan is found in both AF regions, 
whereas decorin and biglycan are mainly found within the outer AF. The inner AF 
contains collagens types I and II whilst the outer AF contains mainly collagen type I. 
Elastin accounts for 2% of the dry weight of the entire AF and forms inter-lamellar 
bridges. There are also cellular differences between the AF regions; outer AF cells are 
fibroblast-like; elongated and fusiform, whereas inner AF cells are spherical in shape 
and resemble the morphology of NP cells and chondrocytes. The cell density of 
mature AF tissue is approximately 9 x 106 cells/cm3 (Roughley, 2004). The inner AF is 
also attached to the CEP, whilst the OAF is attached to vertebral bone.  
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Figure 1.2. Schematic of the organisation of concentric AF lamellae. The direction of 
collagen fibres alternates at a 65° angle between adjacent lamellae. Adapted from 
(Elliott and Setton, 2000). 
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1.2.3 Nucleus pulposus 
 The NP is composed of mainly water (70 – 80%), randomly arranged collagen 
type II fibres (Figure 1.3), radially arranged elastin and small amounts of collagen 
types VI, IX and XI; collagen type X has also been observed within the NP during IVD 
degeneration and is linked to calcification (Grant et al., 2016). These components are 
all embedded within a matrix rich in proteoglycans, which make up to 30 -50% of the 
dry weight of the tissue (Figure 1.3). The main proteoglycan matrix component is 
aggrecan which links to hyaluronan tethering it to the tissue (Figure 1.3); other 
proteoglycans such as versican, perlecan, lubricin and small leucine-rich repeat 
proteoglycans are also present within the NP(Inkinen et al., 1998; Roughley, 2004). 
Crosslinked collagen within the NP confers tensile strength, which is reduced during 
ageing and degeneration as crosslinks between collagen fibrils decreases (Antoniou 
et al., 1996). Proteoglycans and their negatively charged glycosaminoglycans (GAG) 
side chains, such as chondroitin sulphate and keratan sulphate, draw in water and 
cations via osmosis, meaning the NP exhibits high osmotic and hydrostatic pressure 
(Figure 1.3). This provides the NP with viscoelasticity and resistance to compression 
(Doege et al., 1991; Dolan and Adams, 2001). As the NP has no blood supply, the 
oxygen tension is very low, prompting NP cells to rely on the glycolytic pathway for 
energy metabolism (Agrawal et al., 2007).  
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Figure 1.3. NP matrix composition. (A) A disorganised network of collage II fibrils intertwines with proteoglycans to produce a matrix that exhibits high 
hydrostatic pressure and enables resistance to compression. (B) Aggrecan consists of chondroitin sulphate (CS) and keratan sulphate (KS) GAG 
sidechains attached to a protein core, which is linked to hyaluronan (HA), tethering it to the matrix. Adapted from Ulrich-Vinther et al., 2003. 
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The NP is derived from the notochord and during development the NP is 
highly cellular. During development and at birth the NP contains clusters of large cells 
with vacuolated (25 - 85µm) morphology, called notochordal cells (Figure 1.4). During 
aging the population of notochordal cells (and the total cell number in general) 
decreases and is replaced by smaller, spherical, non-vacuolated, chondrocyte-like 
cells (NP cells) (Figure 1.4). However, it has been shown that the proteoglycan to 
collagen ratio in the NP of healthy young adults (15 – 25 years) is much higher (27:1) 
when compared to articular cartilage (2:1), indicating phenotypic differences 
between NP cells and chondrocytes (Mwale, Roughley and Antoniou, 2004). In the 
mature NP, single cells encased within pericellular matrix lacunae are present, along 
with cell clusters that share a single lacuna (Johnson et al., 2006). The cell density is 
approximately 4 x 106 cells/cm3 (Roughley, 2004; Chen, Yan and Setton, 2006). 
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Figure 1.4. Cell types within the NP. (A) Clusters of large, vacuolated notochordal cells, similar to those present during human development, are present 
during in vitro culture 24hr after extraction from murine NP tissue, smaller chondrocyte-like cells are also present. (B) After ~10d in vitro culture, rat 
notochordal cells are completely replaced by/differentiate into smaller, non-vacuolated, mature NP cells, similar to those in the mature human. In vivo, 
the morphology of NC and NP cells is spherical. Scale bar 20µm. 
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It has been determined that during maturation notochordal cells undergo 
differentiation into the smaller chondrocyte-like NP cells found in the adult IVD (Choi, 
Cohn and Harfe, 2008; Minogue et al., 2010b, 2010a; McCann et al., 2012; Séguin et 
al., 2018). Yet, there is also evidence that potentially notochordal cells die and are 
replaced by cells migrating from adjacent tissues as the IVD matures (Kim et al., 2009; 
Yang et al., 2009; Séguin et al., 2018). Therefore, considerable work has been done 
to elucidate the NP phenotype and identify genetic markers to distinguish NP cells 
from AF cells and chondrocytes. Many markers have been proposed; genes involved 
during the development of the notochord such as sonic hedgehog (SHH) (Choi, Lee 
and Harfe, 2012) and brachyury (T) (Minogue et al., 2010b), proteins linked to the 
physiology of NP cells such as (HIF-1α) (Risbud et al., 2006), glucose transporter 1 
(GLUT-1) (Rajpurohit et al., 2002), carbonic anhydrase III and XII (CAIII (Silagi et al., 
2018)and CAXII) (van den Akker et al., 2014), and other proteins like the intermediate 
filaments cytokeratin 18 and 19 (Sakai et al., 2009; Rodrigues-Pinto et al., 2016) and 
cell surface marker cluster of differentiation 24 (CD24) (Rutges et al., 2010; 
Rodrigues-Pinto et al., 2016). A consensus paper, authored by many groups, was 
published that recommended using a panel of these markers to determine the NP 
phenotype (Risbud et al., 2015). However, since this publication other potential 
markers have been identified(Rodrigues-Pinto et al., 2016; Silagi et al., 2018), 
indicating that a true phenotypic marker differentiating NP cells remains to be 
discovered. Also, the panel of markers recommended by Risbud et al., 2015 was 
focussed on determining the young, healthy NP cell phenotype, yet Thorpe et al., 
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2016 identified different markers that distinguished mature, aging NP cells from AF 
cells and chondrocytes, indicating that factors such as NP maturity and the state of 
degeneration must also be considered when attempting to phenotypically 
characterise this elusive cell type. 
1.3 Development of the intervertebral disc 
The IVDs are derived from two embryonic structures called the notochord and 
the sclerotome (Peacock, 1951; Paavola, Wilson and Center, 1980). The central NP 
region is derived from the notochord (Peacock, 1951; Smits and Lefebvre, 2003) and 
the surrounding AF and CEP from the sclerotome (Peacock, 1951; Rodrigo et al., 
2003) (Figure 1.5). The notochord is a continuous rod-like structure positioned 
centrally, forming the axis of the embryo and is one of the defining structures of 
chordates (McCann and Séguin, 2016) (Figure 1.5). In mammals, an acellular sheath 
containing proteoglycans, collagens and laminins surrounds the notochord (Götz, 
Osmers and Herken, 1995). During embryonic development the notochord acts as a 
primitive support system and signalling centre, directing the development and 
differentiation of surrounding tissues and structures, including the neural tube 
(Yamada et al., 1991) and sclerotome (Fan and Tessier-Lavigne, 1994), by secreting 
growth factors and morphogens (Christ, Huang and Scaal, 2004; Nimmagadda et al., 
2007; Christ and Scaal, 2008) (Figure 1.6).  
 The sclerotome is derived from the somites, transient structures adjacent to 
the notochord and neural tube during vertebrate development (Wilting et al., 1994). 
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In response to Wnt signalling from the notochord and neural tube floor plate, and 
SHH signalling from the ectoderm, the somites undergo compartmentalisation 
(Christ and Scaal, 2008; McCann and Séguin, 2016). The development of the 
sclerotome is characterised by the formation of the ventral, lateral and dorsal sub-
compartments from the somites (Monsoro-Burq et al., 1994; Peters et al., 1999). The 
dorsal sub-compartment differentiates and forms the dermomyotome, which 
generates the connective tissues of the axial skeleton (Capdevila, Tabin and Johnson, 
1998). The ventral sub-compartment differentiates into the sclerotome, consisting of 
PAX-1-expressing cells, and produces the vertebral bodies, AF and CEP of IVDs (Peters 
et al., 1999). In addition, each sclerotomal segment demonstrates rostral to caudal 
polarity; anterior vertebral structures are formed from the caudal sclerotome, 
whereas posterior vertebral structures are formed from the rostral sclerotome 
(Christ and Scaal, 2008). 
 As the vertebrae, AF and CEP form, the notochord contracts from the 
vertebral bodies, notochordal cells are expelled from vertebral regions and are 
limited to the centre of the forming IVD, which then expand to produce NP regions 
(Alkhatib et al., 2018). The notochordal sheath contains and directs the retreating 
notochord and its internal hydrostatic pressure, which is essential for notochordal 
expansion and the subsequent formation of the NP (Adams, Keller and Koehl, 1990; 
Alkhatib et al., 2018). 
 In humans, the number of notochordal cells within the notochord and 
subsequent NP starts to decline during maturation, even during embryonic 
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development (Peacock, 1951). The amount of notochordal cells continues to decline 
until they are virtually absent within the NP after the first decade of life (Risbud, 
Schaer and Shapiro, 2010). However, it has been observed in other species, such as 
rats and mice, that notochordal cells are still present beyond the point of skeletal 
maturity (Hunter, Matyas and Duncan, 2003a, 2004a). Curiously, chondrodystrophic 
(CD) dogs (long bodies, short legs) lose notochordal cell populations very early in life 
and suffer frequent, early-onset IVD degeneration, whereas non-chondrodystrophic 
(NCD) dogs (bodies and limbs in proportion) retain notochordal cell populations into 
adulthood and suffer infrequent, later-onset IVD degeneration (Bergknut et al., 2013; 
Smolders et al., 2013). This has led to canine studies determining a link between the 
decline of notochordal cells and IVD degeneration (Hunter, Matyas and Duncan, 
2003, 2004). The exact underlying mechanisms responsible for the differentiation of 
notochordal cells into mature NP cells has not yet been elucidated, yet progressive 
alterations to the mechanical loading of the IVD (and the changes to the 
microenvironment thereafter) during development and growth are likely to influence 
the phenotype of notochordal and NP cells (Navaro et al., 2015; Palacio-Mancheno 
et al., 2018). It has also been shown that notochordal cells require very specific 
culture conditions to retain their phenotype in vitro (Spillekom et al., 2014). 
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Figure 1.5. IVD development. (A.i) During embryonic development, the notochord 
directs the differentiation and segmentation of the sclerotome. (A.ii) At birth, the 
notochord forms the NP, whilst the sclerotome differentiates into the surrounding 
AF, CEP and vertebral bodies. (B) Haematoxylin and eosin staining (black and white) 
of the developing human spine. (B.i) Coronal section of a human 10mm (~7 weeks) 
embryo showing the intact notochord spanning the sclerotome, x415 magnification. 
(B.ii) Sagittal section of a 21mm (~10 weeks) human embryo showing the notochord 
contract towards the future NP and the segmentation of the sclerotome into the AF 
and vertebral bodies, x60 magnification. (B.iii) Sagittal section of a full-term human 
foetus (~40 weeks) showing the completely formed IVD; the concentric lamellae of 
the AF encapsulate the NP, which now contains fewer notochordal cells and 
‘abundant mucoid substance’, x50 magnification. Adapted from (Peacock, 1951). 
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Figure 1.6. Transcriptional regulation of IVD development. The fate of cells during 
IVD development is governed by many transcription factors (green and red), secreted 
proteins and environmental factors (blue). Differentiation of early notochordal cells 
is mediated by T; Sox5, 6 and Jun are required for notochordal cell survival. SHH and 
Noggin are secreted by notochordal cells, and along with downstream signalling by 
Bapx1, PAX1, 9 and Sox9, induce the differentiation of sclerotome cells into pre-
chondrocytes. Sox5 and 6 promote expression of matrix genes that form the 
notochordal sheath and cartilage. Mechanical pressure forces the relocation of 
notochordal cells into the centre of the IVD. Sox5 and 6 promote NP cell 
differentiation whilst also preventing the differentiation of chondroblasts into 
hypertrophic chondrocytes. Runx2 may promote hypertrophic chondrocyte 
maturation in vertebrae. Adapted from (Smits and Lefebvre, 2003). 
1.4 The microenvironment of the intervertebral disc 
 Due to the unique development and positioning of the IVD within the human 
body, many environmental factors contribute to the physiology of the tissue and 
influence cellular behaviour. 
1.4.1 Biomechanics 
 The function of the IVD is to enable movement and withstand the 
compressive forces of the spine; hence the IVD has a loaded environment subjected 
to a number of physical stresses. The biomechanics of the IVD is determined by 
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interactions of loading patterns between all the structures of the IVD. The IVD can 
withstand axial compression, torsion, flexion/extension, lateral bending and disperse 
mechanical energy evenly throughout the spine (Setton and Chen, 2004).  
 Due to the high level of hydration and gelatinous consistency the NP is 
considered a viscoelastic material, demonstrating both fluid and solid-like behaviours 
(Iatridis et al., 1999). Internal stresses and strains exist within the NP, even in the 
unloaded IVD, which arise from the water content resulting in a high hydrostatic 
pressure with a baseline of 0.1 – 0.2MPa when supine, approximately 0.5MPa when 
standing and increasing up to 3 – 4MPa during extreme physical activity (Wilke et al., 
1999). Due to the variation of physical activity and posture during day and night the 
NP undergoes a diurnal change in intradiscal pressure (Chan et al., 2011). Under 
increased load, during load-bearing and vertical posture, the IVD deforms which 
causes an increase in hydrostatic pressure and fluid is slowly expelled from the NP 
(Chan et al., 2011). When in the supine position, the reduced load causes a release 
in intradiscal pressure and fluid is re-imbibed into the NP (McMillan, Garbutt and 
Adams, 1996; Malko, Hutton and Fajman, 2002). During compression the increase in 
NP pressure is constrained by the lamellae of the AF which produces longitudinal and 
circumferential AF tension (Galante, 1967). Therefore, the predominant mechanical 
stimuli acting on AF cells are tensile strain and shear (Galante, 1967). Whereas the 
predominant mechanical stimuli acting on NP cells are compressive and shear 
stresses, alongside hydrostatic pressure due to the water content and swelling 
properties of the NP (Setton and Chen, 2006). 
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 As IVD cells are exposed to mechanical stimuli, it has been determined that 
the type, magnitude, frequency and duration of applied loading are crucial in 
determining cellular responses (Maclean et al., 2004; Wang, Jiang and Dai, 2007; 
Wuertz et al., 2009; Walter et al., 2011). IVD cells respond to mechanical stimuli by 
activating mechanotransduction signalling pathways. The loss of aggrecan expression 
by NP cells due to a decrease in hydrostatic pressure was inhibited by pre-treatment 
with RGD blocking peptides (Le Maitre et al., 2009). However, this was only observed 
in NP cells derived from healthy IVD tissue, not NP cells derived from degenerate IVD 
tissue (Le Maitre et al., 2009). This suggests not only that NP cells respond to pressure 
via RGD domains and integrin signalling, but also that mechanotransduction 
pathways are altered during IVD degeneration (Le Maitre et al., 2009). Healthy 
physiological loading, such as dynamic low pressure loads (0.1 – 1.0MPa), induces 
matrix synthesis and is essential for matrix production and IVD homeostasis (Wuertz 
et al., 2007; Neidlinger-Wilke et al., 2012). In contrast, overloading (1 – 4MPa) has 
been demonstrated to evoke degenerative changes, increasing catabolic gene 
expression, leading to the destruction of matrix (Iatridis et al., 1999; Korecki, 
MacLean and Iatridis, 2008). Thus, indicating that the IVD has adapted to its function 
of withstanding the compressive forces of the spine and that IVD cell biology is finely 
tuned by the biomechanical forces exerted upon them. 
1.4.2 Osmolality 
 The extracellular matrix (ECM) of the IVD enables its mechanical function. 
Proteoglycans and their negatively charged side chains draw water and ions into the 
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NP, increasing the hydrostatic pressure, so the IVD can withstand compression (Chan 
et al., 2011). These actions simultaneously increase the fixed charge density and 
osmotic pressure within the NP, increasing the intradiscal osmolality when compared 
to most other tissues (400 – 500mOsm/kg H2O) (Urban and McMullin, 1985; 
McMillan, Garbutt and Adams, 1996). Similar to responses to mechanical loading, 
culturing NP cells in physiological conditions mimicking the osmolality of the healthy 
IVD increases the expression of matrix genes (Wuertz et al., 2007; Neidlinger-Wilke 
et al., 2012; O’Connell, Newman and Carapezza, 2014) via osmotically regulated 
signalling pathways (Tsai et al., 2006; Hiyama et al., 2009; Johnson, Shapiro and 
Risbud, 2014b). However, these signalling pathways may become altered when the 
osmolality decreases, mimicking the degenerate IVD (~300mOsm/kg H2O) when 
proteoglycan content decreased (Ishihara et al., 1997). Which may lead to the 
production of catabolic genes in preference over matrix genes (Johnson, Shapiro and 
Risbud, 2014b; Johnson et al., 2017), indicating that NP function is controlled by the 
osmotic environment bestowed upon the IVD by proteoglycans and mechanical 
loading. There are numerous signalling pathways, transcription factors and 
transmembrane channel proteins expressed in NP cells that are implicated in their 
adaptation to the hyperosmotic environment of the IVD, yet how NP cells sense and 
respond to this stimulus has not been fully elucidated (Johnson, Shapiro and Risbud, 
2014b; Sadowska et al., 2018). 
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1.4.3 Nutrition, pH and oxygen tension  
 The IVD is the largest avascular tissue in the human body (Urban, 2002). In 
healthy IVDs, blood vessels only penetrate into the periphery of the outer AF and NP 
cells are 6 – 8mm away from the nearest blood supply. Therefore, the transport of 
nutrients and waste products occurs via diffusion (Urban, 2002). Small amounts of 
diffusion take place via the blood vessels at the AF periphery, but the majority of 
transport occurs from blood vessels within the vertebral bodies and across the CEP 
(Roberts et al., 1996). 
  Nutrient transport through the IVD occurs almost exclusively by diffusion 
facilitated by load-induced water transport. This results in steep concentration 
gradients of glucose, oxygen and lactic acid across the IVD (Roberts et al., 1996; 
Urban, 2002; Bibby et al., 2005). As the concentration of glucose and oxygen 
progressively decreases towards the centre of the IVD, the concentration of lactic 
acid increases (Ohshima and Urban, 1992). Therefore, the NP has a slightly acidic pH 
(pH6.9 – 7.2) and low oxygen microenvironment (8 – 10% at the IVD-vertebral 
interface decreasing to 0.3 – 0.5% in the NP) that cells are required to adapt to (Holm 
et al., 1981; Urban, 2002). Oxygen concentration has been observed at 0.7% in 
degenerate human IVDs (Bartels et al., 1998). Consequently, NP cells favour glycolytic 
metabolism (causing the increase of lactic acid) due to the lack of oxygen (Agrawal et 
al., 2007) and have adapted to their acidic surroundings (Urban, 2002; Silagi et al., 
2018a; Silagi et al., 2018b). Such adaptation is mediated by hypoxia-inducible factor-
1α (HIF-1α), which has been shown to support the survival and function of NP cells 
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by driving glycolytic metabolism and ECM production, enabling adaptation to their 
hypoxic niche (Pfander et al., 2003; Risbud et al., 2006; Richardson et al., 2008; Fujita 
et al., 2012; Silagi et al., 2018). 
 The nutrient supply into the IVD can be reduced by a number of factors such 
as CEP calcification (Roberts et al., 1996), decreased blood flow to segmental arteries 
(Kauppila, 1997) or a decrease in the water content of the IVD (Horner and Urban, 
2001). The decrease in nutrient supply has been linked to IVD degeneration due to 
an increase in cell death, caused by decreases in glucose concentration (< 0.5mmol/L) 
and pH (< 6.5) (Horner and Urban, 2001), and the production of catabolic enzymes 
that mediate the destruction of ECM (Urban and Roberts, 2003). However, it may 
also be possible that the nutrient supply can be increased during IVD degeneration, 
due to a possible increase in vascularisation (which may also cause pain due to 
associated nerve ingrowth) ( Freemont et al., 2002; Binch et al., 2014) and the 
presence of fissures, allowing rapid nutrient diffusion (Melrose et al., 2002; 
Stefanakis et al., 2012; Binch et al., 2015). 
1.5 Degeneration of the intervertebral disc 
 Approximately 80% of the population will suffer from low back pain (LBP) 
during their lifetime (Hoy et al., 2015), resulting in a global economic burden (UK 
~£12 billion, US ~$85 billion) (Maniadakis and Gray, 2000; Martin et al., 2008) 2008. 
Recently LBP was found to be one of the 5 top causes of disability worldwide (Vos et 
al., 2017; James et al., 2018). LBP is multifactorial, yet 40% of cases are attributed to 
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IVD degeneration (Luoma et al., 2000). The aetiology of IVD degeneration itself is also 
multifactorial; aging (Gruber and Hanley, 1998), smoking (Battié et al., 1991), genetic 
factors (Matsui et al., 1998), decreased nutrient uptake and waste removal (Horner 
and Urban, 2001; Bibby et al., 2005) and repetitive mechanical loading greater than 
tolerable limits (Adams et al., 2000). IVD degeneration is characterised by progressive 
destruction of the ECM caused by altered cell metabolism and function, matrix 
synthesis and degradation of matrix components (Le Maitre et al., 2007). 
1.5.1 Cytokines 
 IVD cells produce a plethora of cytokines and chemokines (Le Maitre, 
Freemont and Hoyland, 2005; Hoyland, Le Maitre and Freemont, 2008; Phillips et al., 
2013, 2015), interleukin - 1β (IL-1β) and tumour necrosis factor – α (TNF-α) are the 
most studied and are clearly implicated in the pathogenesis of IVD degeneration. IL-
1β, IL-1 receptor I (IL-1RI) and IL-1 receptor antagonist (IL-1Ra) are all expressed in 
healthy IVD cells, but the expression of IL-1β and IL-1RI (not IL-1Ra) is increased with 
increasing severity of degeneration (Le Maitre, Freemont and Hoyland, 2005)and has 
been shown to induce many catabolic events (Le Maitre, Freemont and Hoyland, 
2005; Hoyland, Le Maitre and Freemont, 2008). TNF-α expression is also increased 
during IVD degeneration, but not to as high a level as IL-1β (Le Maitre, Hoyland and 
Freemont, 2007a). Also, as TNF receptor I (TNF-RI) was not increased in degenerate 
IVDs and TNF-α inhibition has no effect on matrix degradation, whereas IL-1β 
inhibition completely abrogated matrix degradation, this may highlight the 
prominent role of IL-1β, over TNF-α, during IVD degeneration (Hoyland, Le Maitre 
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and Freemont, 2008). The importance of IL-1β during degeneration has been 
strengthened by the observation of spontaneous IVD degeneration in a knockout 
mouse model of IL-1Ra, the natural inhibitor of IL-1β (Phillips et al., 2013), and the 
presence of polymorphisms in the IL-1 gene cluster linked to an increased risk of IVD 
degeneration (Solovieva et al., 2004, 2006; Karppinen et al., 2009). Conversely, an 
increase in both TNF-α receptors (TNF-RI and TNF-RII) expression has been identified 
in herniated IVD tissue and showed a positive correlation with pain levels assessed 
by the visual analogue scale (Andrade et al., 2011), indicating TNF-α also plays an 
important role during IVD degeneration and possibly in the manifestation of pain. 
Recently the overexpression of TNF-α in a transgenic mouse model showed the early 
onset of IVD herniation, yet no overt signs of degeneration (Gorth, Shapiro and 
Risbud, 2019), which supports that TNF-α is involved in IVD degeneration, but less so 
than the pivotal role played by IL-1β. These changes in cellular behaviour initiate IVD 
degeneration by leading to the increased production of more cytokines, 
vascularisation and innervation causing pain, and the increased expression of matrix 
degrading enzymes. 
1.5.2 Degeneration of extracellular matrix 
   As IVD degeneration advances, collagen type II within the NP is gradually 
replaced by the more fibrous collagen type I (Roughley, 2004). The overall 
composition of proteoglycans is reduced and altered with decreased aggrecan 
expression and versican, decorin and biglycan expression is increased, thus reducing 
the capacity of the NP to imbibe water, resulting in decreased hydration and loss of 
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IVD height (Inkinen et al., 1998; Cs-Szabo et al., 2002). Concurrently, the increased 
cytokine production by IVD cells upregulate a variety of catabolic mediators including 
matrix metalloproteinases (MMP) -1, -2, -3, -13 and -14, and a disintegrin and 
metalloproteinase with thrombospondin motifs (ADAMTS) -1, -4 and -5 (Séguin et al., 
2006; Le Maitre et al., 2007; Pockert et al., 2009; Wang et al., 2011; Tian et al., 2013). 
MMPs and ADAMTSs are important mediators of matrix remodelling during healthy 
physiology, but their overexpression during degeneration (Roberts et al., 2001; Le 
Maitre, Freemont and Hoyland, 2004; Pockert et al., 2009) brings about the 
destruction of collagen and proteoglycans within the NP, which is exacerbated by the 
suppression of important matrix genes during these processes (Wang et al., 2011; 
Tian et al., 2013; Johnson et al., 2017). The resulting compositional changes during 
degeneration cause alterations to the IVD microenvironment, such as decreased 
nutrition, pH and osmolality and excessive biomechanical loading (Section 1.4) 
(Figure 1.7). This consequently leads to adverse cellular changes, including 
apoptosis/necrosis (Gruber and Hanley, 1998; Ding, Shao and Xiong, 2013), 
senescence (Roberts et al., 2006; Gruber et al., 2007; Le Maitre, Freemont and 
Hoyland, 2007) and a decrease in the viability and number of remaining cells (Le 
Maitre, Freemont and Hoyland, 2007). As the IVD has developed a hostile 
microenvironment during degeneration, those cells still present are also more likely 
to develop a catabolic phenotype, continuing the degenerative cascade. 
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Figure 1.7. Microenvironmental factors within the IVD that dictate cellular function and how these factors are altered during degeneration. 
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1.5.3 Consequences of intervertebral disc degeneration 
 The imbalance between normal matrix synthesis and degradation results in a 
loss of the structural integrity of the NP due to a reduction in hydration, osmotic 
swelling pressure and IVD height (Urban and McMullin, 1988). These changes result 
in a diminished ability of the IVD to withstand and evenly distribute the compressive 
loading of the spine. This may ultimately lead to IVD injuries such as the formation of 
tears and fissures through the AF, due to the asymmetric distribution of compressive 
loading, and the eventual herniation and extrusion of the NP through such tears 
(Adams and Roughley, 2006) (Figure 1.8).  IVD herniation may also be associated with 
the sensation of chronic pain as extruded NP material may impinge on spinal nerves 
(Risbud and Shapiro, 2014) (Figure 1.8), which may also act as an access route for the 
vascularisation and innervation of the IVD (Binch et al., 2014). 
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Figure 1.8. IVD herniation. (A) Schematic showing NP herniation through the AF and impingement on a spinal nerve. (B) A T2-weighted MRI image 
showing posterior L5-S1 IVD herniation (red arrow) in a patient with symptomatic IVD degeneration. Adapted from Risbud and Shapiro, 2014. 
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1.5.4 Current treatment 
 Most current practices for the treatment of LBP are directed towards alleviating 
and managing symptoms, including analgesic medication, physiotherapy, acupuncture 
and chiropractic treatment (Chou et al., 2009). However, as these practices only be able 
to treat symptoms such as pain, they may only be successful in the short term (Carette 
et al., 1997). Other options for patient treatment include surgical procedures to stabilise 
or remove damaged tissue. Microdiscectomy, the removal of herniated NP tissue, and 
spinal fusion, the removal of the degenerated IVD and vertebral fusion, can be offered 
to patients when conservative methods have been unsuccessful (Andrews and Lavyne, 
1990). However, these treatments have been associated with alterations in spinal 
biomechanics and the potential degeneration of adjacent IVDs (Lund and Oxland, 2011). 
It has also been reported that approximately 23% of patients receiving microdiscectomy 
required repeat operations, due to recurrent IVD herniation (Parker et al., 2015).  
 Emerging research has aimed to develop a biological approach to address the 
underlying pathophysiology of IVD degeneration. The use of growth factors and/or 
inhibitors has been investigated in attempts to promote anabolic processes, such as 
matrix synthesis, whilst also inhibiting catabolic processes, such as matrix degradation 
and inflammation (Tim Yoon et al., 2003; Christine L Le Maitre, Hoyland and Freemont, 
2007; Le Maitre, Freemont and Hoyland, 2009; Cao et al., 2012; Gorth et al., 2012; Feng 
et al., 2017; Li et al., 2017; Mern et al., 2017). However, so far, the use of such 
modulating compounds/proteins has failed to substantially treat dysfunctional NP cells 
which continue to display a catabolic phenotype (Roberts et al., 2006; Le Maitre, 
Hoyland and Freemont, 2007; Gruber et al., 2007; Le Maitre, Freemont and Hoyland, 
2007). 
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 Therefore, further research has focussed on the use of regenerative cell sources, 
such as mesenchymal stem cells (MSCs), together with biomaterial scaffolds. With the 
aim of simultaneously repopulating the NP whilst also providing a microenvironment for 
the preferential differentiation into cells that regenerate the correct matrix and inhibit 
the degenerative cascade (Le Maitre et al., 2015). To enable such treatments to become 
successful it is essential that the physiology of the IVD is understood with respect to the 
development and adaptation of NP cells to their multifaceted microenvironment 
(Thorpe et al., 2018). The elucidation of these adaptations may be essential in 
determining how healthy NP cells function and how dysregulation may cause or occur 
during IVD degeneration. Thus, identifying vital physiological traits that must be 
protected and restored to ensure potential future treatments not only work but are 
performed on patients that will benefit from them. 
1.6 Aquaporins 
The movement of water throughout cells and tissues is essential for the 
maintenance of homeostasis in all organisms. In mammals, water can pass freely in and 
out of cells by diffusion through the plasma membrane as individual molecules, or 
passively co-transported with other ions and solutes such as Na+ and glucose (Loo et al., 
1996). However, these modes of water transport cannot account for the rapid and highly 
selective water movement that has been shown to regulate many processes such as 
determining urine concentration in the kidneys (Marples et al., 1995), the secretion of 
saliva (Krane et al., 2001b) and the formation of a fluid-filled cavity alongside oocytes 
during folliculogenesis (McConnell et al., 2002). 
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It was almost fifty years ago when the existence of water channels was 
hypothesised due to the drastic decrease in water permeability observed in cells when 
incubated with mercurial sulfhydryl reagents (Macey and Farmer, 1970). This hypothesis 
was confirmed with the discovery of the first aquaporin (AQP), AQP1, in erythrocytes 
and renal tubules (Denker et al., 1988) and their characterisation as a selective water 
channel within cell membranes (Zeidel et al., 1992; Agre et al., 1993). Since their 
discovery, 13 members of the mammalian AQP family of membrane channel proteins 
have been identified (AQP0-12), which are expressed and have a variety of functions in 
a plethora of different tissues (Day et al., 2014).  
1.6.1 Structure 
Despite the diverse expression and roles of AQPs throughout different tissues 
they contain a highly conserved structure relating to their specific function to transport 
water across cell membranes. Functional AQPs exist as ~28kDa homotetramers, with 
each monomer consisting of six α-helical transmembrane domains (1-6) linked through 
five alternating extracellular and intracellular loops (A-E), with both the C-terminus and 
N-terminus located on the cytosolic side of the cell membrane (Figure 1.9).  
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Figure 1.9. The structure of a single AQP channel monomer. The six transmembrane 
domains (1-6) form two tandem repeats and are attached by five loop regions (A-E). The 
transmembrane domains fold to form a central pore. Loops B and E fold inwards and 
line the pore opening. This produces the hourglass model of AQP monomer folding. 
Adapted from Spring, Robichaux and Hamlin, 2009. 
 
Each monomer folds to form individual water-transporting pores, therefore each 
functional AQP homotetramer contains four pores and not one single, central pore 
(Figure 1.10). This structural information was first determined through electron-
diffraction studies on AQP1 in erythrocytes (Murata et al., 2000), followed by more high-
resolution imagery determining similar structures for other human AQPs (Horsefield et 
al., 2008; Ho et al., 2009).  
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Figure 1.10. The structure of the AQP homotetramer. (A) AQP channels consist of four 
transmembrane monomers folded to produce one water-transporting pore each. Water 
(blue spheres) is transported across an osmotic gradient (arrows) adapted from Ozu et 
al., 2018. (B.i) Side-view of the x-ray crystal structure of human AQP5 monomer. The 
half-helices B and E form the central pore (yellow) that permeates water (red spheres) 
in a single-file. (B.ii) Top-view of AQP tetrameric assembly, with each monomer forming 
a water-transporting pore. Adapted from Nesverova and Törnroth-Horsefield, 2019. 
 
AQPs are highly specific in their roles as water channels as the structure of the 
pore itself determines the type of molecule that can pass through cell membranes via 
these channels. The majority of human AQPs (0, 1, 2, 4, 5 and 8) are selective for water 
molecules only, due to two selection stages within the pore. The first is due to the folding 
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of intracellular loop B and extracellular loop E into the pore, forming two half-helical 
regions, which both contain a conserved amino acid sequence of Asparagine-Proline-
Alanine (NPA) (Sui et al., 2001). Since α-helices have a natural dipole, both half-helices 
focus their positive dipole towards the centre of the channel which creates an 
electrostatic barrier to protons and cations whilst also aligning the dipole of water 
molecules as they pass the NPA signature motifs, when entering the AQP pore (de Groot 
and Grubmüller, 2005) (Figure 1.11).  
The second stage of selectivity is due to a constriction region located on the 
extracellular side of the AQP pore, which contains another conserved amino acid motif. 
The aromatic/Arginine (ar/R) motif facilitates selectivity by re-positioning water 
molecules for their entry into the AQP pore and also contributes to the exclusion of 
protons (Wu et al., 2009) (Figure 1.11). The remaining AQPs (3, 6, 7, 9, 10, 11 and 12) 
have the ability to transport other molecules as well as water (Section 1.6.2). 
 
 
Figure 1.11. Structure of the AQP monomer indicating The NPA and ar/R selectivity 
motifs. (A) Overall structure of an AQP monomer. (B) Detail of the conserved NPA and 
ar/R motifs that confer the selective passage of water molecules (red spheres) through 
the pore. Structures have been drawn from the x-ray structure of human AQP5. Adapted 
from Törnroth-Horsefield et al., 2010.   
55 
 
1.6.2 Function 
The AQP family of membrane channel proteins have been identified to be highly 
selective in their transport of water across cell membranes; however, some are known 
to have the ability of transporting other small molecules in addition to water. AQP6 has 
been shown to be potentially permeable to ionic molecules as well as being highly 
permeable to water (Beitz et al., 2006). Unlike other AQPs that are mainly located within 
the plasma membrane, AQP6 is localised to intracellular membranes in acid-secreting, 
intercalated cells of kidney collecting ducts. This exclusive localisation of AQP6 and its 
potential to transport ionic molecules suggests a role in renal acid-base regulation. 
AQPs 3, 7, 9 and 10 have also been shown to transport other small molecules 
such as glycerol, urea and ammonia (Litman, Søgaard and Zeuthen, 2009). The so-called 
"aquaglyceroporins" additional function may be due to structural changes in the ar/R 
selectivity filter lining the water-transporting pore. When the diameter of the AQP pore 
at the ar/R restriction site is 2.8 Å in diameter this will only allow the passage of water 
molecules, whereas when point mutations were introduced at both the aromatic and 
arginine residues (F56A and R195V, respectively) the diameter of the pore was increased 
to >3.4 Å. This increase led to the conductance of not only water but also other small 
molecules such as glycerol in AQP1 (Beitz, Wu, et al., 2006; Hub and de Groot, 2008). 
Changes to the NPA motif have also been determined in other AQPs that have 
different functions other than as a selective water transport. The structure of this 
conserved motif in the "unorthodox" AQPs (11 and 12) has been demonstrated to be 
altered which may explain their as of yet, unknown role. Tchekneva et al., 2008 
highlighted that by substituting a single amino acid within the E-loop NPA box (C227S) 
in mice gave rise to a phenotype that resembled AQP11 knockout mice, thus suggesting 
a vital role for C227 in the function of the NPA motif in AQP11. AQP structure is related 
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to their function as selective water channels as highly conserved amino acid sequences 
within the AQP family allow for such a high specificity for the movement of water 
molecules through plasma membranes. Changes in these amino acid sequences have 
led to a number of these channels acquiring altered functions such as the ability to 
transport a number of different small molecules in addition to water.  
1.6.3 Expression and physiological roles 
Due to the unique and vital molecular function of AQP channels, they contribute 
to many physiological processes and are expressed almost ubiquitously throughout the 
human body (Figure 1.12). The expression of specific AQP isoforms within specific 
tissues also alludes to their potential roles. AQPs have been shown to regulate many 
processes such as cell volume regulation (Kitchen et al., 2015); cell structure and 
adhesion (Varadaraj and Kumari, 2018); cell migration and proliferation (Papadopoulos, 
Saadoun and Verkman, 2008); water homeostasis in the kidney (Hasler et al., 2008); 
blood-brain barrier function (Clément, Rodriguez-Grande and Badaut, 2018); lens 
function (Schey et al., 2017); fluid secretion (Ramli et al., 2019); sperm motility 
(Laforenza et al., 2016; Fujii et al., 2018); and glycerol metabolism (Méndez-Giménez et 
al., 2018). As such, alteration to AQP expression and function has also been implicated 
in the pathophysiology of many disorders, including: renal water imbalance 
(Kortenoeven and Fenton, 2014); brain oedema (Clément, Rodriguez-Grande and 
Badaut, 2018); cataract formation (Biswas et al., 2014); infertility (Kasimanickam et al., 
2017); and cancer metastasis (Marlar et al., 2017) are all, in-part, due to the 
dysregulation of AQP expression and function. This indicates that aside from passive 
water transport, AQPs play active roles during the adaptation of many important 
physiological processes. Their function, however, relies on their integration into the 
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plasma membrane of cells in which their expression is not ubiquitous; the localisation of 
AQPs within cells is tightly regulated by a number of mechanisms. 
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Figure 1.12. AQP expression in humans. The main AQP isoforms expressed in different 
tissues is indicated. (a) Retina, (b) Olfactory epithelium (c) The inner ear, (d) Brain, (e) 
Spinal cord, IVD, Osteoclasts, (f) Blood vessels, (g) Heart (h) Kidney (nephron in detail), 
(i) Salivary glands, (j) Gastrointestinal tract, (k) Liver, (l) Pancreas, (m) Lungs, (n) Fat 
(adipocytes), skin, (o) Female reproductive system, (p) Male reproductive system. 
Adapted from (Day et al., 2014). 
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1.6.4 Aquaporin gating and channel inhibition 
Gating mechanisms in AQPs have long been debated to regulate their function 
by changing structure of the pore to allow or halt the flow of water through cells. It is 
well documented that plant AQPs contain gating mechanisms that respond to a number 
of different stimuli including phosphorylation (Johansson et al., 1998; Nyblom et al., 
2009), pH (Tournaire-Roux et al., 2003), and divalent cations and protons (Verdoucq, 
Grondin and Maurel, 2008). Yeast AQP gating has also been documented using x-ray 
crystal structures determining the involvement of AQP N-termini (Fischer et al., 2009).  
Potential gating for mammalian AQPs still remains an elusive topic and is not a 
widely-accepted regulatory mechanism (Wang and Tajkhorshid, 2007). However, 
studies into mammalian AQP gating by Reichow et al., 2013 and Janosi and Ceccarelli, 
2013 have identified novel gating mechanisms in mammalian AQP0 and human AQP5 
respectively, potentially indicating a more substantial role for gating mechanisms in 
mammalian AQPs (Figure 1.13). There is also evidence that phosphorylation in response 
to many microenvironmental factors may also contribute to AQP gating (Nesverova and 
Törnroth-Horsefield, 2019) and recently mechanical stimuli has proposed as a potential 
gating mechanism (Hill and Shachar-Hill, 2015; Ozu et al., 2018) (Figure 1.13). 
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Figure 1.13. Comparison of the gating mechanisms in eukaryotic AQPs. (A) Plant 
SoPIP2;1 (green), sheep AQP0 (purple), human AQP4 (red) and yeast Aqy1 (orange). 
Structures show the pore of each AQP monomer with regulatory amino acid residues 
highlighted. All AQPs share the ar/R selectivity filter at the extracellular side of the pore. 
At the cytosolic side of the pore, residues are displayed that contribute to gating; plant 
and yeast mechanisms are well established and recently discovered in sheep. Adapted 
from Törnroth-Horsefield et al., 2010. (B) Membrane stretch as a gating mechanism of 
AQP function. During osmotic stress, rapid water flux causes changes in cell volume and 
membrane tension (horizontal arrows). It is proposed that AQP structure may become 
distorted, halting water transport (vertical arrows), thereby controlling the osmotic 
response of cells. Adapted from Ozu et al., 2018. 
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AQPs are also described as mercury-sensitive water channels due to the ability 
of mercury-containing compounds, such as HgCl2, to inhibit water flow. Mercury 
containing compounds regulate the function of AQPs by binding to amino acid residues 
and occlude the pore. The specific residue is C183 which contains two mercury binding 
sites (Savage and Stroud, 2007). Such compounds could potentially be useful drugs to 
regulate AQPs in disease if it was not for the highly toxic mercury content.  
1.6.5 G-Protein Coupled Receptors and Protein Kinases 
One of the most well-established mechanisms of AQP regulation is the effect of 
vasopressin on the G-protein coupled receptor (GPCR) Vasopressin receptor 2 (V2R), to 
increase AQP2 expression and trafficking in the collecting ducts of the kidney. Upon 
vasopressin binding, the seven-transmembrane domain GPCR initiates adenylate 
cyclase through active Gs-protein (Roos et al., 2012). This results in increased levels of 
intracellular cyclic adenosine monophosphate (cAMP) which in turn activates protein 
kinase A (PKA). PKA is a serine/threonine kinase that increases expression and trafficking 
of AQP2. 
AQP2 expression is also increased as PKA phosphorylates and activates the 
nuclear import and binding of cAMP responsive element-binding protein (CREB) to the 
cAMP responsive binding element (CRE) transcription factor (Moeller and Fenton, 2012). 
CRE resides upstream and is responsible for the up-regulation of many genes, including 
AQP2. 
PKA also has a more direct action in the regulation of AQP2 as phosphorylation 
of specific amino acid residues, C256, causes AQP2 trafficking to the plasma membrane; 
first investigated using site-directed mutagenesis of putative phosphorylation residues 
by Kuwahara et al., 1995. 
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PKA is not the only serine/threonine kinase to play a role in AQP trafficking. The 
lipid-activated and C2 calcium binding domain containing kinase, protein kinase C (PKC), 
also activates AQP phosphorylation and trafficking (Conner et al., 2012). 
Serine/threonine kinase phosphorylation of AQPs is a required action for movement; 
whether this corresponds to trafficking to the plasma membrane or internalisation into 
the cytoplasm. A number of different phosphorylation sites for many human AQPs have 
been determined (Figure 1.14). 
 
Figure 1.14. The phosphorylation sites of AQPs. NPA motifs on B and E-loops are shown 
that orientate and specifically allow the passage of water molecules (grey and white 
spheres) through the channel. The positions of serine/threonine kinase phosphorylation 
sites for individual AQPs are shown as symbols above. Adapted from (Conner, Bill and 
Conner, 2013). 
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1.6.6 Calcium 
Calcium plays a role in numerous cell signalling pathways, including AQP 
regulation. Along with AQP phosphorylation by protein kinases, Ca2+ interactions with 
AQPs is essential for their trafficking (Conner et al., 2012). Ca2+ ions interact via the 
calcium binding protein calmodulin (Yáñez, Gil-Longo and Campos-Toimil, 2012). The 
structure of calmodulin is comprised of four identical helix-loop-helix 'EF-hand' groups. 
Each EF-hand structure contains the binding site for a single Ca2+ ion (Grabarek, 2005). 
AQPs have been identified to share sequence homology with calmodulin (Fotiadis et al., 
2002) and calmodulin binding sites have been identified within the structure of AQP6 
(Rabaud et al., 2009). Ca2+ ions enter cells through numerous pathways including 
voltage-gated ion channels, G-protein coupled receptors (GPCR) and their associated 
second messenger pathways and the transient receptor potential (TRP) families of 
voltage-insensitive Ca2+ channels. These specialist calcium channels are sensitive to a 
number of stimuli such as mechanical stress, temperature and a change in osmolality, 
with an emphasis on the latter regulating AQP trafficking (Benfenati and Ferroni, 2010). 
1.6.7 Cytoskeletal proteins 
When not integrated into the membrane AQPs are stored within intracellular 
vesicles, upon calcium activation and phosphorylation, these AQP-containing vesicles 
are trafficked to the cell surface along microtubules using the motor proteins dynein and 
kinesin (Tietz et al., 2006). There is also evidence that when AQP trafficking is activated 
the actin cytoskeleton is remodelled and relaxed to facilitate the movement of vesicles 
towards the membrane (Nicchia et al., 2008). Figure 1.15 shows an overview of the 
mechanisms the govern AQP expression and function.    
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Figure 1.15. Mechanisms that regulate AQP translocation and function. Many cellular 
processes, such as calcium influx, phosphorylation and cytoskeletal rearrangement all 
contribute to the membrane expression, and therefore function, of AQPs. Transient 
potential receptor channels (TRPs); G-protein coupled receptor (GPCR); calmodulin 
(CaM); cyclic adenosine monophosphate (cAMP); inositol triphosphate (IP3). Adapted 
from Conner, Bill and Conner, 2013. 
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1.7 Aims and objectives 
 The IVD is a unique tissue that is well-adapted to its role in enabling the 
movement of the spine and withstanding compressive forces applied by the human 
body. Due to its location and function, the microenvironment bestowed upon the IVD is 
complex. Resident cells of the IVD have adapted to their microenvironment, which 
enables their overall function to maintain the role of the IVD within the spine. However, 
it is not completely understood how IVD cells have been able to survive and adapt to 
their environment or how such adaptation is affected during IVD degeneration, when 
the microenvironment is permanently altered causing adverse cellular functions and the 
destruction of tissue. 
 The overall aim of this PhD was to test the hypothesis that because the function 
of NP cells is governed by many microenvironmental factors that are in-part controlled 
by the function of AQPs (particularly osmolality), many AQP isoforms are expressed and 
regulated in NP cells, contributing to their adaptation to the unique environment of the 
IVD, and possible dysregulation during degeneration. 
1.7.1 Specific aims 
1. Investigate the expression of all 13 (AQP0-12) AQP isoforms in non-degenerate 
and degenerate human NP tissue, to determine potential changes in expression 
during IVD degeneration. Investigate AQP expression in non-chondrodystrophic 
(NCD) and chondrodystrophic (CD) dogs to determine how the expression of AQPs 
is potentially altered between NC and NP cells during IVD development (Chapter 
2). 
2. Investigate the hyperosmotic regulation of AQP1 and 5 in human and rat NP cells 
and determine if TonEBP, a transcription factor essential for osmoadaptation and 
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matrix synthesis, is essential for the hyperosmotic regulation of AQP1 and 5 in NP 
cells and tissue (Chapter 3). 
3. Determine how AQP4 and TRPV4 function contributes to the adaptation of human 
NP cells to healthy and degenerate osmotic conditions, with respect to 
fundamental cell functions such as the rate and change in cell volume, water 
permeability and calcium influx (Chapter 4).  
4. Investigate how other microenvironmental factors attributed to IVD degeneration 
such as cytokines, pH, oxygen tension and combined ‘healthy’ and ‘degenerate’ 
treatments all regulate the gene expression of AQPs in human NP cells (Chapter 
5).  
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Chapter 2: Aquaporin expression in the human and canine 
intervertebral disc during maturation and degeneration.  
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2.1 Introduction 
 The IVD, composed of the central gelatinous NP, surrounded by the AF and CEP, 
is a highly specialised tissue facilitating the biomechanical function of the spine (Urban 
et al., 1977). Resident cells within the NP produce vast amounts of ECM that contain 
high concentrations of proteoglycans whose hydrophilic GAG side-chains promote water 
and cation retention (Ishihara et al., 1997). This allows the disc to resist compressive 
loading and permits motion of the spine due to a high level of hydration (Maroudas, 
Muir and Wingham, 1969; Maroudas, 1970; Urban et al., 1977; Urban, Holm and 
Maroudas, 1978; Kraemer, Kolditz and Gowin, 1985; Ishihara et al., 1997). Therefore, in 
comparison to other tissues, the healthy IVD maintains a hyperosmolar environment 
(Ishihara et al., 1997; Urban, 2002; van Dijk, Potier and Ito, 2011; Johnson, Shapiro and 
Risbud, 2014a). However, the hydration and osmolality of the disc is not constant (Urban 
and McMullin, 1985). With applied loading, between 18-25% of fluid is recycled during 
a diurnal cycle (McMillan, Garbutt and Adams, 1996; Urban, 2002). The increased 
physiological osmolality within the disc has been shown to increase matrix synthesis by 
NP cells compared to lower osmolalities (Neidlinger-Wilke et al., 2012; O’Connell, 
Newman and Carapezza, 2014). This highlights that NP cells can respond to osmotic 
changes within the disc which may be via control of water transport (Gajghate et al., 
2009). 
 During human IVD development the NP contains populations of large, 
vacuolated notochordal (NC) cell clusters that are replaced by mature NP cells during 
ageing (Risbud, Schaer and Shapiro, 2010). Interestingly, there are differences in IVD 
development between different species and different groups within the same species. 
An example of this difference is highlighted in dogs; those classified as NCD retain NC 
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cells into adulthood, maintain a healthier IVD environment and suffer infrequent 
degeneration. Whereas CD dogs lose NC cells before adolescence and suffer early-onset 
IVD degeneration (Bergknut et al., 2013; Smolders et al., 2013). These differences in 
canine IVD biology enable research into how cell viability, function and differentiation 
are affected by the IVD environment and vice versa. To preserve their phenotype during 
culture, NC cells require a hyperosmolar environment (Spillekom et al., 2014) and they 
have been shown to provide a protective and regenerative effect on NP cells when co-
cultured together (de Vries et al., 2016; Mehrkens et al., 2017). This indicates that the 
behaviour of disc cells during development and maturation is, in some part, controlled 
by fluctuations in extracellular osmolality, and that responses may vary between NC cells 
and mature NP cells. IVD degeneration can also further disrupt the osmotic flux of the 
disc.  
 Around 40% of chronic LBP cases are attributed to IVD degeneration (Luoma et 
al., 2000), which is characterised by altered biomechanical properties of the spine 
caused by an imbalance between anabolic and catabolic mechanisms leading to the 
destruction of the ECM (Freemont et al., 2002; Haefeli et al., 2006; Le Maitre et al., 2007; 
Le Maitre, Freemont and Hoyland, 2007; Le Maitre et al., 2015). The production of pro-
inflammatory cytokines by NP cells are known to play a role in the degenerative cascade 
of IVD degeneration (Takahashi et al., 1996; Burke et al., 2002; Le Maitre, Freemont and 
Hoyland, 2005; Weiler et al., 2005; Le Maitre, Hoyland and Freemont, 2007a; Studer et 
al., 2011; Andrade et al., 2013; Purmessur et al., 2013; Risbud and Shapiro, 2014). 
Specifically, over-expression of cytokines leads to increased production of matrix 
degrading enzymes (Roberts et al., 2000; Le Maitre, Freemont and Hoyland, 2004; Patel 
et al., 2007; Hoyland, Le Maitre and Freemont, 2008; Pockert et al., 2009; Zhao et al., 
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2011), and the resulting loss of hydrophilic proteoglycans causes a decrease in IVD 
osmolality compared to normal physiological conditions. This could further contribute 
to degeneration, as under low osmolality MMP-3 expression is increased and aggrecan 
expression is decreased in NP cells (Wuertz et al., 2007; Neidlinger-Wilke et al., 2012). 
This further highlights the importance of regulating osmotic responses in the disc.  
 Aquaporins (AQPs) are a family of transmembrane channel proteins that 
function as selective water pores driven by osmotic gradients (Agre et al., 2002). 
Aquaporin 1 (AQP1) was the first member to be discovered in erythrocytes and renal 
tubules (Denker et al., 1988) and since then thirteen members have been discovered 
(AQP0-12). These channels are localised to tissues with roles relating to water 
homeostasis, cell volume regulation and structural function (Day et al., 2014), and 
therefore may contribute towards the adaptation and responses of NC and NP cells 
when exposed to the fluctuating osmolality of the healthy and degenerate disc. 
 In human and murine discs, expression of AQP1, 2, 3 and 5 have been identified 
(Richardson, Knowles, Marples, et al., 2008; Gajghate et al., 2009; Wang and Zhu, 2011; 
Taş et al., 2012; Johnson et al., 2015; Palacio-Mancheno et al., 2018). Studies have also 
demonstrated that expression of AQPs in NP and NCs can be regulated by physiological 
conditions. Hyperosmolality upregulates AQP 2 in murine NP cells (Gajghate et al., 
2009), and AQP3 in murine NC cells (Palacio-Mancheno et al., 2018). Whilst the 
expression of AQP1 and AQP5 is maintained at basal levels by hypoxia-inducible factor 
1 alpha (HIF-1α) in NP cells (Johnson et al., 2015). Johnson et al.2015 also reported that 
AQP1 and AQP5 expression decreased in human IVDs with increasing degeneration. To 
date only AQP1, 2, 3 and 5 have been shown to be expressed by NP cells (Richardson, 
Knowles, Marples, et al., 2008; Wang and Zhu, 2011; Taş et al., 2012; Johnson et al., 
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2015) and AQP1, 2 and 3 by NC cells (Gajghate et al., 2009; Palacio-Mancheno et al., 
2018). However, no studies have investigated expression of the remaining AQP family 
members, and few have investigated expression in NC and NP cells and determined 
whether expression alters during maturation or degeneration. Hence, this study aimed 
to identify the expression of all thirteen AQP family members in human and canine NP 
tissues. Discs from NCD and CD canines were used as a model to investigate changes in 
AQP expression during NC to NP cell transition in IVD maturation, and adult human discs 
were used to investigate changes in AQP expression in NP cells during IVD degeneration.  
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2.2 Materials and Methods 
2.2.1 Experimental Design 
As only a few AQP family members have been identified in the human NP, within 
this study firstly qRT-PCR was utilised to identify the gene expression of all 13 AQP family 
members. IHC was then used to determine protein expression of AQPs that were 
expressed at gene level. Human NP samples used were graded histologically from non-
degenerate to severely degenerate which enabled this study to identify changes in AQP 
expression in mature human tissue as IVD degeneration progresses. This study also 
aimed to determine the expression of AQPs during IVD maturation which was achieved 
via AQP protein expression using immunohistochemistry (IHC) in NCD and CD canine NP 
samples. The differences in physiology between NCD and CD canine IVD samples enables 
changes in AQP expression to be identified as NC cells transition into NP cells during IVD 
maturation. The isolation of NP cells and NC cells from human and canine IVD samples, 
and subsequent ICC/IF experiments enabled the localisation of AQPs within IVD cells to 
be investigated. The experimental design is summarised in Figure 2.1. 
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Figure 2.1. Experimental design to investigate AQP expression during IVD maturation and degeneration. 
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2.2.2 Human Tissue 
Human IVD tissue was obtained from patients undergoing microdiscectomy 
surgery for the treatment of nerve root compression as a result of IVD herniation or 
post-mortem (PM) examination with informed consent of the patients or relatives 
(Sheffield Research Ethics Committee (09/H1308/70) approval form Appendix I). This 
study utilised 97 surgical samples from 97 individuals and 5 PM samples from 3 
individuals (Appendix II). 
2.2.3 Canine Tissue 
Canine IVD samples (n=35) were obtained from 19 NCD and CD dogs (Thompson 
grade 1-5) euthanized for unrelated experiments with approval from the Ethics 
Committee of Animal Experiments of Utrecht University (Appendix III). The gross 
morphology of canine discs was categorised using a modified Thompson grading scheme 
(TG), specifically developed for canine IVDs, and each sample given a grade (1-5) to 
determine the state of disc degeneration (Bergknut et al., 2013). Canine IVD samples 
were sent to Sheffield Hallam University after tissue processing (Section 2.2.4). 
2.2.4 Tissue Processing 
Human tissue was fixed in 10% (v/v) neutral buffered formalin (Leica 
Microsystems, Milton Keynes, UK) for 48h and embedded into paraffin wax. Following 
embedding, 4µm sections were cut and human IVDs histologically graded by performing 
haematoxylin and eosin staining. Paraffin was removed from sections using sub-X (Leica 
Microsystems) 3 x 5min washes. Sections were then rehydrated in IMS 3 x 5min before 
1min staining with Mayer's Haematoxylin (Leica Microsystems). Sections were left to 
'blue' in running tap water for 5min before subsequent staining with alcoholic eosin 
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(Leica Microsystems) for 1min. Sections were then dehydrated in IMS 3 x 5min and 
cleared in sub-X (Leica Microsystems) 3 x 5min. Sections were finally mounted with 
pertex (Leica Microsystems). Microscopic tissue morphology was assessed to determine 
the grade of degeneration for each sample based on four distinct changes to IVD 
morphology during degeneration: demarcation of NP tissue, presence of fissures, cell 
clustering and reduction of eosin staining adjacent to NP cells. Each morphological 
feature was scored between 0-3 (higher score is more degenerate) and added together 
for each sample, to give a final grade of 0-12. Samples were separated into cohorts 
depending on grade: non-degenerate (grade 0-4); moderately degenerate (grade 4.1-
6.9) and severely degenerate (grade 7-12).  
Canine lumbar spinal segment (IVD and adjacent ½ vertebral bodies) extraction 
was performed by Bach et al., 2018. Canine vertebral columns (T11-S1) were harvested 
using an electric multipurpose saw (Bosch). Vertebrae were transversely transected 
using a band saw (EXAKT tape saw) and spinal segments were sagitally transected using 
a diamond band saw (EXAKT 312). Lumbar spinal segments were fixed in 4% (v/v) neutral 
buffered formaldehyde (Klinipath, Duiven, the Netherlands) for 14d and decalcified in 
PBS with 0.5M EDTA for 2 months. Spinal segments were then paraffin embedded and 
5µm sections were cut (Bach et al., 2018). The grade of IVD degeneration was 
determined using the modified TG (grade 1-5) developed by Bergknut et al., 2013. 
2.2.5 Investigation of AQP gene expression in directly extracted human NP cells 
NP tissue from surgical and PM IVD tissue was separated from surrounding AF 
and CEP tissue and NP cells were isolated using 2mg/mL collagenase type I (Sigma) in 
DMEM for 4h at 37°C. Cells were then passed through a 40µm cell strainer (Sigma) to 
remove tissue debris. Following extraction, NP cells were either used for direct RNA 
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extraction or cell culture. RNA was extracted by adding trizol (Life Technologies) for 
10min at RT before chloroform (Sigma) was added, samples vortexed and allowed to 
stand for 10min at RT before centrifugation at 12,000g for 15min at 4°C. After separation 
of RNA, DNA and protein layers, the upper, clear, aqueous RNA layer was collected and 
500μL molecular grade isopropanol added (Sigma) for ≥1 hour at -80°C to precipitate 
RNA. Subsequently, RNA was eluted and DNase removed using RNeasy® mini clean-up 
kit (74204, Qiagen, Manchester, UK) as per the manufacturer's instructions. RNA 
samples were incubated at 60°C for 5 minutes prior to adding 36μL reverse transcriptase 
mastermix per 14μL RNA sample (Table 2.1). 
Component Amount per reaction (μL) 
dNTPs 1.5 
Random hexamers 1.0 
Bioscript 5x RT buffer 5.0 
Bioscript RT enzyme 0.5 
RNase free H2O 28.0 
Table 2.3. Reverse transcriptase master mix. Per 14μL RNA sample, 36μL complete 
mastermix is added. dNTPs, Bioscript 5x RT buffer and Bioscript RT enzyme all purchased 
from Bioline. Random hexamers and RNase free H2O purchased from Life Technologies. 
 
Samples were incubated at 42°C for 1 hour, to synthesise cDNA, followed by 10 
minutes at 80°C to denature the MMLV reverse transcriptase in Bioscript RT enzyme 
(Bioline). Expression of target genes: AQP0-12 together with housekeeping genes: 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and 18S rRNA (18S), was 
investigated using quantitative real-time polymerase chain reaction (qRT-PCR) 
employing pre-designed Taqman™ gene expression assays (Life Technologies). A volume 
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of 2μL cDNA sample, per well, was added in duplicate into 96-well FAST PCR plates (Life 
Technologies), qRT-PCR mastermix was prepared (Table 2.2), and 8μL was added per 
well. 
Component Amount (μL) 
Taqman™ gene expression assay 0.5 
2x Taqman™ fast mastermix 5.0 
Sterile deionised H2O 2.5 
Table 4.2. qRT-PCR mastermix. 8μL of complete mastermix were added to 2μL cDNA 
samples. Both Taqman™ gene expression assays and 2x Taqman™ fast mastermix were 
purchased from Life Technologies. 
 
Plates were sealed with MicroAmp™ optical adhesive film (Life Technologies). 
Expression of target genes was determined using a QuantStudio 3 real time PCR machine 
(Life Technologies). Fast programme was used where the temperature was first ramped 
up to 95°C for 10min, to activate Taq polymerase, followed by 50 cycles of denaturing 
at 95°C for 1sec and subsequent annealing and extension at 60°C for 20sec. qRT-PCR 
was conducted on 19 non-degenerate samples (grade ≤4), 13 moderately degenerate 
samples (grade 4.1-6.9), 38 severely degenerate samples (grade 7-12) and 32 samples 
with evidence of cell infiltration identified histologically (Appendix II). Results were 
analysed using the 2-ΔCt method (Livak and Schmittgen, 2001) and presented as relative 
gene expression normalised to the average CT of GAPDH and 18S. Both housekeeping 
genes used in this study have been previously shown to be stably expressed, using 
geNorm algorithm, in human IVD samples across all grades of degeneration (Phillips et 
al., 2015). 
2.2.6 Isolation and culture of NCs from Canine discs 
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NC cells were isolated from spines of six mongrel dogs (mean age 1.4 years; mean 
weight 23kg), performed by Spillekom et al., 2014, euthanized for unrelated 
experiments and made available for other research, which is the policy of the Animal 
Welfare and Ethics Committee of Utrecht University. NP material was collected from 
IVDs within 6h PM. NP tissue from each dog was pooled and digested in 0.1% (w/v) 
pronase (Sigma-Aldrich) for 45min and 0.1% (w/v) collagenase II (Sigma-Aldrich) 
overnight. NC cells were then collected by filtering through a 40μm cell strainer, which 
NC cells cannot pass through and remain on the filter. Cell strainers were then reverse 
rinsed with DMEM/F12 (Invitrogen) containing 10% (v/v) FCS (PAA Laboratories) and 1% 
(v/v) P/S (PAA Laboratories) to collect NC cells. After centrifugation at 300g for 5min, NC 
cell pellets were resuspended in 100% FCS (PAA Laboratories); 24.4 ± 0.9 x 106 (mean ± 
SD) live NC cells were recovered per dog (Spillekom et al., 2014). Cells were 
encapsulated in 2.4% (w/v) sterilised alginate solution (Sigma-Aldrich) with a final cell 
density of 3 x 106 cells/mL. The alginate/cell suspension was gently pressed through a 
26-gauge needle into 102mM CaCl2 (Sigma-Aldrich) and 10mM HEPES (Sigma-Aldrich) to 
form solid, cell-encapsulated, beads. Alginate beads were cultured in 24-well plates (~6 
beads/well). Beads were cultured in 1mL α-MEM (Invitrogen) supplemented with 10% 
(v/v) FCS (PAA Laboratories) and 1% (v/v) P/S (PAA Laboratories) for 28d at 37°C, 5% 
(v/v) CO2. Media osmolarity was raised to 400mOsm/L by adding 1% (w/v) 5M NaCl 
(Merck) and 1% (w/v) 0.4M KCl (Sigma-Aldrich), before the start of culture. Media was 
replaced every 3d. These culture conditions were used as they allow the retention of the 
NC cell phenotype in culture (Spillekom et al., 2014). After culture duration beads were 
fixed in 10% (v/v) neutral buffered formalin (Leica Microsystems) and embedded into 
paraffin wax. NC cell extraction, encapsulation into alginate beads, cell culture, fixation 
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and paraffin embedding were all performed by Spillekom et al., 2014.  Four µm sections 
were cut and used in immunofluorescence experiments (section 2.2.8). 
2.2.7 Immunohistochemistry 
 After identifying which AQPs were expressed at gene level in directly extracted 
human NP cells, investigations into AQP protein expression in human and canine NP 
tissue were performed. Thirty human tissue samples were selected that contained both 
NP and AF tissue and which had been histologically graded; non-degenerate tissue 
(grade 0-4) (n=10), moderately degenerate tissue (grade 4.1-6.9) (n=10) and severely 
degenerate tissue (grade 7-12) (n=10) (Appendix II). Thirty-five canine tissue samples 
were selected to represent TG 1-5; TG 1 (n=8), TG2 (n=7), TG 3 (n=8), TG4 (n=6) and TG5 
(n=6) (Appendix III). IHC was conducted to investigate the protein expression of AQP0, 
2, 3, 4, 6, 7 and 9 in human and AQP0-7 and 9 in canine IVD tissues. Tissue sections were 
dewaxed in sub-X (Leica Microsystems) 3 x 5min and rehydrated in IMS 3 x 5min. 
Endogenous peroxidases were blocked in IMS containing 3% (v/v) H2O2 (Sigma-Aldrich) 
for 30min at RT. Samples were washed 1 x 5min in H2O and then 2 x 5min in 1x tris-
buffered saline (TBS) which was diluted 1:10 with H2O from 10x TBS stock (Table 2.3). 
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Component Concentration (mM) 
Tris 200 
NaCl 1500 
pH 7.5 - 
Table 2.3. 10x TBS composition. Diluted 1:10 with H2O to produce 1x TBS working 
solution. All reagents purchased from Sigma-Aldrich. 
 
 Antigen retrieval methods were then performed. During heat antigen retrieval, 
slides were immersed in heat antigen retrieval buffer (50mM Tris, pH9.5, pre-heated to 
60°C), irradiated for 5min at 40% power in an 800W microwave oven (Sanyo), left to 
stand at RT for 1min, before being irradiated at 20% power for 5min. Slides were then 
cooled at RT for 15min. If enzyme antigen retrieval was required, slides were immersed 
in 300mL enzyme antigen retrieval buffer (Table 2.5) for 30min at 37°C.  
Component Concentration 
TBS (all other components diluted in) 1x 
CaCl2 0.1% (w/v) 
α-chymotrypsin 0.01% (w/v) 
pre-heated to 37°C - 
Table 2.4. Enzyme antigen retrieval buffer composition. CaCl2 and α-chymotrypsin 
purchased from Sigma-Aldrich. 
 
 Slides were washed in 1x TBS 3 x 5min and then non-specific antibody-protein 
interactions were blocked in 1% (w/v) BSA (Sigma, UK) in 1x TBS with either 25% (w/v) 
rabbit or goat serum (Abcam) (matched to the host species of the secondary antibody) 
to neutralise secondary antibody-host interactions (Human samples Table 2.6, canine 
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samples Table 2.7). Blocking was performed in a humidified box for 1h at RT. Excess 
blocking solution was removed and slides were incubated with primary antibodies 
diluted in 1% (w/v) BSA in 1x TBS (Human samples Table 2.6, canine samples Table 2.7). 
IgG controls (Abcam) were used in place of primary antibodies at an equal protein 
concentration.  
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Target 
antibody 
Clonality Optimal 
dilution 
Antigen 
retrieval 
Secondary 
antibody 
Serum 
block 
AQP0 
(ab134695) 
Rabbit 
polyclonal 
1/200 Enzyme Goat anti 
rabbit 
Goat 
AQP2 
(ab85876) 
Rabbit 
polyclonal 
1/400 None Goat anti 
rabbit 
Goat 
AQP3 
(ab125219) 
Rabbit 
polyclonal 
1/1600 Enzyme Goat anti 
rabbit 
Goat 
AQP4 
(ab9512) 
Mouse 
monoclonal 
1/200 Enzyme Rabbit anti 
mouse 
Rabbit 
AQP6 
(ab191061) 
Rabbit 
polyclonal 
1/200 Enzyme Goat anti 
rabbit 
Goat 
AQP7 
(ab85907) 
Rabbit 
polyclonal 
1/100 Enzyme Goat anti 
rabbit 
Goat 
AQP9 
(ab85910) 
Rabbit 
polyclonal 
1/400 Enzyme Goat anti 
rabbit 
Goat 
Table 2.5. Antibody and blocking information used for IHC on human IVD tissue. All 
antibodies diluted in 1% (w/v) BSA in 1x TBS. All antibodies and serum purchased from 
Abcam. ab6720 (goat anti rabbit) and ab7074 (rabbit anti mouse) secondary antibodies 
at 1/500 dilution were used. 
 
Target 
antibody 
Clonality Optimal 
dilution 
Antigen 
retrieval 
Secondary 
antibody 
Serum 
block 
AQP0 
(ab134695) 
Rabbit 
polyclonal 
1/100 Enzyme Goat anti 
rabbit 
Goat 
AQP1 
(ab15080 
Rabbit 
polyclonal 
1/400 None Goat anti 
rabbit 
Goat 
AQP2 
(ab85876) 
Rabbit 
polyclonal 
1/400 Enzyme Goat anti 
rabbit 
Goat 
AQP3 
(ab125219) 
Rabbit 
polyclonal 
1/400 Enzyme Goat anti 
rabbit 
Goat 
AQP4 
(ab9512) 
Mouse 
monoclonal 
1/100 Heat Rabbit anti 
mouse 
Mouse 
AQP5 
(ab92320) 
Rabbit 
monoclonal 
1/100 Heat Goat anti 
rabbit 
Goat 
AQP6 
(ab191061) 
Rabbit 
polyclonal 
1/100 Enzyme Goat anti 
rabbit 
Goat 
AQP7 
(ab85907) 
Rabbit 
polyclonal 
1/100 Enzyme Goat anti 
rabbit 
Goat 
AQP9 
(ab85910) 
Rabbit 
polyclonal 
1/200 None Goat anti 
rabbit 
Goat 
Table 2.6. Antibody and blocking information used for IHC on canine IVD tissue. All 
antibodies diluted in 1% (w/v) BSA in 1x TBS. All antibodies and serum purchased from 
Abcam. ab6720 (goat anti rabbit) and ab7074 (rabbit anti mouse) secondary antibodies 
at 1/500 dilution were used.  
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 After washing in 1x TBS 3 x 5min, slides were incubated with 1:500 dilution of 
biotinylated secondary antibody (Abcam), diluted in 1% (w/v) BSA in 1x TBS, for 30min 
at RT. Slides were washed with 1x TBS 3 x 5min and secondary antibody binding was 
detected by adding ABC elite reagent (Vector Laboratories, UK) for 30min at RT. After 
washing with 1x TBS 3 x 5min, slides were incubated with 0.08% (v/v) H2O2 and 
0.65mg/mL 3,3'-diaminobenzidine tetrahydrochloride (DAB) (Sigma-Aldrich) in 1x TBS 
for 20min at RT. Slides were washed in H2O for 5min and counterstained with Mayer's 
haematoxylin (Leica Microsystems) for 1min before submersion into running tap water 
for 5min to 'blue' slides. Following, slides were dehydrated with IMS 3 x 5min, cleared 
with sub-X (Leica Microsystems) 3 x 5min, and finally mounted with pertex (Leica 
Microsystems).  
2.2.8 Immunofluorescence 
Following extraction, human NP cells were expanded in monolayer in DMEM 
(Life Technologies) supplemented with 10% v/v heat inactivated FBS, 1% (v/v) P/S, 2mM 
glutamine (all Life Technologies), 50µg/mL amphotericin B and 50µg/mL ascorbic acid 
(Sigma) and maintained at 37°C in a humidified atmosphere containing 5% (v/v) CO2. 
Human NP cells, at passage 2, were seeded into chamber slides (Life Technologies) at a 
density of 1x104 cells/well and allowed to adhere overnight. Media was aspirated and 
cells washed with PBS before fixing with 10% (v/v) neutral buffered formalin (Leica 
Microsystems) for 5min at RT. Sectioned canine NC cells in alginate were dewaxed in 
Sub-X 3 x 5min and rehydrated in IMS 3 x 5min. Fixed human NP cells and canine alginate 
sections were washed in PBS for 3 x 5min and human NP cells permeabilised in PBS 1% 
(v/v) Triton-X100 (Sigma-Aldrich) for 5min at RT. For both human NP cells and canine 
samples, non-specific binding sites were blocked for 1h at RT in 1% (w/v) BSA (Sigma-
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Aldrich) in PBS with either 25% (w/v) rabbit or goat serum (Abcam) (Table 2.7). Samples 
were incubated overnight at 4°C with either mouse monoclonal or rabbit polyclonal 
primary antibodies in blocking solution (Table 2.7). Mouse or rabbit IgG controls 
(Abcam) were used in place of primary antibodies at an equal protein concentration. 
After washing in 0.1% (v/v) Tween 20 (Sigma-Aldrich) in PBS (PBST), samples were 
incubated with a 1:500 dilution of fluorescent-conjugated secondary antibody for 1h at 
room temperature (Table 2.7). After 3 x 5min washes in PBST slides were mounted with 
diamond antifade mountant with DAPI (Life Technologies).  
 
Target 
antibody/Dye 
Clonality Optimal 
dilution 
Secondary 
antibody 
Serum 
block 
AQP0  
(ab134695) 
Rabbit 
polyclonal 
1/100 Invitrogen 
A11008 
Goat 
AQP1  
(ab15080) 
Rabbit 
polyclonal 
1/100 Invitrogen 
A11008 
Goat 
AQP2  
(ab85876) 
Rabbit 
polyclonal 
1/400 Invitrogen 
A11008 
Goat 
AQP3  
(ab125219) 
Rabbit 
polyclonal 
1/200 Invitrogen 
A11008 
Goat 
AQP4  
(ab9512) 
Mouse 
monoclonal 
1/200 Abcam 
ab150117 
Rabbit 
AQP5  
(ab92320) 
Rabbit 
polyclonal 
1/100 Invitrogen 
A11008 
Goat 
AQP6  
(ab191061) 
Rabbit 
polyclonal 
1/200 Invitrogen 
A11008 
Goat 
AQP7  
(ab85907) 
Rabbit 
polyclonal 
1/100 Invitrogen 
A11008 
Goat 
AQP9  
(ab85910) 
Rabbit 
polyclonal 
1/400 Invitrogen 
A11008 
Goat 
β-tubulin 
(ab206369) 
Rabbit 
polyclonal 
1/200 n/a n/a 
Alexa Fluor™ 488 
Phalloidin A12379 
n/a 1/1000 n/a n/a 
Table 2.7. Antibody and blocking information used in human and canine 
immunofluorescence experiments. All secondary antibodies were use at 1/500 dilution. 
Alexa Fluor™ 488 Phalloidin was purchased from Invitrogen.  
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2.2.9 Image Capture and Statistical Analysis 
Slides were visualised with an Olympus BX60 microscope and images captured 
using software programme CellSens (Olympus, Southend, UK) and MicroCapture v5.0 
RTV digital camera (Q Imaging, Buckinghamshire, UK). IHC staining was represented as 
percentage immunopostivity following analysis of 200 NP cells per sample. Canine 
analysis was restricted to morphologically distinct NP tissue and the presence of NC cells 
was identified by positive brachyury staining and morphological features (clusters of 
large, vacuolated cells) within the NP on consecutive sections. Data was shown to be 
non-parametric, therefore proportionality tests were performed to identify differences 
between the proportions of samples expressing mRNA for AQPs in directly extracted 
cohorts (p ≤ 0.05). Kruskall-Wallis with Dwass-Steel-Critchlow-Fligner post hoc analysis 
test was used to identify significant differences in immunopositivity between grades of 
degeneration in human and canine cohorts (p ≤ 0.05). To determine significant 
differences in the AQP immunopositivity of NC cells versus NP cells in pair matched 
canine samples, Wilcoxon's signed ranks test was performed (p ≤ 0.05).  
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2.3 Results 
2.3.1 Identification of aquaporin gene expression in human NP cells  
The native gene expression of all mammalian AQP family members in directly 
extracted NP cells was investigated using qRT-PCR, of which AQPs 0-7 and 9 were 
identified within human IVD tissue (Figure 2.2). AQP8 was only expressed in 4 out of 97 
samples, with no trends seen across grades of degeneration (data not shown) and AQPs 
10, 11 and 12 were not identified in any sample. Whilst the levels of AQP 0-7 and 9 
expression did not alter significantly between grades of degeneration, significant 
differences were seen in terms of the proportion of samples expressing AQPs between 
grades of degeneration (Figure 2.2). Proportions of samples expressing AQP0, 1 and 2 
were increased in moderately or severely degenerate samples compared to non-
degenerate samples (p ≤ 0.05), whilst AQP3 was decreased in moderately degenerate 
samples compared to severely degenerate samples (p ≤ 0.05) (Figure 2.2). In contrast 
AQP9 was decreased in degenerate and infiltrated samples compared to non-
degenerate samples and AQP2 and 7 in degenerate compared to moderately 
degenerate samples (p ≤ 0.05) (Figure 2.2). The proportions of samples expressing AQP4, 
5 and 6 did not change significantly across grades of degeneration (Figure 2.2). 
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Figure 2.2. Gene expression of aquaporin family members within directly extracted 
human NP cells. The number of disc samples in each cohort expressing target genes is 
represented as percentage expression; the median value is shown by the bars. Target 
gene expression is separated into cohorts determined by histological grade of 
degeneration and evidence of infiltrating cells - grade 0-4 (non-degenerate n=16), grade 
4.1-6.9 (moderately degenerate n=13), grade 7-12 (severely degenerate n=38), 
infiltrated (n=30), total number of samples n=97. Statistical analysis was performed on 
proportions expressed p ≤ 0.05. 
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2.3.2 Immunodetection of aquaporin proteins in human IVD tissue 
The research group has previously identified AQP1 and 5 in human IVD tissues at 
protein levels (Johnson et al., 2015), therefore AQPs 0, 2, 3, 4, 6, 7 and 9 were 
investigated here for their presence in human NP tissue in different histological grades 
of degeneration. Protein expression of all 7 AQP isoforms investigated was identified in 
the NP cells of human IVD tissues. However, the percentage immunopositivity for AQP0 
and 3 was not significantly altered between grades of degeneration (Figure 2.3). 
 The percentage immunopositivity for AQP4 in human NP tissue significantly 
decreased in moderately and severely-degenerate discs compared to non-degenerate 
discs (p ≤ 0.05) (Figure 2.4). Conversely, immunopositivity of AQP7 in severely-
degenerate human NP tissue was significantly increased when compared to moderately 
and non-degenerate tissue (p ≤ 0.05) (Figure 2.4). The immunopositivity of AQP6 and 9 
was not significantly altered between grades of degeneration (Figure 2.4) (IgG controls, 
Appendix IV). 
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Figure 2.3. Immunopositivity of AQP0, 2 and 3 within human NP tissue. Three cohorts were investigated for the expression of AQP family members in 
human IVD; non-degenerate (grade 0-4, n=10), moderately degenerate (grade 4.1-6.9, n=10), severely degenerate (grade 7-12, n=10). Immunopositive 
cells were expressed as a percentage of total count; the median value is represented by the bars. Statistical significances in % immunopositivity 
determined using Kruskal-Wallis test * = p ≤ 0.05. Scale bar 50µm. 
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Figure 2.4. Immunopositivity of AQP4, 6, 7 and 9 within human NP tissue. Three cohorts 
were investigated for the expression of AQP family members in human IVD; non-
degenerate (grade 0-4, n=10), moderately degenerate (grade 4.1-6.9, n=10), severely 
degenerate (grade 7-12, n=10). Immunopositive cells were expressed as a percentage of 
total count; the median value is represented by the bars. Statistical significances in % 
immunopositivity determined using Kruskal-Wallis test * = p ≤ 0.05. Scale bar 50µm. 
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2.3.3 Aquaporin expression and localisation in cultured human NP cells 
All aquaporins, which were expressed in native human NP tissue (AQPs 0- 7 and 
9) were also identified in monolayer cultured human NP cells. To identify potential 
localisation of AQPs, expression was compared to cytoskeletal components F-actin and 
β-tubulin. Differential localisation was seen for AQPs in human NP cells (Figure 2.5 A), 
interestingly the expression of AQP4 appeared to co-localise with β-tubulin (Figure 2.5 
B), potentially indicating a means of transporting AQP4 throughout the cell in response 
to certain stimuli. 
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Figure 2.5. Localisation of AQPs within human NP cells. (A) All AQPs expressed in human 
NP tissue are also expressed in extracted human NP cells in monolayer culture at 
passage 2. The localisation of AQPs is compared to the expression of cytoskeletal 
components F-actin and β-tubulin within cells. (B) Within 2D cultured human NP cells, 
AQP4 co-localises with β-tubulin. Images taken on a BX60 fluorescent microscope 
(Olympus) at 100x objective magnification. Scale bar 20µm.  
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2.3.4 Aquaporin expression in canine IVD tissue 
Expression of AQPs, identified in human NP tissue, was also investigated in native 
NC and NP cells within canine NP tissue. All AQPs investigated were expressed within 
both NC and NP cells in canine discs. Brachyury staining and the presence of distinct 
morphological features, such as clusters of large, vacuolated cells, enabled the 
distinction between NC and NP cells (Figure 2.6). AQP0-3 expression was maintained in 
NC cell clusters cultured in alginate beads for 28 days in αMEM at 400mOsm/L (Figure 
2.6). Intense immunostaining was observed localised to the membranes of vacuoles 
within NC cell clusters, particularly for AQP2, (Figure 2.6). 
 IHC staining was performed on tissue to identify the immunopositivity of AQP0-
3 across Thompson grades (Figure 2.6). NC cells were only observed in TG1-3 (Figure 2.6 
and Figure 2.8). The number of NP cells expressing AQP2 decreased between TG1-3 
when compared with TG4 (p ≤ 0.05) (Figure 2.7), but the number of NC cells expressing 
AQP2 was not altered by TG (Figure 2.7). Immunopositivity of AQP0, 1 and 3 was not 
significantly altered by TG in both NC and NP cells (Figure 2.7). The percentage of NC 
cells expressing brachyury, AQP2 and 3 was significantly higher than the percentage of 
NP cells expressing these proteins in pair matched canine IVD samples (p ≤ 0.05). The 
percentage of NC cells expressing AQP1 was significantly reduced compared to the 
percentage of NP cells expressing AQP1 in pair matched canine IVD samples (p ≤ 0.05) 
(IgG controls, Appendix V). 
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Figure 2.6. Expression and localisation of AQP0-3 in native canine IVD tissue. Immunofluorescence (IF) images show expression of AQPs in NC cell 
clusters after 3D culture and localisation at vacuolar-like membranes. Scale bar 20µm. IHC staining represents AQP expression in canine NC cells, at 
Thompson grade (TG) 1, and NP cells across TG2 and TG5. Scale bar 50µm. Brachyury staining was used as a positive marker of NC cells.
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Figure 2.7. Immunopositivity of AQP1, 2, and 3 in canine NC and NP cells. Three cohorts 
were investigated for the expression of AQP family members in NC cells; Thompson 
grade (TG) 1-3, and NP cells; TG1-5. Brachyury staining was used as a positive marker of 
NC cells. Immunopositive cells were expressed as a percentage of total count; the 
median value is represented by the bars. Statistical significances in % immunopositivity 
determined using Kruskal-Wallis test * = p ≤ 0.05 
.  
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AQP4-9 expression was also maintained in NC cell clusters cultured in alginate 
beads for 28 days in αMEM at 400mOsm/L (Figure 2.8). Intense immunostaining was 
observed localised to the membranes of vacuoles within NC cell clusters, particularly for 
AQP5, 6 and 9 (Figure 2.8). IHC also indicated that AQP4-9 isoforms were expressed in 
NC and NP cells across Thompson grades (Figure 2.8). AQP4 immunopositivity in both 
NC and NP cells was unaffected by changes in TG in canine IVD tissue (Figure 2.9). 
Immunopositivity of AQP5 in canine NP cells significantly decreased from TG1 to TG4 (p 
≤ 0.05) (Figure 2.9) whilst AQP5 expression in canine NC cells remained unaffected by 
degeneration (Figure 2.9). As degeneration increased from TG1-2 up to TG4-5, AQP6 
expression in NP cells significantly increased (p ≤ 0.05) (Figure 2.9), however AQP6 
expression in NC cell populations decreased with increasing TG from 1 to 3 (p ≤ 0.05) 
(Figure 2.9). NP cell expression of AQP7 also increased from TG1-2 to TG5 (p ≤ 0.05) 
(Figure 2.9), whereas AQP7 immunopostivity in NC cells remained constant across all 
grades of degeneration (Figure 2.9). AQP9 immunopositivity significantly decreased in 
NP cells between TG1-2 to TG5 (p ≤ 0.05) (Figure 2.9) and in NC cells between grade TG1 
and TG3 (p ≤ 0.05) (Figure 2.9). The percentage of NC cells expressing AQP6 and 9 was 
significantly higher when compared to the percentage of NP cells expressing AQP6 and 
9 in pair matched canine IVD samples (p ≤ 0.05) (Appendix V). 
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Figure 2.8. Expression and localisation of AQP4-9 in native canine IVD tissue cells. Immunofluorescence (IF) images show expression of AQPs in NC cell 
clusters after 3D culture and localisation at vacuolar-like membranes. Scale bar 20µm. IHC staining represents AQP expression in canine NC cells, at 
Thompson grade (TG) 1, and NP cells across TG2 and TG5. Scale bar 50µm.  
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Figure 2.9. Immunopositivity of AQP4, 5 ,6 and 9 in NC and NP cells within canine IVDs. 
Three cohorts were investigated for the expression of AQP family members in NC cells; 
Thompson grade (TG) 1-3, and NP cells; TG 1-5. Immunopositive cells were expressed as 
a percentage of total count; the median value is represented by the bars. Statistical 
significances in % immunopositivity determined using Kruskal-Wallis test * = p ≤ 0.05. 
  
102 
 
2.4 Discussion 
NP cells reside within an osmotically challenging environment (Kraemer, Kolditz 
and Gowin, 1985; Urban, 2002; van Dijk, Potier and Ito, 2011; Johnson, Shapiro and 
Risbud, 2014a), where cells must be able to adapt to their environment to allow correct 
function. Previously AQPs 1, 2, 3 and 5 have been shown to be expressed by NP cells 
(Richardson et al., 2008; Gajghate et al., 2009; Wang and Zhu, 2011; Taş et al., 2012; 
Johnson et al., 2015), expression of AQP1, 2, and 5 are regulated by physiological 
conditions found in the disc such as hyperosmolality (Gajghate et al., 2009) and AQP1 
and 5 expression levels decreased with IVD degeneration (Johnson et al., 2015). This 
highlights that water transport via AQPs in the disc must be tightly controlled to allow 
the survival and function of NP cells, and such regulation is diminished in degeneration, 
possibly aggravating the catabolic cascade. However, to date, no studies have 
investigated the expression of all AQP family members in the IVD or determined how 
their expression is altered with degeneration, thus it is difficult to gain a complete 
understanding of the roles for AQPs in the IVD. For the first time the expression of ten 
AQP isoforms, AQPs 0-9, in human and canine NP tissue were shown. We determined 
that the expression of certain AQPs is altered during IVD degeneration of humans and 
canines. Utilising canine discs, we were also able to investigate expression and 
localisation during cellular maturation and demonstrated nine AQPs were expressed in 
canine NC cells, which were particularly associated with vacuolar membranes, 
suggesting a role in water transport into vacuoles. 
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2.4.1 AQP expression in IVD tissues 
Our results agree with studies that have shown AQP1, 2, 3 and 5 expression in 
NP cells (Richardson, Knowles, Marples, et al., 2008; Gajghate et al., 2009; Wang and 
Zhu, 2011; Taş et al., 2012; Johnson et al., 2015). However, whilst Richardson et al. 2008 
identified that AQP1 and AQP3 were expressed within human IVD in agreement with 
our study, they failed to demonstrate expression of AQP2. However, in the current study 
both gene and protein expression of AQP2 was identified in human discs and protein in 
canine discs. In the earlier study (Richardson, Knowles, Marples, et al., 2008) only ten 
PM samples from human discs were used for the identification of AQP protein 
expression, in contrast, here we have used a larger sample size with a total of 102 human 
samples to assess gene expression, and 30 surgical and PM human and 35 PM canine 
samples for IHC analysis. Our data is in agreement with a study by Gajghate et al. which 
demonstrated AQP2 gene and protein expression in rat and human IVD tissues (Gajghate 
et al., 2009). 
Limited AQP family members have been identified in other musculoskeletal 
tissues, including AQP1, 3, 4 and 9 in articular cartilage (Mobasheri et al., 2004; Trujillo 
et al., 2004; Cai et al., 2017; Steinberg et al., 2017; Takeuchi et al., 2018), AQP1 and 
AQP9 in synovial tissues (Trujillo et al., 2004; Nagahara et al., 2010), AQP1 and 3 in 
osteoblasts (Mobasheri, Wray and Marples, 2005; Barron et al., 2017) and AQP9 
expression in osteoclasts (Aharon and Bar-Shavit, 2006; Liu et al., 2009). Here, for the 
first-time gene expression of AQPs0, 4, 6-9 was shown in human NP tissue, although 
AQP8 was only expressed in a small number of samples at gene level (n=4). Furthermore 
we demonstrate for the first time protein expression of AQPs 0, 4, 6, 7 and 9. Together 
this data demonstrates NP cells express many AQPs which may play important roles in 
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the disc such as contributing towards water homeostasis, solute transport, cell volume 
regulation, cell adhesion and protein localisation (Day et al., 2014; Kitchen et al., 2015).  
All AQPs expressed within human discs were also identified in canine discs from 
NCD and CD dog breeds, which were used to study AQP expression in the transition from 
NCs to NPs. Both NC and NP cells from canine discs expressed all AQPs investigated 
suggesting AQP family members are important during the development and maturation 
of the IVD. In canines and humans, the proportion of cells expressing AQPs and changes 
in their expression during degeneration differed, suggesting functions of AQPs during 
different stages of disc biology and within different species may vary. On the other hand, 
differences in sample preparation methods between human and canine samples may 
have resulted in the differences in immunopositivity results between species, as 
decalcification which was utilised for canine but not human samples, has been shown to 
effect IHC staining on IVD tissue previously (Binch et al., 2015). 
2.4.2 AQP expression during maturation of the IVD 
 Whilst NC and NP cells were seen to express all AQPs investigated, AQP 
expression was observed on higher numbers of NC cells v/s NP cells for AQPs 2, 3, 6, and 
9, whilst AQP1 was seen on higher numbers of NP cells than NCs in pair matched canine 
discs. This may be due to differences in the disc environment, such as osmolality, 
nutrition, pH and mechanical loading that both NC and NP cells withstand during 
development, suggesting a role for AQPs in NC physiology. Of particular note IHC on 
native canine tissue and immunocytochemistry on cultured canine NC cells revealed 
AQP expression along vacuolar membranes, particularly for AQP2, 5, 6 and 9. The 
expression of these AQPs may be indicative of the roles vacuoles may play within NC 
cells. AQP5, along with AQP1 and 4, contributes to regulatory volume decrease and the 
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control of cell volume in response to osmotic flux, there is also evidence to suggest AQP2 
is also involved (Galizia et al., 2012). Therefore, AQP2 and 5 expression may indicate that 
vacuoles regulate NC cell responses to their hyperosmolar environment, and their 
decreased expression during NC to NP transition could regulate the decreased cell size 
seen during maturation. AQP6 expression potentially indicates that vacuoles play a role 
in regulating acid-base balance in NC cells. In the kidney, where AQP6 is expressed 
intracellularly, low pH activates the anion permeability of AQP6 (Yasui et al., 1999) and 
increases AQP6 expression (Promeneur et al., 2000). An increase in AQP6 expression in 
response to low pH also potentially explains the increase in AQP6 observed in canine NP 
cells during degeneration, where extracellular pH decreases. 
2.4.3 AQP expression during degeneration of the IVD 
 Expression of AQP1 and 5 in the disc has been shown to be sensitive to 
degeneration within human IVD tissue previously (Johnson et al., 2015), with levels 
decreasing with degeneration. Here, AQP4 protein expression was also shown to 
decrease during human IVD degeneration. This potentially indicates shared functions of 
these AQPs which, during degeneration when expression is decreased, results in a 
diminished ability of NP cells to control water transport and cell volume regulation as 
the surrounding environment becomes increasingly osmotically challenging. This 
decrease in AQP4 expression is of particular importance as within the AQP family, AQP4 
has the fastest rate of water permeability followed by AQP1 and 5 (Yang and Verkman, 
1997; Kitchen et al., 2015), and these AQPs have all been implicated in the control of 
regulatory volume decrease when cells are exposed to hypo-osmotic stimuli (Benfenati 
et al., 2011a; Mola et al., 2016). Thus the decreased expression of AQPs 1, 4 and 5 seen 
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during human IVD degeneration could be a result of hypo-osmotic stimuli observed 
during IVD degeneration (Ishihara et al., 1997).  
 An important response to osmotic stress is translocation of AQPs to the plasma 
membrane, in primary rat cortical astrocytes, HEK293 and MDCK cells AQP4 is rapidly 
translocated to the plasma membrane in response to osmotic changes (Mazzaferri, 
Costantino and Lefrancois, 2013; Kitchen et al., 2015). This translocation is governed by 
many mechanisms including vesicle transport along microtubules (Mazzaferri, 
Costantino and Lefrancois, 2013; Kitchen et al., 2015). In human NP cells we observed 
that AQP4 co-localised with β-tubulin, a major component of microtubules, indicating 
AQP4 is possibly translocated between the cytosol and plasma membrane in order to 
respond and adapt to changes in the extracellular osmolality.  
In contrast to the decrease seen in AQP1, 4 and 5 with degeneration, the number 
of NP cells expressing AQP2 and AQP7 increased in moderate or severely degenerate 
human IVD tissues respectively. This may indicate that AQP2 and 7 are regulated by 
different underlying mechanisms and have different functions compared to AQP1, 4 and 
5. The increase in the number of cells expressing these proteins may be a consequence 
of degeneration or a potential repair mechanism employed by NP cells to re-establish 
homeostasis dysregulated during degeneration. As the disc degenerates, the micro-
environment in which cells reside, irreversibly changes, such as a decrease in disc pH 
(Urban, 2002). This potentially explains the increase in AQP2 protein expression, as 
AQP2 expression is increased in the rat kidney when exposed to lowered pH (Amlal, 
Sheriff and Soleimani, 2004). Immunopositivity of AQP3, 6 and 9 in human IVD tissue 
was not altered during degeneration, yet the majority of NP cells in native IVD tissue 
expressed all three AQPs, potentially indicating roles which may not be sensitive to IVD 
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degeneration. Within canine discs some effects mirrored the effects seen in human 
discs; however, some AQPs showed differential responses between species that remain 
to be explored. AQP5 immunopositivity decreased (Johnson et al., 2015) and AQP7 
immunopositivity increased in human and canine NP cells with IVD degeneration.  
2.4.4 Conclusion  
 As the disc is an osmotically challenged tissue which is further altered during 
degeneration, NP cells must employ several tightly regulated mechanisms to survive and 
function within their unique environment. We postulate that the expression of 
numerous AQP family members in the disc highlights the importance of maintaining 
intricate control over regulation of water transport and cell volume in NP cells (Figure 
2.10). The increased proportion of NP cells expressing AQP2 and AQP7 during 
degeneration may reflect consequences or potential repair mechanisms employed by 
the disc as NP cells lose their ability to adapt to the degenerate hypo-osmolar 
environment, which is identified by the loss of AQP1, AQP4 and AQP5 expression during 
degeneration.  The expression of numerous AQPs within the disc may highlight the 
importance of controlling water and solute transport in relation to maintaining NC and 
NP cell function. As yet the actual roles of AQPs within disc maturation and degeneration 
are unknown; further investigation is warranted to identify mechanisms of regulation 
and functions of AQPs to elucidate the true action of these transmembrane channel 
proteins on the overall behaviour and health of the disc.
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Figure 2.10. How AQP expression is altered during canine IVD maturation and degeneration and human IVD degeneration. AQPs are present in both 
NC cells during maturation and NP cells during degeneration. Alterations in AQP expression and the disc environment are shown as ↓=decrease and 
↑=increase. References indicate where similar changes in expression, due to changes in the extracellular environment, have been observed. 
References in bold indicate where AQP expression in the disc has been investigated.  
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Chapter 3: Hyperosmotic regulation of AQP1 and 5 in nucleus 
pulposus cells. 
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3.1 Introduction 
 Many factors contribute to the correct function of the NP. The environment in 
which NP cells reside plays a big role in the physiology of the tissue; the correct 
biomechanical loading, pH, nutrition, O2 tension and adaptation to a diurnal cycle all 
allow NP tissues to function correctly (McMillan, Garbutt and Adams, 1996; Ishihara et 
al., 1997; Urban, 2002; Bibby et al., 2005; Hartman et al., 2018). As the NP has a high 
content of negatively charged, hydrophilic GAGs within its matrix, allowing water and 
cation retention, this provides a high osmotic pressure environment within the disc 
(Ishihara et al., 1997; van Dijk, Potier and Ito, 2011; Johnson, Shapiro and Risbud, 2014a). 
This physiologically hyperosmotic environment has been shown to stimulate matrix 
synthesis (van Dijk, Potier and Ito, 2011; Neidlinger-Wilke et al., 2012; O’Connell, 
Newman and Carapezza, 2014), providing evidence that NP cells have adapted to the 
higher osmolality and hydrostatic pressure imposed on them by the NP tissue 
environment. However, osmotic stress (both hyper- and hypo-) is known to cause many 
disruptions to cellular activity such as elevation of ROS, cytoskeletal rearrangement, 
inhibition of transcription and translation, damage to DNA and proteins and eventually 
cell death (Burg, Ferraris and Dmitrieva, 2007). So how have NP cells been able to adapt 
to this constantly changing hyperosmotic environment? 
3.1.1 TonEBP 
 There are many cell signalling pathways that are activated during osmotic stress 
including p38 MAPK (Han et al., 1994), Jnk (Galcheva-Gargova et al., 1994) and ERK1/2 
(Burg, Kwon and Kültz, 1996), but one of the most well-known, classical pathways, which 
many tissues and cell types employ to counter osmotic stress involves the function of 
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tonicity enhancer binding protein (TonEBP). TonEBP, is also known as nuclear factor of 
activated T cells 5 (NFAT5), is part of a family of transcription factors (NFAT1-5) that 
contains rel homology domains (DNA binding domains), but unlike NFAT1-4, TonEBP 
function is independent of calcineurin (a calcium-dependent serine/threonine 
phosphatase that activates T cells) and activator protein 1 (AP-1 ,a transcription factor 
controlling cellular processes such as growth and differentiation) (Macián, López-
Rodríguez and Rao, 2001). Within many tissues TonEBP has the role of hyperosmotic 
adaptation; the exact mechanisms by which cells sense osmotic shifts is unknown, but 
studies suggest that integrins α6β4 (Jauliac et al., 2002) and α1β1 (Moeckel et al., 2006), 
a guanine nucleotide exchange factor, Brx (also known as A-kinase anchoring protein 13 
(AKAP13)) (Kino et al., 2009), and biomechanical stretching (Scherer et al., 2014) may all 
activate TonEBP signalling. When cells are exposed to hyperosmotic stimuli, TonEBP is 
translocated into the nucleus. In the nucleus it forms homodimers and binds to tonicity 
response elements (TonE) on target genes, via rel homology domains, causing their 
upregulation (Miyakawa et al., 1999). These well-described target genes include Sodium 
myo-inositol transporter (SMIT), aldose reductase (AR), Betaine-γ-amino butyric acid 
transporter (BGT1) and taurine transporter (TauT), that all facilitate the exchange of 
charged ions within cells for small non-ionic osmolytes (Miyakawa et al., 1999; Burg, 
Ferraris and Dmitrieva, 2007; Halterman, Kwon and Wamhoff, 2012; Johnson, Shapiro 
and Risbud, 2014a) (Figure 3.1). Thus, restoring the osmotic pressure across the cell 
membrane and enabling cellular adaptation to the hyperosmotic extracellular 
environment.  
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Figure 3.1. The function of TonEBP. Increased extracellular osmolality are sensed by the 
cell. These mechanisms activate TonEBP in the cytosol by phosphorylation. Activated 
TonEBP is translocated to the nucleus where it dimerises and binds to tonicity response 
elements (TonE) upstream of osmotic response genes. The expression of osmotic 
response genes (SMIT, BGT1, TauT and AR) is upregulated, enabling the cell to produce 
and transport non-ionic osmolytes across the cell membrane, restoring the osmotic 
balance in and out of the cell. Thereby controlling the cellular adaptation to 
hyperosmolality. 
 
 TonEBP has an emerging role in the function of the IVD and similar tissues. It has 
been shown that TonEBP is a key regulator of aggrecan (Tsai et al., 2006) and the 
synthesis of chondroitin sulphate sidechains (Hiyama et al., 2009) in NP cells. Whilst in 
the chondrogenic ATDC5 cell line, TonEBP was involved in the hyperosmotic induction 
of sox9, collagen type II and X, Runx2 and aggrecan (Caron et al., 2013). As TonEBP allows 
NP cells to adapt to their hyperosmotic surroundings, regulate the matrix composition 
and osmotic status of the NP, it is important to determine what other pathways are 
potentially regulated by TonEBP to provide the correct function to the IVD. 
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3.1.2 Osmotic regulation of AQP expression  
 Many AQPs are present within NP tissue (Chapter 2). Their presence suggests 
that water transport is tightly controlled and very important for NP cell function. AQP1 
and 5 expression in human NP tissue has previously been shown to decrease during IVD 
degeneration (Johnson et al., 2015). The basal expression levels of AQP1 and 5 in NP 
cells is regulated by HIF-1α (Johnson et al., 2015) which does not explain their decreased 
expression, therefore other degenerative changes may be implicated in the 
dysregulation of AQP1 and 5. AQP expression across many tissues and cell types has 
been shown to be regulated by alterations in extracellular osmolality, with many 
pathways implicated (Table 3.1), however only one study to date has investigated this 
within the IVD, which showed increased AQP2 expression (Gajghate et al., 2009). 
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 Tissue/cell type AQP Treatment Regulation Pathways References 
Bladder Rat bladder AQP1 Hyperosmotic −  (Spector et al., 
2002) 
 Rat bladder AQP2, 3 Hyperosmotic ↑  (Spector et al., 
2002) 
 Human 
urothelium 
AQP3, 9 Hyperosmotic ↑  (Rubenwolf et 
al., 2012) 
 Human 
urothelium 
AQP4, 7 Hyperosmotic −  (Rubenwolf et 
al., 2012) 
Brain Primary rat 
astrocytes 
AQP4, 9 Hyperosmotic ↑ p38 (Arima et al., 
2003) 
 Rat brain 
 
AQP4 Hyperosmotic ↑  (Mesbah-
Benmessaoud 
et al., 2011) 
 Mouse brain AQP4 Hyperosmotic ↓  (Cao et al., 
2012) 
 Rat choroid 
plexus 
AQP1 Hypo-osmotic ↑  (Moon et al., 
2006) 
Eye Human retinal 
epithelial cells 
AQP5, 8 Hyperosmotic ↑ p38, ERK1/2, 
NF-κB, 
TonEBP 
(Hollborn et 
al., 2015) 
 Human retinal 
epithelial cells 
AQP5 Hypo-osmotic ↓  (Hollborn et 
al., 2015) 
 ARPE-19 cell 
line 
AQP4 Hyperosmotic ↓ Proteasomal 
degradation 
(Willermain et 
al., 2014) 
 Rat retina AQP1 Hyperosmotic ↓  (Qin et al., 
2009) 
 Rat retina AQP4 Hyperosmotic −  (Qin et al., 
2009) 
Heart Mouse cardiac 
endothelial cells 
AQP1 Hyperosmotic ↑  (Rutkovskiy, 
Mariero, et 
al., 2012a) 
 Mouse 
cardiomyocytes 
AQP4 Hyperosmotic ↓  (Rutkovskiy, 
Mariero, et 
al., 2012a) 
IVD Rat NP cells AQP2 Hyperosmotic ↑ TonEBP (Gajghate et 
al., 2009) 
 Mouse NC cells AQP3 Hyperosmotic ↑  (Palacio-
Mancheno et 
al., 2018) 
Lung Rat alveolar 
epithelial cells 
AQP5 Hyperosmotic ↑ HIF-1α (Zhou et al., 
2007) 
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 Tissue/cell type AQP Treatment Regulation Pathways References 
Kidney mIMCD-3 cell 
line 
AQP1 Hyperosmotic ↑  (Jenq et al., 
1998) 
 mIMCD-3 cell 
line 
AQP1 Hyperosmotic ↑ p38, ERK1/2, 
JNK, TonE 
(Umenishi et 
al., 2003) 
 mIMCD-3 cell 
line 
AQP1 Hyperosmotic ↑ TonEBP (Lanaspa, 
Miguel A et 
al., 2010) 
 Rat kidney 
collecting duct 
cells 
AQP2 Hyperosmotic ↑ p38, ERK1/2, 
JNK 
(Hasler et al., 
2008) 
 MDCK cell line AQP3 Hyperosmotic ↑  (Matsuzaki et 
al., 2001) 
Ovary 3AO ovarian 
cancer cell line 
AQP1, 5 Hyperosmotic −  (Chen et al., 
2015) 
 3AO ovarian 
cancer cell line 
AQP3, 9 Hyperosmotic −  (Chen et al., 
2015) 
Skin Human 
keratinocytes 
AQP3 Hyperosmotic ↑  (Sugiyama et 
al., 2001) 
 Human 
keratinocytes 
AQP9 Hyperosmotic −  (Sugiyama et 
al., 2001) 
Table 3.1. Regulation of AQP expression by alterations in extracellular osmolality. The 
expression of many AQP isoforms, across many tissue and cell types is upregulated (↑) 
or downregulated (↓) by osmolality. AQP expression may also be unaltered by changes 
in osmolality (−). 
 
Specifically, AQP1 expression is upregulated by hyperosmolality in mIMCD-3 
kidney cells (Jenq et al., 1998; Umenishi and Schrier, 2003; Lanaspa, Miguel A et al., 
2010) and mouse cardiac endothelial cells (Rutkovskiy, Mariero, et al., 2012a). AQP5 
expression has also been shown to be upregulated by hyperosmolality in 3AO ovarian 
cancer cells (Chen et al., 2015), rat alveolar epithelial cells (Zhou et al., 2007) and human 
retinal epithelial cells (Hollborn et al., 2015), in which AQP5 expression was reduced 
after hypo-osmotic treatment (Hollborn et al., 2015). TonEBP has also been implicated 
with the hyperosmotic upregulation of both AQP1 (Umenishi and Schrier, 2003; 
Lanaspa, Miguel A et al., 2010) and AQP5 (Hollborn et al., 2015). This potentially 
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indicates that both AQPs are also regulated in the same manner in NP cells, as the 
osmolality of NP tissue decreases during degeneration. There is also a precedence of 
AQP regulation in the IVD; AQP3 expression was upregulated by hyperosmolality in 3D 
cultured murine NC cells (Palacio-Mancheno et al., 2018) and the hyperosmotic 
upregulation of AQP2 in 2D cultured murine NP cells was dependent on TonEBP 
(Gajghate et al., 2009). If AQP1 and 5 are regulated in this manner, it may implicate them 
in enabling the adaptation of NP cells to their hyperosmotic environment along with 
other TonEBP target genes. This adaptation may be diminished during degeneration 
when their expression is reduced, possibly by the lowered extracellular osmolality.  
AQP expression and function has also been implicated in enabling cells to sense 
osmotic stress via membrane tension changes (Ozu et al., 2018), interactions with other 
osmotically activated membrane channels (Benfenati et al., 2011a; Mola et al., 2016) 
and the control of cell volume regulation (Kitchen et al., 2015), indicating that AQPs may 
also function upstream of TonEBP to enable cellular adaptation to osmolality changes. 
As TonEBP also regulates the expression of NP matrix genes, if AQP1 and 5 expression 
in NP cells is linked to TonEBP, they may also be linked to matrix production and 
therefore the fundamental function of NP cells to maintain the integrity of the IVD.  
This study aimed to investigate if AQP1 and 5 expression was regulated by 
hyperosmolality in 2D and 3D cultured human NP cells to determine why their 
expression is decreased during degeneration. Also, to identify if AQP1 and 5 are similarly 
regulated in rat NP cells, which may determine if this response is common across 
different species, highlighting that it is a fundamental process for IVD function, and how 
TonEBP is involved in the osmotic regulation of both AQPs. To assess the in vivo role of 
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TonEBP in the expression of AQP1 and 5, expression in wildtype (WT) and TonEBP -/- 
mice embryos were also investigated. 
 
3.2 Materials and methods 
3.2.1 Experimental design 
 As the reasons for the decrease in AQP1 and 5 expression during in NP tissue 
during IVD degeneration are unknown, 2D cultured human NP cells were treated with 
hyperosmotic media (representative of physiological to healthy IVD). qRT-PCR and 
western blotting were utilised to determine if AQP1 and 5 gene and protein expression 
were sensitive to alterations in extracellular osmolality, which has been shown in a 
number of other tissue types. Furthermore, gene expression was also investigated in 3D 
cultured human NP cells exposed to hyperosmotic treatment to determine if AQP1 and 
5 were regulated in a similar manner in more in vivo-like NP cells. Similarly, gene and 
protein regulation of AQP1 and 5 was investigated in 2D cultured rat NP cells, to 
determine if responses to hyperosmolality were similar across species. Subsequently, 
TonEBP was knocked down in rat NP cells prior to the application of hyperosmotic 
stimuli to determine if TonEBP controlled the hyperosmotic regulation of AQP1 and 5 
expression. To investigate if TonEBP regulated in vivo expression of AQP1 and 5, IHC was 
performed on the spines and tails of WT and TonEBP -/- mouse embryos and 
fluorescence intensities compared. The experimental design is summarised in Figure 3.2. 
 
118 
 
 
Figure 3.2 Experimental design to investigate the in vitro osmotic regulation of AQP1 and 5 in NP cells and in vivo regulation of AQP1 and 5 by TonEBP 
in IVD tissue. 
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3.2.2 Human Tissue 
 Human IVD tissue was obtained from patients undergoing microdiscectomy 
surgery for the treatment of nerve root compression as a result of IVD herniation or 
post-mortem (PM) examination with informed consent of the patients or relatives. 
Ethical approval was granted from Sheffield Research Ethics Committee 
(09/H1308/70) (Section 2.2.2). 
3.2.3 Tissue Processing 
 Human tissue was fixed in 10% (v/v) neutral buffered formalin (Leica 
Microsystems) and embedded into paraffin wax. Following embedding, 4µm sections 
were cut and human IVDs histologically graded using methods described previously 
(section 2.2.4) to determine severity of IVD degeneration. 
3.2.4 Human NP cell extraction and culture 
 Human NP cells were isolated from surgical and PM tissue and expanded in 
2D culture as described previously (Section 2.2.5). Human NP cells at passage 2 were 
utilised for all experiments.  
3.2.5 Hyperosmotic gene regulation of AQPs in human NP cells 
 Once expanded, human NP cells were seeded into 6-well plates in standard 
culture media (Section 2.2.8) with an osmolality of 325mOsm/kg. Cells were treated 
with 425mOsm/kg media for 8, 12, 24, 48 and 72h to mimic the osmolality of the 
native, non-degenerate disc in monolayer (2D) culture. To alter the osmolality from 
325 to 425mOsm/kg, 50mM NaCl was added to media and the osmolality of all 
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solutions was determined using a freezing point osmometer (Model 3320, Advanced 
Instruments, Horsham, UK). NP cells in 325mOsm/kg media at 0h time point were 
used as untreated controls. Following treatment, media was aspirated and 1mL Trizol 
(Life Technologies) was added to lyse cells. Lysate was collected and 200μL 
Chloroform (Sigma-Aldrich) added per mL Trizol (Life Technologies). Samples were 
vortexed for 15 seconds and left to stand at room temperature for 10min, prior to 
4°C centrifugation at 12000g for 15min to separate protein, DNA and RNA-containing 
layers. The clear, upper phase containing RNA was taken forward and 500μL of 
molecular grade 2-propanol was added and samples were stored at -80°C for at least 
1h to precipitate RNA. Samples were then centrifuged at 12,000g for 30min at 4°C 
and supernatant was discarded. Pellets were resuspended and washed in 200-proof 
ethanol (Sigma-Aldrich) and centrifuged at 7500g for 15min at 4°C. Supernatant was 
removed and samples were allowed to air-dry for 10min. RNA was finally 
resuspended in 14μL RNase-free water (Qiagen, Manchester, UK) before proceeding 
to cDNA synthesis. 
 To explore how AQP gene expression was potentially altered by hyperosmotic 
stimulus in an environment mimicking the in vivo IVD conditions, as compared to 2D 
culture where NP cells are known to de-differentiate. Human NP cells were 
resuspended, cultured and treated following encapsulation into alginate beads. After 
expansion up to passage 2, human NP cells were resuspended at a density of 4x106 
cells/mL in sterile filtered 1.2% (w/v) alginic acid (Sigma-Aldrich) in 0.15M NaCl. 
Human NP cell-containing alginate was polymerised by passing through a 20G needle 
into 0.2M CaCl2 drop-by-drop to produce alginate beads and left for 10 mins to fully 
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gel. Newly formed beads were washed with 0.15M NaCl to remove excess CaCl2 and 
washed twice with DMEM before standard culture media was added. Alginate beads 
were polymerised and cultured in 24-well plates with 6 beads per well. Alginate 
beads were cultured in standard conditions for 2 weeks prior to treatment to allow 
human NP cells to differentiate into an in vivo-like phenotype (Le Maitre, Freemont 
and Hoyland, 2004). Once differentiated, alginate beads were treated (2 beads per 
well of a 96-well plate) with 325mOsm/kg (standard culture media), 425mOsm/kg or 
525mOsm/kg, produced by adding 50mM or 100mM NaCl added to standard culture 
media respectively, for 48h. Following treatment, beads were added to alginate 
dissolving buffer (55mM sodium citrate, 30mM EDTA, 0.15 M NaCl in H2O) for 10min 
at 37°C on an orbital shaker before centrifugation at 300g for 10min. Supernatant 
was discarded and pellets resuspended in DMEM containing 0.4mg/mL collagenase 
(Sigma-Aldrich) for 10min at 37°C on an orbital shaker to degrade ECM which had 
been deposited by NP cells during 3D culture. Samples were centrifuged for a further 
10min at 300g, supernatant removed and 1mL Trizol (Life Technologies) added to 
each sample. RNA was extracted using RNeasy mini kit (Qiagen) (Section 2.2.5). RNA 
was finally eluted from RNeasy mini kit columns with 14μL RNase free water 
(Qiagen). RNA from both 2D and 3D alginate samples was synthesised into cDNA 
following protocols outlined in section 2.2.5. qRT-PCR was utilised to identify 
regulation of gene expression of AQP1 and 5, employing pre-designed primer/probe 
mixes (Life Technologies) (section 2.5.5). 
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3.2.6 Hyperosmotic protein regulation of AQPs in human NP cells 
 Human NP cells were seeded into T25 culture flasks (Nunc, Paisley, UK) and 
treated with 425mOsm/kg media for 8, 24 or 48h. Cells in standard culture media 
(325mOsm/kg) at 0h were used as controls. Following treatment, cells were washed 
twice with ice-cold PBS before 500μL Radioimmunoprecipitation assay (RIPA) buffer 
was added to lyse cells. RIPA buffer was used to lyse cells as it contains both ionic 
and non-ionic surfactants that enable the effective lysis of whole cell extracts and 
membrane-bound proteins. Components of RIPA buffer are outlined in Table 3.2. 
RIPA buffer component Concentration 
Sodium chloride 150mM 
Triton X-100 1% (v/v) 
Sodium deoxycholate 0.5% (w/v) 
Sodium dodecyl sulphate 0.1% (w/v) 
Tris 50mM 
cOmplete™ protease inhibitor cocktail 
tablets 
1 tablet/50mL 
PhosSTOP phosphatase inhibitor tablets 1 tablet/10mL 
pH 8 - 
Table 3.2. RIPA buffer components and final concentration when added to H2O. All 
reagents purchased from Sigma-Aldrich. 
 
 Lysates were vortexed at 4°C for 20min to complete cell lysis. The protein 
concentration of lysates was determined using the BCA assay. BCA reagent was 
produced by adding 4% (w/v) copper (II) sulphate (Sigma-Aldrich) to bicinchoninic 
acid solution (Sigma-Aldrich) at a ratio of 1:50 (e.g. 100μL copper (II) sulphate was 
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added to 4900μL bicinchoninic acid solution). A standard curve of protein standards 
(0, 0.05, 0.5, 0.1, 1 and 2mg/mL BSA in RIPA buffer) was performed in triplicate. To 
samples and protein standards BCA reagent was added at a ratio of 1:8 (e.g. 160μL 
of BCA reagent added to 20μL of standard/sample). Plates were incubated at 37°C 
protected from light for 30min. BCA assay works by the formation of Cu2+-protein 
complexes followed by reduction of Cu2+ to Cu1+ in alkaline solutions. Cysteine, 
cystine, tryptophan, tyrosine and the peptide bond are able to reduce Cu2+ to Cu1+ 
and the amount of reduction is proportional to the amount of protein present. As 
reduction occurs BCA forms a complex with Cu1+, changing colour to purple-blue, 
allowing the measurement of proteins at absorbance 562nm. Once incubation was 
completed the absorbance of standards and samples was recorded at 562nm on a 
CLARIOstar plate reader (BMG Labtech). Protein concentration of samples was 
determined by producing a standard curve from the absorbance of BSA protein 
standards from which to extrapolate the concentration of total protein.  
 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was used to separate 
whole cell lysates according to molecular mass. Gels consisted of a lower separating 
gel and stacking gel layered above (Table 3.3). 
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Gel component Separating gel (mL) Stacking gel (mL) 
H2O 3.4 2.9 
40% (w/v) acrylamide 2.4 0.75 
1.5M Tris-HCl pH 8.8 2 - 
0.5M Tris-HCl pH 6.8 - 1.25 
10% (w/v) SDS 0.08 0.05 
10% (w/v) Ammonium 
persulphate 
0.08 0.05 
N, N, N', N'-
Tetramethylethylenediamine 
0.008 0.005 
Table 3.3. The composition of 12% SDS-PAGE gel. Tris acquired from Fisher Scientific. 
All other reagents acquired from Sigma-Aldrich. 
 
 Before SDS-PAGE, samples were diluted with 4x Laemmli protein sample 
buffer (Bio-Rad) and incubated at 70°C in a water bath to denature proteins. Samples 
were not boiled as this may cause membrane-bound proteins to aggregate, stopping 
movement through gels. Samples were loaded into gels at 30μg total protein per 
well. To determine molecular weight of proteins 5μL Chameleon™ duo pre-stained 
protein ladder (LI-COR) was loaded into one well. Samples where electrophoresed at 
100V for 90min in 1x running buffer, after dilution with H2O from 10x running buffer 
(Table 3.4).  
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10x running buffer component Concentration 
Tris-HCl 250mM 
Glycine 1920mM 
SDS 1%(w/v) 
pH 8.3 - 
Table 3.4. 10x running buffer composition. Tris and glycine acquired from Fisher 
Scientific. SDS acquired from Sigma-Aldrich. 
 
Following completion of SDS-PAGE, proteins were transferred from gels onto 
polyvinylidene (PVDF) membranes (Amersham). PVDF membranes were activated in 
methanol for 5min before the assembly of transfer cassettes containing sponges, 
filter paper, gel and PVDF membrane. Cassettes were orientated with the PVDF 
membrane towards the anode within western blot apparatus. Proteins were 
transferred at 90V for 3h on ice at 4°C in 1x transfer buffer containing 20% (v/v) 
methanol, diluted from 10x transfer buffer (Table 3.5). 
10x Transfer buffer component Concentration 
Tris 250mM 
Glycine 1920mM 
pH 8.3 - 
Table 3.5. 10x transfer buffer composition. All reagents purchased from Fisher 
Scientific. 
Membranes were then blocked in TBS 0.1% (v/v) tween 20 (TBS-T) containing 
5% (w/v) non-fat dried milk (NFDM) (Marvel) for 1h at RT, followed by overnight 
incubation with rabbit polyclonal antibody against AQP1 (1:5000, AB3272, Millipore) 
and mouse monoclonal antibody against β-actin (1:5000, Abcam) in TBS-T containing 
1% (w/v) NFDM. Membranes were washed in TBS-T 3 x 5min before incubation with 
126 
 
IRDye® 800CW goat anti-rabbit IgG (H + L) antibody (1:10000, 926-32211, LI-COR) and 
IRDye® 680RD goat anti-mouse IgG (H + L) antibody (1:10000, 926-68070, LI-COR) in 
TBS-T containing 1% (w/v) NFDM for 1h at RT. Membranes were washed in TBS-T 3 x 
5min before visualisation of protein bands using LI-COR Odyssey and Odyssey 
infrared imaging software (LI-COR). 
3.2.7 Rat NP cell extraction and culture 
 Wistar rats (200-250g) were euthanised with CO2 and spinal columns 
dissected under aseptic conditions. Lumbar IVDs were separated from the spinal 
column and the NP separated from the AF using a dissecting microscope. NP tissue 
was partially digested with 0.1% (w/v) collagenase (Sigma-Aldrich) and 10U/mL 
hyaluronidase (Sigma-Aldrich) for 4-6h and then maintained in DMEM supplemented 
with 10% (v/v) FBS and P/S. Rat NP cells migrated out of explant tissue after 1w; when 
confluent, cells were passaged using trypsin (0.25%) EDTA (1mM) and subsequently 
cultured.  
3.2.8 Hyperosmotic gene regulation of AQPs in rat NP cells 
 Rat NP cells were seeded at 3x104 cells/well in 6-well plates and treated with 
altered osmolality media (425mOsm/kg or 525mOsm/kg) for 8 and 24h. NP cells 
cultured in standard media (325mOsm/kg) at time point 0h were used as controls. 
After treatment cells were washed in ice-cold PBS before cell lysis and RNA extraction 
as described in section 2.2.5. RNA was finally eluted in 20μL RNase-free water. 
Extracted RNA was then converted to cDNA by adding 20μL RNA to EcoDry™ premix 
(Takara) and incubated at 42°C for 1h, followed by 10min at 70°C,. cDNA was stored 
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at -20°C. To determine regulation of AQP1 and 5 gene expression under 
hyperosmotic treatment qRT-PCR was performed using Taqman methods outlined in 
section 2.2.5. Pre-designed primer/ probe mixes (Life Technologies) were used to 
determine gene expression of AQP1, 5 and GAPDH, which was used as a 
housekeeping control.  
3.2.9 Hyperosmotic protein regulation of AQPs in rat NP cells 
 Rat NP cells were seeded at 4x104 cells/well in 6-well plates and treated with 
altered osmolality media (425mOsm/kg or 525mOsm/kg) for 8 and 24h. NP cells 
cultured in standard media (325mOsm/kg) at time point 0h were used as controls. 
After treatment cells were washed in ice-cold PBS before adding 200μL homemade 
lysis buffer, (made up in mammalian protein extraction reagent MPER, Sigma-
Aldrich) (Table 3.6) per well, cell lysates were collected and vortexed for 20min at 
4°C.  
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Cell lysis buffer component Concentration 
cOmplete™ protease inhibitor cocktail 
tablets 
1 tablet/50mL 
NaCl 150mM 
NaF 4mM 
Na3VO4 20mM 
β-glycerophosphate 25mM 
Dithiothreitol (DTT) 0.2mM 
Table 3.6. Cell lysis buffer composition. used to lyse rat NP cells for western blot 
analysis of proteins. All reagents made up to final concentration in mammalian 
protein extraction reagent (MPER). All reagents purchased from Sigma-Aldrich. 
 
 Determination of cell lysate protein concentration, separation of proteins 
using SDS-PAGE and transfer onto PVDF membranes is described in section 3.2.6. The 
only difference in the SDS-PAGE procedure was the use 5μL of pPrecision plus 
protein™ dual colour standards ladder (Bio-rad) to determine the molecular mass of 
proteins. After transfer PVDF membranes were cut horizontally at ~45kDa to 
separate higher molecular mass proteins (β-tubulin, 55kDa, used as housekeeping 
control) and lower molecular mass proteins (AQP1 and 5, 28kDa, proteins of 
interest). Membranes were blocked in TBS-T containing 5% (w/v) NFDM for 1h at RT, 
before overnight incubation with either rabbit polyclonal antibody against AQP1 
(1:500, AB3272, Millipore), rabbit polyclonal antibody against AQP5 (1:500, A4979, 
Sigma-Aldrich) or mouse monoclonal antibody against β-tubulin (1:1000, MA5-
16308, Invitrogen). Membranes were washed in TBS-T 3 x 5min before incubation 
with goat anti-rabbit IgG (H+L) secondary antibody, HRP conjugated (1:1000, 31460, 
Invitrogen, for AQP1 and 5 probed membranes) or goat anti-mouse IgG (H +L) 
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secondary antibody, HRP conjugated (1:2000, 31430, Invitrogen, for β-tubulin 
probed membranes) for 1h at RT. All antibodies were diluted in TBS-T containing 1% 
(w/v) NFDM. Immunolabelling of protein bands was detected by adding ECL reagent 
(Amersham) to membranes for 2min before removing excess liquid and visualised 
under chemiluminescence using ImageQuant™ LAS 4000 (GE Healthcare). 
3.2.10 TonEBP knockdown in rat NP cells 
 To investigate the potential role of TonEBP in the hyperosmotic regulation of 
AQP1 and 5 in rat NP cells, the expression of this transcription factor was knocked 
down. HEK293T cells were seeded in 10cm2 culture plates at 5x106 cells/plate in 
DMEM with 10% (v/v) heat-inactivated FBS 24h prior to transfection. Cells were 
transfected with 9μg shCTR (no knockdown control) or shTonEBP (TonEBP 
knockdown) plasmids along with 6μg psPAX2 packaging plasmid and 3μg pMD2.G 
VSV-G envelope expressing plasmid using Lipofectamine 2000 (Invitrogen). After 6h 
transfection media was replaced with fresh DMEM with 10% (v/v) FBS. Lentiviral 
media was harvested at 48h and 60h post transfection and virus was precipitated by 
adding 7% PEG 6000 solution and storing at 4°C for at least 12h. Supernatant/PEG 
mixture was centrifuged at 1500g for 30min at 4°C to pellet lentiviral particles. Rat 
NP cells were transduced with fresh media containing viral particles and 8μg/mL 
polybrene (Sigma-Aldrich). Knockdown of TonEBP occurred for 5 days. On day 4, 
hyperosmotic media (425mOsm/kg) was added to rat NP cells for 24h of 
hyperosmotic treatment. Cells were harvested on day 5 of TonEBP knockdown and 
downstream experiments were performed to assess gene and protein regulation of 
AQP1 and 5, as described previously (Section 3.2.8 and 3.2.9). 
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3.2.11 TonEBP -/- mice immunohistochemistry 
 The generation of TonEBP -/- mice was performed as described by Mak et al., 
2011. The generation of TonEBP -/- mice used in these experiments were generated 
by Makarand Risbud’s laboratory (Thomas Jefferson University, Philadelphia, PA, 
USA). The gene-targeting vector contained the tyrosine kinase gene and a 2.5kb 
TonEBP genomic DNA with part of exon 5 and 6 replaced by neomycin resistance 
gene. The TonEBP targeting vector was transfected into AB2.2 embryonic stem cells 
by electroporation. Cells with the vector incorporated into their genome by 
homologous recombination were selected by the addition of G418 and FIAU into 
culture media after transfection. Vector-integrated cells were then injected into 
blastocytes from C57BL/6J mice. Blastocytes were then implanted into the uterus of 
ICR mice to carry the embryos to term. Mice with deletion of part of exon 5 and 6 
were detected with PCR. TonEBP+/- mice were then backcrossed to C57BL/6J mice 
once and germline transmission confirmed with PCR and southern blotting. TonEBP 
-/- embryos were generated by timed mating of TonEBP +/- mice. The morning of 
vaginal plug detection was considered to be embryonic day 0.5 (E0.5) (Mak et al., 
2011). TonEBP-/- embryos did not develop normally and died after 14.5 days of 
embryonic development due to impaired cardiac development and function (Mak et 
al., 2011). Spines and tails from wildtype TonEBP+/+ (WT) and TonEBP-/- mouse 
embryos were dissected and paraffin embedded. Paraffin embedded 4μm sections 
of spines and tails from WT and TonEBP-/- complete knockout mice at 12.5 days of 
embryonic development (E12.5) were used to investigate the effect of TonEBP 
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knockdown on the in vivo protein expression of AQP1 and 5 within the IVD using 
immunohistochemistry. 
  Sections were dewaxed in histoclear (Leica Microsystems) (3 x 5min), 
rehydrated through 100% ethanol (3 x 5min), 95% ethanol (3 x 1min) and water 
(5min) before washing in PBS (5min). Antigens were retrieved by placing slides in 
citric acid-based antigen unmasking solution (1:100, Vector Laboratories), the 
solution was boiled for 2min and allowed to incubate in solution for 10min at RT. 
Heat antigen retrieval methods were repeated with fresh antigen unmasking solution 
and then slides were cooled at RT for 30min before washing in PBS (2 x 2min). Tissues 
were blocked in 5% (v/v) donkey serum (Abcam), 0.4% (v/v) triton X-100 (Sigma-
Aldrich) in PBS for 1h at RT. All antibodies and wash steps were performed using 
blocking solution. Slides were incubated overnight at 4°C with either rabbit 
polyclonal antibody against AQP1 (1:100, AB3272, Millipore) or rabbit polyclonal 
antibody against AQP5 (1:100, A4979, Sigma-Aldrich). Slides were washed (3 x 5min) 
and incubated with donkey anti-rabbit IgG (H+ L) highly cross-adsorbed secondary 
antibody conjugated to Alexa Fluor® 594 (1:700, A-21207, Invitrogen) for 1h at RT. 
Slides were washed (3 x 5min), mounted with ProLong™ diamond antifade mountant 
with DAPI (Life Technologies) and allowed to cure at RT overnight, protected from 
light. Slides were stored at 4°C. Mounted slides were visualised using an Axio Imager 
A2 (Zeiss). All images were taken at identical exposures to enable the quantification 
of fluorescent intensities. 
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3.2.12 Statistical analysis 
 The regulation of AQP1 and 5 gene and protein expression, in both human 
and rat NP cells, was performed in triplicate on 3 patients or pooled rat cells on 
different days. Data was found to be non-parametric, therefore Kruskall-Wallis with 
Dwass-Steel-Critchlow-Fligner post hoc analysis test was used to identify significant 
differences between AQP1 and 5 gene expression (investigated by qRT-PCR), and 
protein expression (investigated by western blotting). IHC was performed on 3 WT 
and TonEBP-/- rats each, in at least duplicate. Fluorescent images were taken, all at 
the identical exposure, gain and magnification. Fluorescent intensity of NP regions 
was determined using ImageJ software and normalised to the number of NP cells 
within the same IVD. Data was found to be non-parametric, therefore Kruskall-Wallis 
with Dwass-Steel-Critchlow-Fligner post hoc analysis test was used to identify 
significant differences between fluorescent intensities of WT and TonEBP-/- mice, 
after AQP1 and 5 IHC experiments, to determine putative changes in expression. 
  
133 
 
134 
 
3.3 Results 
3.3.1 Hyperosmotic regulation of AQP1 and 5 expression in human NP cells 
 AQP1 gene expression was significantly upregulated in 2D monolayer 
cultured human NP cells after 24h and 72h hyperosmotic treatment (425mOsm/kg) 
(p ≤ 0.05) when compared to untreated controls (325mOsm/kg) at time 0 (Figure 
3.3A). The gene expression of AQP5 in 2D monolayer cultured human NP cells was 
upregulated by the same hyperosmotic treatment at 12, 24, 48 and 72h, when 
compared with untreated controls (p ≤ 0.05) (Figure 3.3B). During 3D alginate culture 
of human NP cells, to restore their in vivo phenotype, AQP1 gene expression was 
upregulated by 48h of both hyperosmotic treatments (425 and 525mOsm/kg) (p ≤ 
0.05) (Figure 3.3C), whereas AQP5 expression was only upregulated by 425mOsm/kg 
treatment for 48h, compared to untreated controls (p ≤ 0.05) (Figure 3.3D). No 
osmotic treatments effected NP cell viability (Appendix VI). 
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Figure 3.3. Hyperosmotic regulation of AQP1 and 5 gene expression in human NP 
cells. (A, B) Regulation of AQP1 and AQP5 gene expression, after 8 - 72h treatment 
with 425mOsm/kg media, in human NP cells cultured in monolayer up to passage 2 
prior to treatment. (C, D) Regulation of AQP1 and AQP5 gene expression, after 48h 
treatment with 425 or 525mOsm/kg media, in human NP cells cultured for 2w 
encapsulated in alginate beads prior to treatment. The osmolality of untreated 
controls in standard culture media was 325mOsm/kg. The osmolality of treatment 
media was altered using NaCl and was measured using a freezing point depression 
osmometer (Model 3320 osmometer, Advanced Instruments). Statistical significance 
determined using Kruskal-Wallis test * = p ≤ 0.05. 
  
136 
 
 AQP1 protein expression in human NP cells, in 2D monolayer culture, was 
significantly upregulated after 8, 24 and 48h of hyperosmotic treatment 
(425mOsm/kg) when compared to untreated controls (325mOsm/kg) at 0h (p ≤ 0.05) 
(Figure 3.4). 
 
Figure 3.4. Hyperosmotic regulation of AQP1 protein expression in human NP cells. 
(A) Western blot analysis of AQP1 expression in human NP cells when exposed to 8, 
24 and 48h of 425mOsm/kg media treatment, when compared to 325mOsm/kg 
(untreated) media controls at 0h. β-actin was used as a loading control. Chameleon® 
duo pre-stained protein ladder (LI-COR) was used to determine the size (kDa) of 
protein bands on blots. (B) Densitometry measurements of AQP1 protein expression, 
in human NP cells, when exposed to 8, 24, and 48h 425mOsm/kg media treatment 
compared to 325mOsm/kg control at 0h. The relative AQP1 expression is normalised 
to β-actin expression. Statistical significance determined using Kruskal-Wallis test * = 
p ≤ 0.05. 
 
3.3.2 TonEBP expression in native human NP tissue 
TonEBP is expressed in non-degenerate (Figure 3.5A), moderately degenerate 
(Figure 3.5B) and severely-degenerate (Figure 3.5C) native human NP tissue. The 
percentage of cells expressing TonEBP within the human NP is high and there is no 
significant difference across any grade of degeneration (Figure 3.5D). 
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Figure 3.5. Protein expression of TonEBP within native human NP tissue, determined 
using IHC on 4μm sections. Representative images if IHC from non-degenerate (A), 
moderately-degenerate (B) and severely-degenerate (C) human NP tissue. (D) 
Immunopositivity results determining the percentage of cells within NP tissue 
expressing TonEBP. Two-hundred cells per patient sample were counted as positive 
or negative. Each point represents an individual patient NP sample. The grades of 
degeneration are described as followed: non-degenerate (0-4), moderately-
degenerate (4.1-6.9) and severely-degenerate (7-12). Positive staining for TonEBP is 
indicated by brown staining and cell nuclei are counterstained blue with Mayer's 
haematoxylin. 
 
3.3.3 Hyperosmotic regulation of AQP1 and 5 expression in rat NP cells 
 AQP1 gene expression was significantly upregulated in rat NP cells after 8h 
treatment with 425mOsm/kg media (p ≤ 0.05) (Figure 3.6A) and after 8h and 24h 
treatment with 525mOsm/kg media (p ≤ 0.05) (Figure 3.6A). After 8h of 525mOsm/kg 
media treatment AQP1 gene expression was significantly higher compared to when 
rat NP cells were exposed to the same treatment for 24h (p ≤ 0.05) (Figure 3.6A). 
Although both time points with 525mOsm/kg treatment significantly upregulated 
AQP1 expression when compared to untreated controls (Figure 3.6A). Treatment 
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with 425mOsm/kg media failed to significantly regulate AQP1 gene expression 
(Figure 3.6A). AQP1 protein expression was upregulated following 8h and 24h of 
425mOsm/kg media treatment and 8h 535mOsm/kg media treatment, when 
compared to untreated controls at 0h (p ≤ 0.05) (Figure 3.6B). The localisation of 
AQP1 protein within monolayer cultured rat NP cells is observed after 
immunofluorescence staining (Figure 3.6C) (secondary antibody controls, Appendix 
VII).  
 Treatment with 525mOsm/kg media, at both 8h and 24h, significantly 
upregulated AQP5 gene expression in rat NP cells compared to untreated controls (p 
≤ 0.05) (Figure 3.6D). Similar to AQP1 gene regulation, AQP5 gene expression was 
significantly increased after 8h of 525mOsm/kg treatment when compared to 24h of 
the same treatment in rat NP cells (Figure 3.6D). All hyperosmotic treatments (425 
and 525mOsm/kg) at 8h and 24h upregulated the protein expression of AQP5 in rat 
NP cells, when compared to 325mOsm/kg (untreated) controls at 0h (p ≤ 0.05) 
(Figure 3.6E). The localisation of AQP5 protein within monolayer cultured rat NP cells 
is observed after immunofluorescence staining (Figure 3.6F) (secondary antibody 
controls, Appendix VII).  
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Figure 3.6. Hyperosmotic regulation and localisation of AQP1 and 5 in monolayer cultured rat NP cells. Gene regulation of AQP1 (A) and AQP5 (D) 
under hyperosmotic conditions. Western blotting results identifying the regulation of AQP1 (B) and AQP5 (F) protein expression under hyperosmotic 
conditions. The localisation of AQP1 (C) and AQP5 (F) within monolayer cultured rat NP cells. Statistical significance determined using Kruskal-Wallis 
test * = p ≤ 0.05. 
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3.3.4 The effect of TonEBP knockdown on the hyperosmotic regulation of AQP1 and 5 
in rat NP cells 
 In rat NP cells, transduced with shTonEBP lentiviral vector (325 and 
525mOsm/kg treatments), the gene and protein expression of TonEBP was 
significantly reduced compared to TonEBP expression in rat NP cells transduced with 
shCTR (325 and 525mOsm/kg treatments) (p ≤ 0.05) (Figure 3.7A and B). In shCTR 
cells, TonEBP gene and protein expression was significantly upregulated in cells 
treated with 525mOsm/kg media when compared with untreated controls 
(325mOsm/kg) (p ≤ 0.05) (Figure 3.7A and B). These results highlight that TonEBP is 
functional within shCTR cells and expression is successfully knocked down in 
shTonEBP cells.  AQP1 gene and protein (expression was upregulated when rat NP 
cells were treated for 24h with hyperosmotic media (525mOsm/kg) in shCTR NP cells 
(p ≤ 0.05) (Figure 3.7C and D). When TonEBP expression was knocked down, AQP1 
gene expression in both untreated and hyperosmotic treatment groups was 
significantly reduced (p ≤ 0.05) (Figure 3.7C). However, AQP1 protein was still 
upregulated after 24h hyperosmotic treatment in shTonEBP transduced cells (p ≤ 
0.05), comparable to the relative expression of AQP1 observed in 24h hyperosmotic 
treatment of shCTR cells (Figure 3.7D).  AQP5 gene and protein expression was still 
upregulated when rat NP cells were treated for 24h with hyperosmotic media 
(525mOsm/kg) in shCTR NP cells (Figure 3.7E and F). When TonEBP expression was 
knocked down, AQP5 gene and protein expression in both untreated and 
hyperosmotic treatment groups was significantly reduced (p ≤ 0.05) when compared 
to the same treatment in shCTR cells (Figure 3.7E and F).   
141 
 
 
Figure 3.7. The effects of TonEBP knockdown on the hyperosmotic regulation of 
AQP1 and 5 in rat NP cells. Rat NP cells were exposed to control (325mOsm/kg) or 
hyperosmotic (525mOsm/kg) treatment for 24hr, after 4d of TonEBP knockdown 
(shTonEBP) or no knockdown control (shCTR). After knockdown and treatment, the 
gene and protein expression of TonEBP (A, B), AQP1 (C, D) and AQP5 (E, F) was 
determined respectively. Results were normalised to 325mOsm/kg shCTR controls. 
Statistical significance determined using Kruskal-Wallis test * = p ≤ 0.05. 
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3.3.5 Effect of TonEBP expression on in vivo expression of AQP1 and 5 
AQP1 was expressed in the spine and tail discs of wild type TonEBP +/+ (Figure 
3.8A and B), and complete knockout TonEBP -/- (Figure 3.8C and D) embryonic mice. 
The relative fluorescence of AQP1 immunostaining in TonEBP +/+ spine discs was 
significantly higher when compared with TonEBP +/+ tail discs, spine and tail discs 
from TonEBP -/- mice (p ≤ 0.05) (Figure 3.8E) (secondary antibody controls, Appendix 
VII).  
AQP5 was expressed in the spine and tail discs of wild type TonEBP +/+ (Figure 
3.9A and B), and complete knockout TonEBP -/- (Figure 3.9C and D) embryonic mice. 
The relative fluorescence of AQP1 immunostaining in TonEBP +/+ spine discs was 
significantly higher when compared with TonEBP +/+ tail discs, spine and tail discs 
from TonEBP -/- mice (p ≤ 0.05) (Figure 9.8E) (secondary antibody controls, Appendix 
VII).  
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Figure 3.8. Expression of AQP1 in the spine and tail IVDs of 
TonEBP +/+ mice at 20x (A) and 63x (B) magnification and TonEBP 
-/- mice at 20x (C) and 63x (D) magnification. (E) Fluorescence 
intensity measurements of AQP1 immunostaining images (20x) 
normalised to cell number. All images were captured at the same 
exposure on an Axio Imager A2 using Zen software (both Zeiss). 
Statistical significance determined using Kruskal-Wallis test * = p 
≤ 0.05. 
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Figure 3.9. Expression of AQP5 in the spine and tail IVDs of TonEBP 
+/+ mice at 20x (A) and 63x (B) magnification and TonEBP -/- mice 
at 20x (C) and 63x (D) magnification. (E) Fluorescence intensity 
measurements of AQP1 immunostaining images (20x) normalised 
to cell number. All images were captured at the same exposure 
on an Axio Imager A2 using Zen software (both Zeiss). Statistical 
significance determined using Kruskal-Wallis test * = p ≤ 0.05. 
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3.4. Discussion 
NP cells have adapted to the environment in which they reside. The 
physiological O2 tension (Fujita et al., 2012), pH (Silagi et al., 2018), nutrient diffusion 
(Urban, 2002), mechanical loading (Neidlinger-Wilke et al., 2012) and osmolality 
(O’Connell, Newman and Carapezza, 2014) of the healthy disc allows NP cells to 
function correctly. When the IVD undergoes degeneration, this environment is 
altered, exacerbating cellular dysfunction. Previous studies, along with results 
presented in this thesis (Chapter 2), have identified that many AQPs are expressed 
by NP tissue (Richardson et al., 2008; Gajghate et al., 2009; Wang and Zhu, 2011; Taş 
et al., 2012; Johnson et al., 2015). However, only a few studies identify how the 
expression of AQPs is regulated in the disc. Those that have investigated AQP 
regulation have found that AQP2 and 3 are upregulated by hyperosmolality, 
physiological to healthy IVD, in murine NP (Gajghate et al., 2009) and NC cells 
(Palacio-Mancheno et al., 2018) respectively. AQP1 and 5 expression is decreased 
during human IVD degeneration (Johnson et al., 2015), yet the cause of this, and how 
both AQPs are regulated, is unknown. Therefore, for the first time this study has 
identified that AQP1 and 5 gene and protein expression in NP cells is upregulated by 
hyperosmolality, which potentially explains why their expression decreases during 
IVD degeneration, as the osmolality of the NP decreases. This study also determined 
that the in vitro and in vivo expression of AQP1 and 5 expression in NP cells is reliant 
on TonEBP. As TonEBP is an important transcription factor involved in the overall 
function of the IVD, the regulation of AQPs by TonEBP may also implicate that their 
function is also important for the health of the IVD. 
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3.4.1 Hyperosmotic regulation of AQP1 and 5 in NP cells 
 AQP1 and 5 in human and rat NP cells were upregulated in hyperosmotic 
conditions that mimic the physiological conditions of the healthy IVD. AQP1 and 5 
are also regulated in a similar manner, under similar hyperosmotic conditions, in a 
range of other tissues and cell types (Jenq et al., 1998; Umenishi and Schrier, 2003; 
Zhou et al., 2007; Lanaspa et al., 2010; Rutkovskiy et al., 2012; Chen et al., 2015; 
Hollborn et al., 2015), possibly indicating shared mechanisms of regulation. However, 
hyperosmotic treatment has also led to the reduction of AQP1 and 5 expression 
(Muller, Sendler and Hildebrandt, 2006) and hypo-osmotic treatment has led to 
increased expression of AQP1 (Moon et al., 2006) in other tissues, highlighting that 
the osmotic regulation of AQP expression is also tissue and cell type-specific. 3D 
hyperosmotic treatment of human NP cells also showed upregulation of AQP1 and 5, 
along with 2D treatment, indicating that this response may be relevant in vivo, as NP 
cells are known to re-differentiate into an in vivo-like state when cultured in 3D. 
 AQP1 and 5 gene expression in human NP cells was upregulated by 
hyperosmotic conditions with an osmolality of 425mOsm/kg, yet the highest 
upregulation of AQP1 and 5 gene expression in rat NP cells was observed with 
525mOsm/kg treatment. This potentially indicates that there are differences in 
regulation across species, possibly due to the differences in NP environments 
between adult human and young rat discs. NC cells are preserved within rat IVDs 
compared to adult human IVDs where NC cells are replaced by NP cells; NC cells 
produce more hydrophilic matrix when compared to NP cells and therefore may raise 
the osmolality of the young rat NP to higher levels when compared to a mature 
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human IVD. Consequently, rat NP cells may respond to a higher osmolality treatment 
(with regards to AQP1 and 5 upregulation), compared to human NP cells, as this 
mimics the in vivo environment more closely, the same going for the response in 
human NP cells, where 425mOsm/kg may represent NP tissue osmolality more 
closely. The differences in gene expression may also be a result of the treatment 
timeframe. AQP1 expression in rat NP cells is significantly upregulated after 8h 
treatment, yet after 24h there is no significant difference compared to baseline 
levels, and AQP5 is not upregulated at either time point. This may simply be due to 
AQP regulation by 425mOs/kg occurring before 8h or after 24h.  
 However, the protein expression of AQP1 and 5 in both human and rat NP 
cells was significantly upregulated by 425mOsm/kg treatment, highlighting that 
protein expression is regulated similarly across species. Yet the results for AQP1 and 
5 protein expression in rat NP cells may not be entirely trustworthy as membranes 
were cut horizontally to separate differently sized protein bands; so AQP1/5 and β-
tubulin could be probed at the same time without needing to strip PVDF membranes. 
This is not best practice as there is the potential to miss out staining of differently 
sized bands which may relate to protein dimers/trimers and post-translationally 
modified proteins, and therefore results may not reflect changes in the total protein 
concentration, only selected species. In human NP cell western blotting the whole 
intact membrane was scanned which may have provided more accurate results. Only 
1 band, at ~28kDa, for AQP1 was observed in human experiments; this increases 
confidence in the observed band, also at ~28kDa, in rat experiments. Also, 
housekeeping proteins were used to normalise against for western blotting analyses. 
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This poses questions as to whether these proteins are really stably expressed under 
treatment and whether there is biological variation between different samples, 
however, published research articles have used the same housekeeping proteins, 
suggesting they are suitable controls under similar treatments in identical cell types 
(Gajghate et al., 2009; Johnson et al., 2017; Choi et al., 2018). 
 As AQP1 and 5 are regulated by osmolality in a similar manner in human and 
rat NP cells, this indicates there are shared mechanisms of regulation and that AQP 
regulation is important for IVD function across species. AQP1 and  5 may enable NP 
cells to adapt to their hyperosmolar environment, and when expression decreases in 
degeneration (Johnson et al., 2015) this may be due to the decrease in the 
extracellular osmolality, causing further dysfunction of NP cells. This may mean that 
AQP1 and 5 expression is decreased as a consequence of initial degeneration, but 
also leads to a continuation of the degenerative cascade where cells can no longer 
adapt to their environment.  
3.4.2 The role of TonEBP on the expression of AQP1 and 5 
TonEBP is important in enabling cells to adapt to a hyperosmotic 
environment, which is essential for NP cells, which reside within a hyperosmotic 
environment during healthy IVD physiology. Hyperosmolality increases TonEBP 
mRNA and protein expression and causes nuclear import and upregulation of target 
genes (TauT, SMIT, BGT1, AR) (Burg, Ferraris and Dmitrieva, 2007) to enable cellular 
adaptation to the IVD environment. TonEBP also controls aggrecan and GAG 
synthesis under hyperosmotic conditions in NP cells (Tsai et al., 2006; Hiyama et al., 
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2009), therefore TonEBP function has important implications for IVD function and 
the maintenance of NP osmolality.  
This study identified that AQP1 and 5 gene expression, along with their 
hyperosmotic upregulation, in rat NP cells was significantly reduced when TonEBP 
expression was knocked down. These results highlight that AQP1 and 5 expression in 
NP cells is potentially governed by the expression and function of TonEBP. TonEBP 
has also been shown to regulate the expression of AQP1 and 5 in other tissues 
(Umenishi and Schrier, 2003; Lanaspa, Miguel A. et al., 2010; Hollborn et al., 2015), 
providing a precedent for results observed in this study. TonEBP expression is also 
required for the hyperosmotic upregulation of AQP2 in NP cells (Gajghate et al., 
2009), therefore AQP1, 2 and 5 may enable the adaptation of NP cells to their 
hyperosmolar environment along with the classical TonEBP-targeted osmotic 
response genes. 
Expression and hyperosmotic upregulation of AQP5 protein is significantly 
down-regulated by TonEBP knockdown suggesting that TonEBP is essential for the 
correct expression of AQP5 in NP cells. However, basal levels of AQP1 protein 
expression were slightly reduced (not significantly) by TonEBP knock down, yet the 
hyperosmotic up-regulation of AQP1 remained unaffected under the same 
conditions. Even though AQP1 gene expression was clearly regulated by TonEBP, 
other mechanisms may control protein expression. A possible explanation is that 
under hyperosmotic conditions, AQP1 protein expression is somehow stabilised for 
longer periods. Evidence for such an explanation is provided by Leitch, Agre and King, 
2001, who identified that in fibroblasts isolated from BALB/c mice AQP1 expression 
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was upregulated by hyperosmotic treatment, which reduced ubiquitination and 
proteasomal degradation of AQP1, ultimately leading to increased protein stability 
under these conditions (Leitch, Agre and King, 2001). This is potentially how AQP1 
protein expression is still upregulated in response to hyperosmolality, when TonEBP 
is knocked down in NP cells, even though gene expression is significantly reduced. 
Along with the classical function in regulating the cell's response to 
hyperosmotic stress, TonEBP has also been shown to increase the expression of TNF-
α (Esensten et al., 2005), IL-6 (Ueno et al., 2013) and MCP-1 (Küper, Beck and 
Neuhofer, 2012; Ueno et al., 2013) under hyperosmotic conditions, all of which are 
upregulated in IVD degeneration (Le Maitre, Hoyland and Freemont, 2007a; Andrade 
et al., 2013; Phillips et al., 2015). Parallel to the role under hyperosmotic stress, 
TonEBP is also activated by TNF-α signalling in NP cells, which leads to the 
upregulation of genes involved in IVD degeneration, rather than the classical osmotic 
response genes (Johnson et al., 2017). This highlights that TonEBP may also play a 
role during IVD degeneration; as the osmolality decreases TonEBP no longer 
upregulates osmotic response genes, possibly including AQP1, 2 and 5, but rather is 
activated by TNF-α signalling, intensifying the degenerative cascade (Johnson et al., 
2017). This could also explain why altered TonEBP signalling has been seen during 
degeneration, yet this study demonstrated no change in numbers of cells expressing 
TonEBP. 
It is currently unknown if AQP1 and 5 could also function upstream of TonEBP, 
this may be possible if AQP1 and 5 at the membrane are able sense changes in 
membrane tension, via modulating the flow of water in response to changes in 
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osmolality (Ozu et al., 2018). They may also contribute to the activation of TonEBP 
along with other proposed mechanisms (Moeckel et al., 2006; Kino et al., 2009). 
Activated TonEBP consequently upregulates AQP1 and 5, forming a positive feedback 
loop, to ensure adaptation to the environment. 
NP expression of AQP1 and 5 was shown to be higher in the spines of WT mice 
compared to TonEBP-/- mice. This suggests that in vivo expression of AQP1 and 5 in 
the IVD is reliant upon TonEBP expression, strengthening the in vitro regulation also 
discovered in this chapter. WT spine expression was also higher than WT tail 
expression. This highlights that AQP1 and 5 expression may be different in mouse 
spine IVDs compared to mouse tail IVDs, but as humans do not have tails, this may 
not be completely relevant to human physiology. It does, however, potentially 
indicate that other factors may contribute to AQP expression in the IVD, along with 
TonEBP, such as mechanical stimuli. Due to the anatomical position of spinal and 
caudal IVDs in mice, there may be differences to the NP microenvironment, such as 
the levels of mechanical stimuli that also provide vital cues to finely tune AQP 
expression. The in vivo expression of AQP1 and 5 was only able to be investigated 
during embryonic development due to the lethality of TonEBP knockdown (Mak et 
al., 2011). Results highlight that during development TonEBP is essential for the 
maintenance of AQP1 and 5, at least in IVDs in the spine. However, it is still unknown 
if TonEBP contributes to in vivo expression in the adult NP, where many other factors 
(which are altered compared to the embryonic environment). Which would implicate 
a role for TonEBP regulation of AQPs in physiology of mature NP cells, as compared 
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to the physiology of notochordal cells, which are the abundant cell type of the NP 
during development.   
3.4.3 Conclusion 
 AQP1 and 5 expression is decreased during human IVD degeneration 
(Johnson et al., 2015). This study has identified that AQP1 and 5 are upregulated by 
hyperosmolality, mimicking the healthy NP, and may explain why expression is 
decreased during degeneration, when the osmolality is decreased. This suggests 
AQP1 and 5 may be part of the mechanisms that allow NP cells to adapt to their 
hyperosmotic environment. TonEBP has already been established as an integral part 
of those mechanisms; as the hyperosmotic upregulation of AQP1 and 5 is dependent 
on TonEBP, this implies they both participate in the osmoadaptation process and 
matrix synthesis (Figure 3.10). During IVD degeneration TonEBP function is 
uncoupled from the altered osmolality and catabolic genes are upregulated instead 
of the classical osmotic response genes, which may also include AQP1 and 5. As 
expression of these genes (and AQP1 and 5) is reduced, NP cells can no longer adapt 
to the degenerate environment and degeneration is exacerbated (Figure 3.10). 
Therefore, AQPs may play a role in adapting NP cells to their environment and 
maintaining the function of NP tissue. 
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Figure 3.10. Hyperosmotic regulation and potential roles of AQP1 and 5 in NP cells. Under hyperosmotic conditions AQP1 and 5 expression is 
upregulated in NP cells. Hyperosmotic upregulation of AQP1 and 5 is controlled by TonEBP, along with the classical osmotic response genes. Therefore, 
possibly indicating that AQP1 and 5 also enable the adaptation of NP cells to their environment and contribute to the maintenance of matrix expression 
during healthy physiology. There is evidence that AQPs may also function as osmosensors when membrane tension is altered, potentially implicating 
AQP1 and 5 in the activation of TonEBP, however this is speculative at present (dashed arrow). During IVD degeneration osmolality is decreased and 
cytokines, such as TNF-α, are present. This may lead to the activation of TonEBP by non-canonical pathways which changes the genes TonEBP targets.  
TonEBP now favours catabolic gene expression over osmotic and matrix genes, contributing to degeneration. This may explain why AQP1 and 5 
expression is decreased during IVD degeneration; decreased osmolality means TonEBP no longer increases expression of osmotic response genes 
(including AQP1 and 5), NP cells fail to adapt to their altered environment and start to produce catabolic factors that intensify the degenerative cascade. 
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Chapter 4: Effect of AQP4 and TRPV4 function on the water 
permeability of human nucleus pulposus cells 
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4.1 Introduction 
The local environment of the NP is hyperosmotic, when compared to many other 
tissues (Ishihara et al., 1997). Yet, the osmolality never remains constant as loading 
applied onto the disc forces water and ions out of the tissue as proteoglycans are 
compressed (McMillan, Garbutt and Adams, 1996). Therefore, the IVD and its 
environment undergo a diurnal cycle where NP cells must adapt to daily fluctuations in 
tissue osmolality and mechanical loading. The diurnal cycle of loading and consequential 
changes to the NP environment are important for regulating the correct function of NP 
cells (Ishihara et al., 1997; Wuertz et al., 2007; Neidlinger-Wilke et al., 2012; O’Connell, 
Newman and Carapezza, 2014). During degeneration, when proteoglycan content of the 
IVD is reduced, the osmolality and mechanical loading of the tissue is permanently 
altered, interfering with the usual diurnal cycle. The altered environment contributes to 
degenerative processes, during which cells lose their ability to adapt to osmotic and 
mechanical cues and start producing catabolic factors (Le Maitre et al., 2009; Gilbert, 
Hoyland and Millward-Sadler, 2010; Gilbert et al., 2011; Sowa et al., 2012). The ability 
of cells to perceive and respond to their environment is essential for their correct 
function, yet the exact mechanisms NP cells employ to adapt to the osmotic and 
mechanical environment, and how these are altered during degeneration, aren’t 
completely understood.  
This thesis has identified that AQPs are upregulated by the hyperosmotic 
environment of the healthy IVD and their expression is regulated at least in part by 
TonEBP, indicating roles relating to the adaptation of NP cells to their environment 
(Chapter 3). An adaptation that is lost during degeneration, when AQP expression is 
decreased (Johnson et al., 2015). However, the regulation of AQPs by osmolality in the 
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IVD does not determine how they function or may contribute to physiological 
adaptations and cellular dysregulation during degeneration. 
4.1.1 AQP function and cellular water permeability 
 Changes in extracellular osmolality causes flux of water, which results in cell 
swelling or shrinkage, depending on the osmotic gradient. The ability of cells to regulate 
their volume is essential for the maintenance of cellular homeostasis. AQPs allow the bi-
directional movement of water and other small solutes through the cell membrane and 
control the water permeability of cells in response to even very small osmotic gradients 
(Agre et al., 2002). Thus, AQPs provide cells a means by which to alter their volume in 
response to changes to the osmotic environment. AQP expression and function allows 
the control of water permeability, enabling  fundamental functions of cells (Krane et al., 
2001b; Tanaka and Koyama, 2011; Day et al., 2014; Kitchen and Conner, 2015; Galan-
Cobo, Ramirez-Lorca and Echevarr, 2016; Ozu et al., 2018). However, changes in cell size 
do not go unchecked; cells initiate complex mechanisms to regulate volume changes 
which prevent excessive swelling or shrinkage which could lead to cell damage. 
4.1.2 TRPV4 
Cells have adapted complex mechanisms to sense and respond to environmental 
stimuli. A group of transmembrane proteins that play a key role in adaptation to the 
environment are TRP channels. The TRP channel family (of which there are 28 members) 
is classified into six subfamilies that enable the cell to respond to a variety of 
environmental stimuli by altering the intracellular Ca2+ concentration. These changes in 
Ca2+ concentration induce transduction of signalling pathways, enabling cells to respond 
to their environment (Samanta et al., 2018). The TRPV subfamily (TRPV1-6) were 
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thought to be activated by alterations in temperature as the first member to be 
identified, TRPV1, is a nociceptor activated by temperature (>42°C) and capsaicin 
(Caterina et al., 1997). However the remaining TRPV family members have diverse 
functions, TRPV4 has been shown to play an important role in the cellular response to 
osmotic and mechanical stress (Liedtke et al., 2000; Strotmann et al., 2000; Nilius et al., 
2001; Köhler et al., 2006; Toft-Bertelsen, Larsen and Macaulay, 2018)  
TRPV4 is expressed in a wide variety of tissues (Everaerts, Nilius and Owsianik, 
2010a) and is activated by hypo-osmotic stimuli, when cell volume increases, enabling 
the influx of Ca2+. This leads to the activation of Ca2+-dependent K+ channels (Arniges et 
al., 2004) and RVD mechanisms (Liedtke and Friedman, 2003; Wu et al., 2007) as cells 
balance external and intracellular osmotic pressure, to regulate cell volume changes 
(Figure 4.1). 
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Figure 4.1. Function of TRPV4 during hypo-osmotic stress and activation of regulatory volume decrease mechanisms. Cell swelling during a decrease 
in extracellular osmolality activates TRPV4 and causes rapid Ca2+ influx. Intracellular Ca2+ activates dependent K+ channels and K+ is transported out of 
the cell. AQPs transport water out of the cell along the osmotic gradient produced by K+ efflux, decreasing cell volume and restoring the osmotic 
balance inside and outside of the cell. 
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However, there have been limited studies on TRPV4 expression and function in 
the IVD. It has been shown that exposing mouse MSCs to low magnitude compression 
enables their differentiation to an NP cell-like phenotype via a TRPV4-dependent 
pathway (Gan et al., 2018) and in bovine NP cells TRPV4 expression was upregulated by 
hypo-osmolality (Walter et al., 2016). The same study also showed preliminary data that 
suggested TRPV4 expression in human IVDs was decreased during degeneration, 
however results were only reported for 2 human discs (Walter et al., 2016). However, 
no studies to date have identified how TRPV4 function potentially affects NP cell 
physiology in response to osmotic stimuli. 
However, TRPV4 has a more established role in cartilage physiology. 
Mechanotransduction of human articular chondrocytes under dynamic loading has been 
shown to be TRPV4-mediated, which regulates expression of matrix genes (O’conor et 
al., 2013). Furthermore, TRPV4 plays an important role in regulating RVD mechanisms 
in chondrocytes after hypo-osmotic stimuli (Lewis, Feetham and Barrett-Jolley, 2011), 
indicating that TRPV4 contributes to healthy cartilage physiology. Indeed, mutations to 
TRPV4 have been shown to reduce channel activity and induce osteoarthritis (Lamandé 
et al., 2011) and deletion of TRPV4 in a mouse model leads to a lack of osmotically-
driven Ca2+ influx and the onset of osteoarthritis (Clark et al., 2010). As TRPV4 is clearly 
important for the correct function of chondrocytes and a lack of expression/function 
leads to osteoarthritis, which has similar pathology to IVD degeneration; TRPV4 may also 
be implicated in the adaptation of NP cells to their hyperosmotic environment and the 
overall health of the disc.  
Interestingly, there is also evidence that the functions of AQPs and TRPV4 may 
be linked. The ability of many cell types to sense changes in extracellular osmolality and 
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trigger RVD mechanisms may rely on AQPs and TRPV4 functioning in synergy. In rabbit 
cortical collecting duct cells hypo-osmotic activation of TRPV4 and RVD mechanisms 
were reliant on AQP2 expression (Galizia et al., 2012). Similar activation of TRPV4 and 
RVD was reliant on AQP5 in mouse salivary gland cells (Liu et al., 2006) and AQP4 and 
TRPV4 have been shown to interact to control RVD in mouse retinal Müller cells (Jo et 
al., 2015). AQP4 has also been shown to co-localise with TRPV4 in mouse astrocytes and 
form a complex that controls the regulation of cell volume (Benfenati et al., 2011a) and 
Mola et al., 2016 identified that AQP1 and 4-influenced swelling was the main trigger 
for RVD and TRPV4 mediated calcium signalling in mouse astrocytes. This regulatory role 
suggests AQPs have many fundamental roles in cell biology other than their function as 
a passive water channel. Which have been suggested as one of many mechanisms that 
potentially enable NP cells to sense changes in their extracellular environment 
(Sadowska et al., 2018). As AQP4 is the isoform that is most permeable to water (Yang 
and Verkman, 1997; Kitchen et al., 2015), understanding its role in NP cells and whether 
it works in unison with TRPV4, to enable adaptation to the fluctuating osmotic 
environment is important to determine. Especially as a decrease in AQP4 is seen in IVD 
degeneration (Chapter 2), which could result in a loss of adaptation, when the 
environment becomes hypo-osmotic.  
To determine the physiological roles of AQP4 and TRPV4 in the IVD, this study 
investigated the expression of TRPV4 in native human NP tissue to determine if levels 
were altered during degeneration. Furthermore, how human NP cells adapt to changes 
in extracellular osmolality was determined by measuring changes in cell volume and the 
rate at which cell size changed within altered osmolality. In addition, the potential 
involvement of AQP4 and TRPV4 was investigated using specific inhibitors and the water 
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permeability of NP cells following osmotic challenge was determined in the presence 
and absence of channel inhibitors. Finally, calcium influx in human NP cells, when 
exposed to altered osmolality, was investigated as changes in extracellular osmolality 
often cause calcium flux in cells which leads to cell volume regulation. To determine 
whether AQP4 and TRPV4 facilitated this, calcium influx was investigated in the presence 
and absence of channel inhibitors.  
4.2 Materials and methods 
4.2.1 Experimental Design 
To investigate TRPV4 expression, IHC was performed on non-degenerate and 
degenerate human NP tissue and co-localisation of AQP4 and TRPV4 in human NP cells 
was determined using confocal microscopy. To investigate how human NP cells 
responded to shifts in extracellular osmolality, human NP cells were exposed to rapid 
physiological alteration to osmolality to mimic healthy and degenerate conditions. A 
plate-reader based assay, utilising the self-quenching effects of Calcein-AM in response 
to relative intracellular concentration, was used to determine the rate at which NP cells 
respond to extracellular osmolality changes by modulating their size (Fenton et al., 
2010). To determine the actual change in cell volume to rapid changes in osmolality, 
flow cytometry and fluorescent microscopy methods were utilised. Measurements 
taken from both the rate of cell volume change and the actual cell volume change were 
used to determine the relative water permeability from equations outlined by Fenton et 
al., 2010. Calcium influx in response to altered osmolality, an important cellular 
adaptation response, was measured using Fluo-4 direct calcium assay in a plate reader 
setup. To investigate the effects of AQP4 and TRPV4 function on these processes, NP 
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cells were either treated with specific inhibitors to block channel function or left as 
controls during all experiments. The experimental design is outlined in Figure 4.2. 
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Figure 4.2. Experimental design of methods used in this chapter. 
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4.2.2 Human Tissue, NP cell extraction and culture 
Human IVD tissue was obtained with ethical consent, NP cells extracted and 
monolayer cultured according to methods outlined in section 2.2. 
4.2.3 TRPV4 gene expression in native human NP tissue 
The gene expression of TRPV4 was identified from directly extracted RNA, 
subsequent cDNA synthesis and qRT-PCR of non-degenerate and degenerately graded 
human NP tissue, using methods outlined in section 2.2. Pre-designed primer/probe mix 
for human TRPV4 gene (Hs01099348_m1, Life Technologies) was used and normalised 
to GAPDH and 18s. 
4.2.4 TRPV4 protein expression in native human NP tissue 
The expression of TRPV4 protein in non-degenerate and degenerately graded 
human NP tissue was assessed using IHC as outlined in section 2.2.7. Slides were blocked 
in 1% (w/v) BSA in 25% (v/v) goat serum (Abcam) and 75% (v/v) TBS. Using rabbit 
polyclonal primary antibody against TRPV4 (1:200, ab94868, Abcam) and goat anti-
rabbit IgG (H&L) (Biotin) secondary antibody (1:500, ab6720, Abcam). 
4.2.5 Immunofluorescence 
Human NP cells were seeded into chamber slides and immunofluorescence 
protocols were performed as described in section 2.2.8. To determine potential co-
localisation of TRPV4 and AQP4, dual immunostaining was performed by incubating 
fixed NP cells with rabbit polyclonal antibody against TRPV4 (1:200, ab94868, Abcam) 
and mouse monoclonal antibody against AQP4 (1:200, ab9512, Abcam). During 
secondary antibody staining, fixed cells were incubated with goat anti-rabbit IgG (H +L) 
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cross-adsorbed, Alexa Fluor® 488 (1:500, A-11008, Invitrogen) and goat anti-mouse IgG 
(H+L) cross-adsorbed, Alexa Fluor® 633 (1:500, A-21050, Invitrogen). Staining and co-
localisation images were captured with a LSM 800 confocal microscope (Zeiss) using Zen 
software (Zeiss). 
4.2.6 Rate of human NP cell swelling and shrinkage 
Human NP cells were seeded into black-walled 96-well plates (Corning) at a 
density of 1x104 cells/well for 48h prior to experiments. Calcein, AM (C1430, Invitrogen) 
stock at 5mM in DMSO was produced. Cells were loaded with 5μM calcein, AM (1:1000 
from stock) in standard culture media for 90min at 37°C. After calcein incubation, cells 
were washed twice with standard culture media, a final volume of 75μL standard culture 
media was added per well and cells were allowed to equilibrate to new media for at 
least 5min at 37°C. Prior to experiments, protocols to measure the rapid rate of change 
in calcein fluorescence (Figure 4.3) within cells treated with altered osmolality media 
were set up on a CLARIOstar plate reader (BMG Labtech). Utilising the well mode to 
detect fluorescent intensity, protocols was set up with a preset of calcein optical settings 
(ex. 483-14, em. 530-30). Two kinetic windows were setup: a baseline reading of 5s (time 
-5s to 0s) at 50ms intervals, followed by injection (at time 0s) of 75μL osmotically altered 
media and a final kinetic window reading for 50s (0s - 45s) at 50ms intervals (total of 
1000 intervals). Protocol setup and timing is shown in Figure 4.4.  
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Figure 4.3. Mechanism of calcein-AM fluorescence in response to cell size. (A) Calcein-AM structure. (B) The fluorescence of intracellular calcein is 
dependent on its relative concentration within the cell. At higher intracellular concentrations, when the cell shrinks in response to hyperosmolality, 
calcein undergoes self-quenching; at lower intracellular concentrations, when the cell swells in response to hypo-osmolality, calcein fluorescence 
increases. These rapid changes in calcein fluorescence can be recorded on a plate reader and the rate of cell volume change determined (Fenton et al., 
2010).  The process of calcein self-quenching is not completely understood, but it may depend on dye dimerisation, energy transfer to non-fluorescent 
dimers and collisional quenching interactions between dye monomers (Chen and Knutson, 1988). 
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Figure 4.4. Plate reader parameters. (A) Basic parameters of protocol to determine rapid 
rate of change in calcein fluorescence using a CLARIOstar plate reader (BMG Labtech). 
(B) Timing overview of kinetic windows and injection within protocol to determine rapid 
rate of change in calcein fluorescence using a CLARIOstar plate reader (BMG Labtech). 
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The protocol temperature was set to 37°C and the plate reader injector and 
tubing was primed with an appropriate amount of treatment media prior to 
experiments. The production of treatment media from standard culture media is 
outlined in Table 4.1. 
Treatment media 
(mOsm/kg) 
Production of treatment  Final mOsm/kg once 
injected onto cells 
125 38.5%(v/v) dH2O 225 
325 Nothing added - control 325 
525 200mM Sucrose 425 
725 400mM Sucrose 525 
Table 4.1 Production of the final osmotically altered treatment media, within a 
physiological range, to induce NP cell swelling and shrinkage when 75μL is injected into 
wells containing 75μL of standard culture media. All media used in experiments was 
phenol red-free. 
 
Plates were loaded into the plate reader and protocols were performed on NP 
cells from 3 patients in triplicate to determine the rate of human NP cell swelling and 
shrinkage in response to physiological alterations in extracellular osmolality. 
Experiments were repeated after 1h incubation of NP cells (already seeded into 96-well 
plates at 1x104 cells/well) with 300μM AQP4 inhibitor (AQP4i) (TGN 020, Tocris) or 
4.8μM TRPV4 inhibitor (TRPV4i) (HC-067047, Sigma-Aldrich) to determine the function 
of these channels on the rate of NP cell swelling and shrinkage. During inhibition 
experiments, all washes and treatment injections were performed with media 
containing 300μM AQP4i or 4.8μM TRPV4i when appropriate. Relative fluorescence of 
calcein (F1/F0) over time (s) curves were plotted and the rate of the change in F1/F0 was 
determined by fitting plateau followed by one phase association/decay nonlinear 
regression analysis to curves using GraphPad Prism v7.03 software.  
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4.2.7 Cell size determination 
Human NP cells (from 3 individual patients in triplicate) were trypsinised and 
resuspended in standard culture media at a density of 2x105 cells/mL. Live cells were 
labelled with CFSE - Cell Labelling Kit (1:1000, ab113853, Abcam) for 10min at RT 
protected from light and washed before being resuspended in 1mL standard culture 
media (without phenol red). An equivalent amount (1mL) of altered osmolality 
treatment media (Table 4.1) was added to cells for approx. 30s (time taken for calcein 
F1/F0 curves to plateau) before forward scatter (FSC) (proportional to cell size) was 
determined on 10,000 events using a FACSCalibur flow cytometer (BD Biosciences) and 
CellQuest Pro v5.2.1 software (BD Biosciences). Furthermore, to determine actual cell 
size after 30s treatment, cells at a density of 2x105 cells/mL were added to Countess™ 
cell counting chamber slides (Invitrogen) and images of live (CFSE stained), suspended 
NP cells were captured using a BX60 fluorescent microscope (Olympus) using cellSens 
software (Olympus). The area of at least 200 cells/repeat from 2D images was 
determined using ImageJ; cells that had an aspect ratio of ≥1.5 and an area of ≤100 pixels 
were excluded to remove doublets/clumps of cells and cell debris. Size calculations of 
cells in suspension relied on the presumption that all suspended cells used for the 
analysis of 2D and 3D cell size had spherical morphology. Cell size was calculated from a 
series of equations, firstly to determine the radius of cells from 2D area measurements 
(Equation 4.1). 
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𝑟 = √
𝐴
𝜋
 
Equation 4.1. Radius of a circle. Where r = radius, A = area, π = pi. 
Once the average radius of cells was determined this was used to determine the 
average cell surface area (Equation 4.2) and average cell volume (Equation 4.3) for each 
repeat experiment. 
𝐴 = 4𝜋𝑟2 
Equation 4.2. Surface area of a sphere. Where A = surface area, π = pi, r = radius. 
𝑉 =  
4
3
𝜋𝑟3 
Equation 4.3. Volume of a sphere. Where V = volume, π = pi, r = radius. 
Both cell surface area and cell volume measurements, along with the rate of 
change in F1/F0 over time, were used to determine the water permeability of human NP 
cells in response to altered extracellular osmolality (Section 4.2.8). All cell size 
determination experiments were also performed after 1h incubation of NP cells with 
either AQP4i (300μM TGN 020, Tocris) or TRPV4i (4.8μM HC-067047, Sigma-Aldrich), 
which were also added to each wash, resuspension and CFSE incubation steps 
throughout the experimental procedure. 
4.2.8 Water permeability determination  
Using values calculated from the rate of NP cell swelling and shrinkage (section 
4.2.6) and NP cell size determination (section 4.2.7), the water permeability of human 
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NP cells in response to alterations in extracellular osmolality, and the potential 
involvement of AQP4 and TRPV4, was determined using Equation 4.4. 
𝑃𝑓 =
𝐾 × [𝑉0 − 𝑉𝑚𝑖𝑛2]
𝐴 × ∆𝜋 × 𝑉𝑤
 
Equation 4.4. Water permeability. Where Pf = water permeability, K = rate constant for 
one phase decay/association, V0 = starting cell volume, Vmin2 = cell volume after 
treatment, A = cell surface area, Δπ = applied osmotic gradient, Vw = partial molar 
volume of water (1.8x10-5m3/mol). As [V0 - Vmin2] reflects the total cell volume change 
in response to the change in extracellular osmolality, K x [V0 - Vmin2] describes the 
theoretical fraction of total volume change per one x-axis unit change (50ms) at the 
initial rate of volume change. Adapted from (Fenton et al., 2010). 
 
Average Pf of human NP cells, for each patient, was calculated in response to 
physiological changes in osmolality (325mOsm/kg → 225, 425 or 525mOsm/kg) with or 
without AQP4i and TRPV4i. All Pf values were normalised to the average Pf of controls 
in the absence of inhibitors, to determine the effect of AQP4i and TRPV4i on the Pf of 
human NP cells at each extracellular osmolality change. 
4.2.9 Fluo-4 Direct™ Calcium influx assay 
Calcium influx into human NP cells in response to extracellular osmolality 
alterations was measured using Fluo-4 Direct™ calcium assay kit (F10471, Invitrogen). 
Human NP cells were seeded into black-walled 96-well plates (Corning) at a density of 
1x104 cells/well for 48h prior to experiments. Fluo-4 Direct™ (2x) calcium reagent 
loading solution (Invitrogen) was prepared following the manufacturer's guidelines: 
10mL Fluo-4 Direct™ calcium assay buffer was added to one bottle of Fluo-4 Direct™ 
calcium reagent (component A). Media was aspirated from cells and an equal volume of 
Fluo-4 Direct™ (2x) calcium reagent loading solution (37.5μL) and standard culture 
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media (37.5μL) was added to cells, for a total volume of 75μL per well. Plates were 
incubated for 1h at 37°C protected from light. Following incubation, plates were ready 
for experimental use without removing Fluo-4 Direct™ (2x) calcium reagent loading 
solution and standard culture media from wells. Calcium influx into human NP cells in 
response to physiological alterations of extracellular osmolality (325mOsm/kg →225, 
325, 425 or 525mOsm/kg) was performed on a CLARIOstar plate reader (BMG Labtech) 
following the same protocol outlined in section 4.2.6, with optic settings changed to 
excitation at 494nm and emission at 516nm. Treatment media (Table 4.1) injected into 
wells after the first kinetic window (-5s to 0s). Experiments were also performed after 
1h incubation of cells with either AQP4i (300μM TGN 020, Tocris) or TRPV4i (4.8μM HC-
067047, Sigma-Aldrich), simultaneously added to cells with Fluo-4 Direct™ (2x) calcium 
reagent loading solution and media. During AQP4i and TRPV4i experiments, inhibitors 
were also added to treatment media prior to injection. 
4.2.10 Statistical Analysis 
TRPV4 protein expression in human NP tissue (assessed by IHC) was found to be 
non-parametric, therefore Kruskall-Wallis with Dwass-Steel-Critchlow-Fligner post hoc 
analysis test was used to identify significant differences between expression across 
grades of degeneration. The rate of cell swelling/shrinkage (determined by calcein 
fluorescence) was investigated in triplicate in human NP cells from 3 patients. Data was 
non-parametric and to determine significance between paired samples from the same 
patient across 3 treatment groups (CTR, AQP4i and TRPV4i), the Friedman test was used 
with Conover post hoc analysis. Cell volume data was non-parametric, therefore 
Kruskall-Wallis with Dwass-Steel-Critchlow-Fligner post hoc analysis test was used to 
identify significant differences in cell volume, at a fixed osmolality, when comparing 
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treatment groups (CTR, AQP4i and TRPV4i). The Friedman test was used to determine 
significance between the geometric mean of the FSC, and the Pf, from paired patient 
samples when comparing 3 treatment groups (CTR, AQP4i and TRPV4i), at a fixed 
osmolality. Ca2+ influx data was non-parametric, therefore Kruskall-Wallis with Dwass-
Steel-Critchlow-Fligner post hoc analysis test was used to identify significant differences 
in the max-min F1/F0 and time taken to reach maximum F1/F0 in NP cells treated with 
different osmolalities, or inhibitors (CTR, AQP4i and TRPV4i) at 225mOsm/kg. 
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4.3 Results 
4.3.1 Expression of TRPV4 within native human NP tissue 
TRPV4 was expressed at both gene and protein level within native human NP 
tissue (Figure 4.5). The relative gene expression of TRPV4 did not change significantly 
during IVD degeneration (p ≤ 0.05) (Figure 4.5A). The majority of NP cells expressed 
TRPV4 protein in native tissue, however, immunopositivity was unaffected by IVD 
degeneration (Figure 4.5B) (IgG controls, Appendix VIII). TRPV4 was also still expressed 
by NP cells extracted from human IVD tissue at passage 2. (Figure 4.5C) Within 2D 
cultured human NP cells TRPV4 was found to co-localise with AQP4 (Figure 4.5C), 
potentially suggesting related functions shared between these transmembrane channel 
proteins (IgG controls, Appendix VIII). 
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Figure 4.5. TRPV4 expression within native human NP tissue and cultured NP cells. (A) Gene expression of TRPV4. Each point indicates an 
individual patient. (B) Immunopositivity results determining the percentage of cells within NP tissue expressing TRPV4. Two-hundred cells per 
patient sample were counted as positive or negative (B.iv). Each point represents an individual patient. NP tissue was graded: non-degenerate 
(0-4, B.i), moderately-degenerate (4.1-6.9, B.ii) and severely-degenerate (7-12, B.iii). Positive staining for TRPV4 is indicated by brown staining 
and cell nuclei are counterstained blue with Mayer's haematoxylin. (C) Immunofluorescence highlighting the expression of TRPV4 (green) in 2D 
cultured human NP cells co-localises with AQP4 (red). Cell nuclei counterstained with DAPI (blue). Images taken at 63x objective magnification, 
using a LSM 800 confocal microscope (Zeiss). Scale bar 20μm. Statistical significance determined using Kruskal-Wallis test * = p ≤ 0.05. 
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4.3.2 Rate of NP cell swelling and shrinkage in response to extracellular osmolality 
The relative fluorescence (F1/F0: F1 = fluorescence at time n / F0 = fluorescence 
at baseline) of intracellular calcein was altered, in real-time, when no-inhibition 
control NP cells were exposed to altered extracellular osmolality (225, 425 and 
525mOsm/kg), after 5s baseline readings in standard culture media (325mOsm/kg) 
(Figure 4.6A). When control media (325mOsm/kg) was added after baseline, the F1/F0 
was unchanged (Figure 4.6A). Incubation with AQP4i (300μM, TGN 020) or TRPV4i 
(4.8μM, HC-067047) altered the real-time change in intracellular calcein F1/F0 when 
NP cell were exposed to 225mOsm/kg (Figure 4.5B.i), 325mOsm/kg (Figure 4.6B.ii), 
425mOsm/kg (Figure 4.6B.iii) and 525mOsm/kg (Figure 4.6B.iv) treatments 
(Determination of rate of cell volume change, Appendix IX and X). 
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Figure 4.6. The real-time rate of change in the relative fluorescence (F1/F0) of calcein, 
when NP cells are exposed to physiological alterations in extracellular osmolality (A). 
Baseline fluorescence of calcein-loaded NP cells was recorded for 5s (-5s - 0s), before 
injection of altered osmolality media and change in calcein fluorescence recorded for 
a further 45s (0s - 45). Change in F1/F0 was recorded in control cells and NP cells 
treated with AQP4i (300μM, TGN 020) or TRPV4i (4.8μM, HC-067047) for 1hr prior to 
injection with (B.i) 225, (B.ii) 325, (B.iii) 425 and (B.iv) 525mOsm/kg. 
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The rate of change in fluorescence (K Δ F1F0) at 225mOsm/kg treatment was 
significantly reduced in AQP4i and TRPV4i treated NP cells when compared to no-
inhibition control NP cells (CTR) (p ≤ 0.05) (Figure 4.7A). At 425mOsm/kg treatment 
K Δ F1F0 was significantly decreased in AQP4i and TRPV4i compared to CTR (p ≤ 0.05) 
(Figure 4.7B). At 525mOsm/kg treatment K Δ F1F0 was significantly decreased in 
TRPV4i compared to CTR (p ≤ 0.05) (Figure 4.7C).  
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Figure 4.7. The rate of change in intracellular calcein fluorescence during alterations to extracellular osmolality. The rate of change in relative 
fluorescence (K Δ F1/F0) was determined from curves showing the real-time change in fluorescence of calcein, which is proportional to cell swelling and 
shrinkage in response to alterations in extracellular osmolality. Rate values were extrapolated by fitting plateau followed by one-phase association 
(225mOsm/kg)/ decay (425, 525mOsm/kg) non-linear regression analysis to curves. K Δ F1F0 was determined for 3 patient sample NP cells in triplicate, 
average values are plotted and normalised against no inhibition controls (CTR) for each treatment: (A) 225, (B) 425 and (C) 525mOsm/kg. Extracellular 
osmolality was altered for each treatment from a starting osmolality of 325mOsm/kg. Statistical significance determined using Freidman test * = p ≤ 
0.05. 
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4.3.3 Change in NP cell volume in response to extracellular osmolality alterations 
The volume of AQP4i and TRPV4i treated human NP cells exposed to 
225mOsm/kg was significantly reduced, when compared to no-inhibition control 
(CTR) NP cells (p ≤ 0.05) (Figure 4.8A). The volume of TRPV4i treated NP cells was 
significantly reduced compared to CTR cells at 325mOsm/kg (p ≤ 0.05) (Figure 4.8B). 
AQP4i and TRPV4i failed to significantly alter cell volume of NP cells, compared to 
CTR, when exposed to 425 (Figure 4.8C) and 525mOsm/kg (Figure 4.8D) (CFSE-loaded 
NP cells, Appendix XI).  
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Figure 4.8. NP cell volume changes in response to altered extracellular osmolality. 
Effect of AQP4i (1h, 300μM, TGN 020) and TRPV4i (1h, 4.8μM, HC-067047) on NP cell 
volume, when compared to no inhibition controls (CTR), after standard culture media 
(325mOsm/kg) was altered to a final osmolality of 225 (A), 325 (B), 425 (C) and 
525mOsm/kg (D). Cell volume was calculated from the area of 2D images of at least 
200 CFSE-stained live NP cells in suspension from 3 patients in triplicate. Each point 
represents an individual image used for the analysis of cell volume. Statistical 
significance determined using Kruskal-Wallis test * = p ≤ 0.05. 
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The forward scatter of the geometric mean (FSC-Geo. Mean) of human NP 
cells was altered when extracellular osmolality was decreased or increased from 
control osmolality (325mOsm/kg) (Figure 4.9 and 4.10). Pre-treatment with AQP4i 
(Figure 4.9) and TRPV4i (Figure 4.10)  also altered FSC-Geo. Mean at 225 (Figure 4.9A 
and 4.10A), 325 (Figure 4.9B and 4.10B), 425(Figure 4.9C and 4.10C) and 
525mOsm/kg (Figure 4.9D and 4.10D) (Flow cytometry gating, Appendix XI).  
 
Figure 4.9. Flow cytometry analysis of NP cell geometric mean of forward scatter 
(FSC-H) changes in response to extracellular osmolality changes and the effect of 
AQP4i (1h, 300μM, TGN 020) at 225 (A), 325 (B), 425 (C) and 525mOsm/kg (D). 
Histograms show representative experiments from an individual patient (HD540). 
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Figure 4.10. Flow cytometry histogram analysis of NP cell geometric mean of forward 
scatter (FSC-H) changes in response to extracellular osmolality changes and the effect 
of TRPV4i (1h, 4.8μM, HC-067047) at 225 (A), 325 (B), 425 (C) and 525mOsm/kg (D). 
Histograms show representative experiments from an individual patient (HD540).  
 
FSC-Geo. Mean of AQP4i and TRPV4i treated NP cells was significantly 
reduced when compared to FSC-Geo. Mean of CTR NP cells at 225mOsm/kg 
treatment (p ≤ 0.05) (Figure 4.11A). FSC-Geo. Mean was also significantly reduced in 
TRPV4i treated cells at 325mOsm/kg treatment, when compared with CTR NP cells 
(p ≤ 0.05) (Figure 4.11B). Treatment with 425 (Figure 4.11C) or 525mOsm/kg (Figure 
4.11D) media failed to significantly alter the FSC-Geo. Mean of AQP4i or TRPV4i 
treated NP cells when compared to CTR. 
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Figure 4.11. Forward scatter of geometric mean (FSC-Geo. Mean) measurements of 
NP cells exposed to extracellular osmolality changes. Average FSC-Geo. Mean is 
determined for each patient after NP cells are exposed to (A) 225, (B) 325, (C) 425 
and (D) 525mOsm/kg. Prior to treatment, media osmolality was 325mOsm/kg. At 
each treatment osmolality, the FSC-Geo. Mean of AQP4i (1h, 300μM, TGN 020) and 
TRPV4i (1h, 4.8μM, HC-067047) treated cells was compared to no inhibition control 
cells (CTR). Statistical significance determined using Freidman test * = p ≤ 0.05. 
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4.3.4 Effect of AQP4 and TRPV4 inhibition on the water permeability of human NP 
cells 
The normalised water permeability of human NP cells was significantly 
reduced with AQP4i and TRPV4i, when compared with no-inhibition control cells, at 
both 225mOsm/kg (p ≤ 0.05) (Figure 4.12A) and 425mOsm/kg (p ≤ 0.05) (Figure 
4.12B). At 525mOsm/kg treatment, the normalised water permeability of TRPV4i 
treated NP cells was also significantly reduced when compared to no-inhibition 
control cells (p ≤ 0.05) (Figure 4.12C). AQP4i did not significantly change the water 
permeability of human NP cells, when compared to no-inhibition controls, at 
525mOsm/kg treatment (Figure 4.12C). 
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Figure 4.12. Water permeability of human NP cells in response to extracellular osmolality alterations and the effect of AQP4 and TRPV4 inhibition. 
Water permeability (Pf) is calculated using the rate of change in calcein fluorescence (K Δ F1F0), the actual change in cell volume and cell surface area, 
after alterations to extracellular osmolality, and applied to Equation 4.4. All Pf values were normalised to the average of no inhibition controls (CTR) 
and averaged per patient. The normalised Pf of AQP4i (1h, 300μM, TGN 020) and TRPV4i (1h, 4.8μM, HC-067047) was compared to CTR at (A) 225, (B) 
425 and (C) 525mOsm/kg treatments. Prior to treatment, media osmolality was 325mOsm/kg. Statistical significance determined using Freidman test 
* = p ≤ 0.05. 
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4.3.5 Human NP cell Ca2+ influx in response to altered extracellular osmolality 
The F1/F0 of intracellular Fluo-4 direct, relative to Ca2+, was altered in real-
time, when NP cells were exposed to altered extracellular osmolality (225, 325, 425 
and 525mOsm/kg), after 5s baseline readings in standard culture media 
(325mOsm/kg) (Figure 4.13A). The max-min F1/F0 of intracellular Fluo-4 direct was 
significantly increased in 225mOsm/kg treated NP cells, compared to all other 
osmotic treatments (p ≤ 0.05) (Figure 4.13B). The max-min F1/F0 of intracellular Fluo-
4 direct was significantly increased in 325 and 425mOsm/kg treated NP cells, 
compared to 525mOsm/kg treated NP cells (p ≤ 0.05) (Figure 4.13B). The time taken 
to reach maximum F1/F0 of intracellular Fluo-4 direct in 225mOsm/kg treated NP cells 
was significantly decreased when compared to all other osmotic treatment groups (p 
≤ 0.05) (Figure 4.13C). 
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Figure 4.13. Ca2+ influx in human NP cells when exposed to altered extracellular 
osmolality. (A) Fluo-4 direct assay (Invitrogen) was used to measure the rate of Ca2+ 
influx into human NP cells. Baseline fluorescence of calcein-loaded NP cells was 
recorded for 5s (-5s - 0s), before injection of altered osmolality media and change in 
relative Fluo-4 fluorescence (F1/F0), dependent on the intracellular Ca2+ 
concentration, was recorded for a further 45s (0s - 45).  (B) Max-min F1/F0 values for 
Ca2+ influx at each treatment osmolality, indicating total Ca2+ influx over time. (C) 
Time (s) taken for max F1/F0 (Ca2+ influx) to be reached in human NP cells at each 
treatment osmolality. Statistical significance determined using Kruskal-Wallis test * 
= p ≤ 0.05. 
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4.3.6 Effect of AQP4 and TRPV4 inhibition on hypo-osmotic Ca2+ influx in human NP 
cells 
The F1/F0 of intracellular Fluo-4 direct, relative to Ca2+, was altered in real-
time, when NP cells were exposed to 225mOsm/kg extracellular osmolality after 
AQP4i, TRPV4i or CTR treatment, and 5s baseline readings in standard culture media 
(325mOsm/kg) (Figure 4.14A). The max-min F1/F0 of intracellular Fluo-4 direct was 
significantly increased in CTR treated NP cells, compared to AQP4i and TRPV4i 
treated NP cells (p ≤ 0.05) (Figure 4.14B). The time taken to reach maximum F1/F0 of 
intracellular Fluo-4 direct in AQP4i treated NP cells was significantly increased when 
compared to CTR and TRPV4i treated NP cells (p ≤ 0.05) (Figure 4.14C). 
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Figure 4.14. Effect of AQP4 and TRPV4 inhibition on the hypo-osmotic induction of 
Ca2+ influx. (A) Fluo-4 direct assay (Invitrogen) was used to measure the rate of Ca2+ 
influx into human NP cells when exposed to hypo-osmotic treatment (225mOsm/kg). 
Baseline fluorescence of calcein-loaded NP cells was recorded for 5s (-5s - 0s), before 
injection of 225mOsm/kg media and change in relative Fluo-4 fluorescence (F1/F0), 
dependent on the intracellular Ca2+ concentration, was recorded for a further 45s (0s 
- 45). (B) Max-min F1/F0 values for Ca2+ influx at 225mOsm/kg.(C) Time (s) taken for 
max F1/F0 (Ca2+ influx) to be reached in human NP cells. Change in F1/F0 was recorded 
in control cells (CTR) and NP cells treated with AQP4i (300μM, TGN 020) or TRPV4i 
(4.8μM, HC-067047) for 1hr prior to injection. Statistical significance determined 
using Kruskal-Wallis test * = p ≤ 0.05. 
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4.4 Discussion 
The hyperosmotic environment of the IVD is constantly changing due to 
diurnal loading, where water is imbibed and then dissipated as the mechanical 
loading of the spine changes. In physiologically-matched osmolality, matrix 
expression is increased in NP cells (Wuertz et al., 2007; Neidlinger-Wilke et al., 2012; 
O’Connell, Newman and Carapezza, 2014), indicating NP cells have adapted their 
function to the hyperosmotically fluxing environment within the IVD.  Therefore, 
mechanisms must be in place to protect NP cells, and enable their adaptation to 
hypo- and hypertonic shifts in extracellular osmolality. It is well documented that 
TonEBP contributes to NP cells’ long-term adaptation to hyperosmolality (Chapter 3) 
and the expression of matrix molecules (Tsai et al., 2006; Hiyama et al., 2009; 
Johnson, Shapiro and Risbud, 2014b). However, the mechanisms that control the 
initial response to altered extracellular osmolality, such as the rapid flux of water and 
ions and changes in cell volume, in NP cells are not completely understood. Especially 
how hypo-osmotic conditions, observed during IVD degeneration, may impacts these 
fundamental cellular processes and the overall function of the IVD. 
This study identified that NP cells rapidly modulate their cell volume and the 
rate which volume is changed in response to extracellular osmolality alterations that 
mimicked the environment of the healthy and degenerate IVD. The magnitude of the 
rate of cell volume change, actual cell volume change and water permeability 
responses to extracellular osmolality alterations in NP cells was reliant upon the 
function of AQP4 and TRPV4. Under hypo-osmotic treatment, AQP4i decreased NP 
cell water permeability, maximum Ca2+ influx and time taken to reach maximum Ca2+ 
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influx; this indicates that during degeneration, when osmolality and AQP4 expression 
is decreased (Chapter 2), NP cells are no longer adapting to their environment. The 
expression of TRPV4 in human NP tissue was not sensitive to IVD degeneration and 
its function was required to maintain water permeability across all osmotic 
treatments, indicating TRPV4 enables fundamental cellular processes, such as 
volume regulation, regardless of IVD degeneration. As TRPV4i decreased the water 
permeability, and AQP4i decreased hypo-osmotic Ca2+ influx, in NP cells; this suggests 
that the function of both channels is linked and may play joint roles during NP cell 
adaptation to its microenvironment.  
4.4.1 NP cell volume change in response to extracellular osmolality 
Upon exposure to alterations in extracellular osmolality, cells adapt by 
altering their volume accordingly via osmotically driven water transport and the 
activation of regulatory volume changes (Corasanti, Gleeson and Boyer, 1990; Lang 
et al., 1998). This study has shown that human NP cells are no different; under hypo-
osmotic treatment cell volume was increased, and under hyperosmotic treatment, 
cell volume was reduced. These results may indicate that during IVD degeneration, 
when osmolality is decreased compared to healthy conditions, human NP cell size 
increases. Bovine NP cells show a similar trend when exposed to low osmolality 
(Maidhof et al,. 2014) and rabbit NP cell size was also increased after an AF puncture 
model of degeneration (He et al., 2013), indicating that NP cell size could possibly be 
used to determine the degenerative state of the IVD.  
Fluorescent microscopy was used to quantify the volume of CFSE-labelled NP 
cells when exposed to altered osmolality. Flow cytometry, specifically shifts in FSC, 
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was used alongside microscopy to determine how NP cell size was altered. Shifts in 
FSC have been previously used to determine changes in cell size after osmotic 
alteration (MacDonald and Zaech, 1982; Sloot, Hoekstra and Figdor, 1988; Adan et 
al., 2017) and NP cell size has been characterised using the same method (Chen, Yan 
and Setton, 2006). As results from independently analysed microscopy and flow 
cytometry experiments on NP cell size both indicate a similar response to osmotic 
stimuli, this strengthens the observations presented in this study.  
However, FSC measurements may not be directly related to the changes in 
cell size, as it may alter depending on the light scattering properties of different cells 
(McGann, Walterson and Hogg, 1988; Adan et al., 2017; Yurinskaya et al., 2017), 
therefore flow cytometry results presented here may only reflect the relative change 
in NP cell size, rather than the actual change in size. Furthermore, the actual size of 
human NP cells could not be determined from flow cytometry measurements 
because the FSC of NP cells could not be integrated with the FSC of size calibration 
beads, indicating again that FSC is not always directly proportional to cell size. Many 
properties may effect FSC, such as cell hydration state (Yurinskaya et al., 2017). This 
may explain why the FSC of NP cells and calibration beads did not align; as the 
pericellular matrix surrounding NP cells in culture (Sato et al., 2001, Sato et al., 2004; 
Horner et al., 2002) changes the hydration and light scattering properties of NP cells 
compared to non-fluorescent polystyrene size calibration beads. Both microscopy 
and flow cytometry results relied on the presumption that analysed cells were 
spherical in morphology, in order to calculate the 3D cell volume from 2D 
measurements. A coulter counter enables the experimental determination of actual 
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cell size; cells are pulled through microchannels (separating two chambers of 
electrolyte solution) at the same time as an electrical current, causing impedance 
which is proportionate to the volume of the cells traversing the channels (Behind the 
Coulter Principle - Beckman Coulter, 2018). This would be a more accurate measure 
of cell volume in response to altered osmolality (Fenton et al., 2010), enabling 
measurements of precise volume change in NP cells.  
4.4.2 Role of AQP4 and TRPV4 on NP cell size 
When exposed to decreased extracellular osmolality (225mOsm/kg), NP cell 
volume was increased compared to osmotic controls (325mOsm/kg). In the presence 
of either AQP4i or TRPV4i, the hypo-osmotic increase in NP cell size was significantly 
reduced. These results indicate that the function of both AQP4 and TRPV4 is required 
for NP cells to respond in the correct manner to decreased osmolality, by increasing 
volume. Potentially indicating that both channels work synergistically, enabling NP 
cells to correctly regulate their volume and trigger downstream mechanisms (such as 
RVD), in order to adapt to their environment. This synergistic function of AQP4 and 
TRPV4 has been observed in astrocytes and the regulation of the blood-brain-barrier 
previously (Solenov et al., 2004; Jo et al., 2015; Kitchen et al., 2015; Mola et al., 2016). 
Cell volume responses to increased osmolality (425 and 525mOsm/kg) showed no 
significant change, possibly meaning there is no effect of channel inhibition or the 
methods used to measure cell volume were not sensitive enough to detect the 
decrease in cell size that normally follows a decrease in extracellular osmolality.  
4.4.3 The rate of NP cell volume change in response to altered osmolality  
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 This is the first time the rate of NP cell volume change in response to altered 
osmolality, and the effects of AQP4 and TRPV4 inhibition, has been investigated. The 
rate of NP cell swelling and shrinkage was determined using calcein-AM loaded cells 
in a plate reader-based method, used previously to investigate volume change rates 
and AQP function within vesicles, proteoliposomes, MDCK and CHO cell lines, 
astrocytes, erythrocytes and fibroblasts (Mola et al., 2009; Fenton et al., 2010; 
Kitchen et al., 2016). 
 Calcein-AM has been used in experimental systems such as vesicles (Chen and 
Knutson, 1988), proteoliposomes (Zeidel et al., 1992), and mammalian cells (Solenov 
et al., 2004) to determine rapid changes in volume and AQP function. These 
measurements are achieved by the self-quenching properties of calcein at higher 
concentrations (Chen and Knutson, 1988) and insensitivity to pH, Ca2+ or NaCl 
concentration (Wehner et al., 1995; Solenov et al., 2004). Hamann et al., 2002 were 
the first to discover that the fluorescent intensity of calcein-loaded mammalian cells 
was rapidly altered according to the osmotic challenge applied (increase during hypo-
osmotic, decrease during hyperosmotic), demonstrating the usefulness of calcein to 
measure the rapid changes and rate of cell volume. The first methods utilising this 
technique relied on fluorescent microscopy (Wehner et al., 1995; Hamann et al., 
2002; Solenov et al., 2004), more recently plate reader methods have been 
developed which enable rapid and reproducible investigations into the rapid real-
time rate of cell volume changes and screening of membrane protein modulators 
(Mola et al., 2009; Fenton et al., 2010).  
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 This study followed protocols of Fenton et al., 2010, who determined how 
calcein fluorescence intensity was related to cell volume, and speculated that a 
variety of cell types could be tested with their protocols (Fenton et al., 2010). This is 
also the first time that this method has been used to determine the rate of cell 
volume change in response to extracellular osmolality in human NP cells. Calcein 
fluorescence depends linearly on extracellular osmolality in MDKC cells (Fenton et 
al., 2010), which has also been shown to be the case for human NP cells (Appendix 
X). Demonstrating these methods can be used to accurately investigate the 
fundamental functions of NP cells, regarding how they respond to their osmotically 
fluxing environment, and what molecules/proteins/pathways contribute to their 
adaptation. One caveat to this technique is that it is performed on 2D cultured cells, 
therefore cell volume and the rate at which it changes may not represent how NP 
cells respond in their in vivo environment.  
4.4.4 Role of AQP4 and TRPV4 on the rate of NP cell volume change 
 AQP4 function was required for NP cells to swell at the normal rate under 
225mOsm/kg treatments and shrink at the normal rate under 425mOsm/kg 
treatment. TRPV4 function was required for NP cells to alter their volume at the 
correct rate across all osmotic treatments (225, 425 and 525mOsm/kg). Highlighting 
that AQP4 and TRPV4 not only contribute to overall NP cell volume, but also dictate 
the rate at which the desired volume is reached, further implicating both channels in 
the control of NP cell responses to their osmotically fluxing environment.  
4.4.5 Control of NP cell water permeability 
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 The water permeability of NP cells was determined by combining cell volume 
changes and the rates of change in volume (Fenton et al., 2010). AQP4i decreased 
the water permeability of NP cells when exposed to healthy (425mOsm/kg) and 
degenerate (225mOsm/kg) osmolalities, but not when NP cells were exposed to 
higher osmolality (525mOsm/kg). This may indicate that AQP4 only controls NP cell 
responses under specific conditions within the microenvironment of the IVD. It has 
previously, been shown that AQP4 driven water permeability may depend on cell 
membrane compression and tension (Tong, Briggs and McIntosh, 2012; Ozu et al., 
2018), which changes as cells respond to altered osmolality. Thus, AQP4 may exert a 
greater effect on NP cells within a certain osmotic range, and multiple other AQPs 
expressed by NP cell may contribute outside this range.  
 TRPV4 function on the other hand, significantly impacted on the water 
permeability of NP cells across all osmolalities and was expressed by the vast majority 
of NP cells regardless of degenerative state. This indicates a potential overarching 
role during NP cell physiology and adaptation to the hyperosmotic environment of 
the IVD. TRPV4 is known to enable chondrocyte mechanotransduction and matrix 
synthesis (O’conor et al., 2013) and lack of TRPV4 expression can induce 
osteoarthritis in animal models (Clark et al., 2010; Lamandé et al., 2011), thus may 
contribute to similar functions in the IVD. TRPV4 contributes to NP cell water 
permeability, yet it is not a water channel itself. Therefore, TRPV4 function must 
somehow be linked to the function of AQPs and cell volume regulation. TRPV4 has 
been shown to have physical and functional links with AQPs to enable cells to sense 
extracellular osmolality changes and initiate cell volume responses (Liu et al., 2006; 
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Benfenati et al., 2011a; Galizia et al., 2012; Jo et al., 2015; Mola et al., 2016). TRPV4 
was also found to co-localise with AQP4 in human NP cells suggesting related 
functions and interaction between both channels.  
 Increased osmolality treatments (425 and 525mOsm/kg) used in these 
experiments were produced using sucrose as the key osmolyte. This ensured that the 
actual water permeability of NP cells was able to be determined. NP cells contain 
transmembrane channel proteins that readily transport osmolytes such as Na+ and 
Cl+, urea and mannitol. Therefore, if any of these were used to alter osmotic 
treatments, cell volume may have reached equilibrium at a different rate as NP cells 
could utilise the movement of osmolytes used to regulate volume changes, rather 
than employing the actual mechanisms used to regulate cell volume. However, as 
IVD matrix is negatively charged, one of the main ions imbibed into the tissue will be 
Na+ (Urban, 2002). So repeating experiments using NaCl will enable the comparison 
between methods of changing medium osmolality (determining if results are an 
osmotic or substrate effect) and may be more physiological to the in vivo 
environment of the IVD. 
4.4.6 Ca2+ influx in response to extracellular osmotic shifts 
 Cellular response to osmotic shifts in their environment is to modulate 
calcium flux to trigger downstream pathways to enable adaptation to altering 
environment. TRPV4 in particular has a well-established role in regulating the cellular 
response to hypo-osmotic shifts in extracellular osmolality, where calcium influx is 
increased. This enables the triggering of RVD mechanisms and shrinkage to adapt 
(Caterina et al., 1997; Liedtke and Friedman, 2003; Arniges et al., 2004; Everaerts, 
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Nilius and Owsianik, 2010; Toft-Bertelsen, Larsen and Macaulay, 2018). NP cells 
showed they also increase Ca2+ influx under hypo-osmotic conditions, compared to 
hyper-osmotic conditions, suggesting they may employ similar pathways to adapt to 
their diurnal environment. Previous research has also shown that NP cells do not 
increase calcium influx under similar hyperosmotic conditions. (Pritchard, Erickson 
and Guilak, 2002). Pritchard, Erickson and Guilak, 2002 also identified that Ca2+ influx 
and cell volume may be controlled by an actin cytoskeletal-dependent mechanism. 
Which in turn could potentially be regulated by AQP4; as in astrocytes AQP4 
knockdown lead to drastic rearrangement of the actin cytoskeleton network and 
reduced water permeability (Nicchia et al., 2005). Cytoskeletal rearrangement under 
alterations in osmolality have also been observed in bovine NP cells (Maidhof, 
Jacobsen, Papatheodorou and Chahine, 2014). However, when NP cells were injected 
with control media (325mOsm/kg, same as pre-injection media) a Ca2+ influx 
response was still observed. This highlights that Ca2+ influx may also be due to 
mechanical pressure applied onto NP cells from the injection system of the plate 
reader, as TRPV4 and other Ca2+ channels are also known to be mechanotransducive 
(Samanta et al., 2018). This may indicate Ca2+ influx observed was not solely 
attributable to the extracellular osmolality, however hypo-osmotic increased Ca2+ 
influx to a greater extent than control injection.  
TRPV4i significantly reduced hypo-osmotic Ca2+ influx, suggesting important 
NP cell responses to hypo-osmotic stimuli and the potential activation of RVD. 
However, Ca2+ influx was not totally nullified, therefore other channels may also be 
involved in these processes. AQP4i significantly reduced the time taken for maximum 
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Ca2+ influx and the maximum Ca2+ influx, despite its sole function as a water channel. 
AQP4 and TRPV4 function is linked to osmosensing and the adaptation to 
extracellular osmolality of astrocytes (Benfenati et al., 2011a; Jo et al., 2015; Mola et 
al., 2016; Chmelova et al., 2019), and results described here also indicate there may 
be similar mechanisms employed by NP cells.  
4.4.7 Conclusion 
 AQP4 and TRPV4 function may be linked in NP cells in order to control the 
rate of cell volume regulation, water permeability and Ca2+ influx, triggering 
downstream mechanisms enabling the adaptation of NP cells to their osmotically 
challenging environment (Figure 4.15). During IVD degeneration AQP4 expression is 
decreased (Chapter 2); as a result, NP cells will not be able to respond to the hypo-
osmotic environment due to impaired cell volume regulation and Ca2+ influx (Figure 
4.15). Due to the lack of osmotic response, downstream mechanisms may not be 
employed by NP cells to ensure their survival and function in the increasingly 
degenerate environment. Further study is warranted to determine what impact 
AQP4 and TRPV4 expression and function have on potential downstream 
mechanisms such as RVD, cell survival and matrix synthesis. 
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Figure 4.15. NP cell responses to extracellular osmolality alterations: potential roles of AQP4 and TRPV4. 
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Chapter 5: Regulation of AQP expression by physiological 
conditions within the intervertebral disc  
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5.1 Introduction 
 This thesis has identified that certain AQPs are regulated by the physiological 
osmolality of the IVD, which potentially indicates how they are regulated in vivo and 
alludes to the specific functions of these AQPs surrounding the osmotic adaptation 
of NP cells. However, the native environment in which NP cells reside is also hypoxic, 
acidic and has low nutrient supply, when compared to other tissues, and also has to 
withstand biomechanical loading (Urban, 2002). During degeneration these 
conditions can be severely altered and the degenerative cascade is exacerbated by 
the increased production of cytokines, which trigger degenerative processes 
(Takahashi et al., 1996; Le Maitre, Freemont and Hoyland, 2005; Le Maitre, Hoyland 
and Freemont, 2007a; Risbud and Shapiro, 2014). Therefore, the functions of NP cells 
are, at least in part, regulated by their environment and dysregulated during 
degeneration when the environment is altered. This indicates that AQPs may also be 
regulated by many of the other environmental cues within the IVD. 
 AQP expression in many tissues has been shown to be regulated by 
physiological conditions which change in the IVD during degeneration, such as O2 
concentration, cytokines and pH (Tables 5.1-5.3 respectively). However, there have 
been few studies which have investigated the regulation of AQP expression by these 
conditions in NP cells. It was determined that AQP1 and 5 expression in rat NP cells 
was not regulated by changes in O2 concentration, but basal expression levels were 
maintained under hypoxia by HIF-1α (Johnson et al., 2015) (Table 5.1), indicating that 
within the native environment of the IVD, where O2 concentration is always low and 
HIF-1α is stably expressed (Fujita et al., 2012), the maintenance of AQP expression in 
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NP cells is controlled by the environment. In bovine NP cells it was determined that 
TNF-α decreased expression of AQP1 (Maidhof, Jacobsen, Papatheodorou and 
Chahine, 2014) (Table 5.2), signifying that during  IVD degeneration, when TNF-α 
expression is increased (Le Maitre, Hoyland and Freemont, 2007a), AQP expression 
may be differentially regulated when compared to healthy IVD physiology. These 
studies show that potentially more than one environmental factor may contribute to 
the regulation of AQP expression and function within NP cells. No studies, to date 
have investigated pH regulation of AQP expression in NP cells, with only a few 
identifying such regulation in the kidney (Promeneur et al., 2000; Amlal, Sheriff and 
Soleimani, 2004), where AQP2 and 6 are potentially involved in acid-base regulation 
(Table 5.3). It may be that AQPs are only regulated by pH within tissues that exhibit 
fluctuations which cells need to adapt to, such as the IVD. 
 Tissue/cell type AQP Treatment Regulation Pathways References 
Brain Mouse brain, 9L 
glioma cell line 
AQP1 10% O2, 
DMOG, 
CoCl2 
↑ HIF-1α (Abreu-
Rodríguez 
et al., 
2011) 
 9L glioma cell 
line 
AQP1 20 - 0 % O2 ↑  (Hayashi et 
al., 2007) 
 Mouse Schwann 
cells 
AQP1 CoCl2 ↑ HIF-1α (Zhang, J. 
et al., 
2013) 
 Mouse cortical 
astrocytes 
AQP5 0% O2 ↓  (Chai et al., 
2013) 
 Rat spinal cord AQP1, 
4 
Spinal cord 
injury 
↑ HIF-1α (Wang, Y. 
et al., 
2011) 
 Rat brain AQP4, 
9 
Middle 
cerebral 
artery 
occlusion 
↑ HIF-1α (Higashida 
et al., 
2011) 
 Rat brain AQP4, 
9 
traumatic 
brain 
injury 
↑ HIF-1α (Ding et al., 
2009) 
Eye Rat retina AQP0, 
9, 12 
Ar laser-
induced 
retinal vein 
occlusion 
↑  (Hollborn 
et al., 
2012) 
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 Tissue/cell type AQP Treatment Regulation Pathways References 
 Rat retina AQP1, 
3, 4, 
5, 6, 
8, 11 
Ar laser-
induced 
retinal vein 
occlusion 
↓  (Hollborn 
et al., 
2012) 
 Human retinal 
vascular 
endothelia cells 
AQP1 1% O2 ↑  (Kaneko et 
al., 2008) 
 Human retinal 
vascular 
endothelia cells 
AQP1 1% O2 ↑ HIF-1α, HIF 
binding site 
(Tanaka et 
al., 2011) 
Heart Human heart 
tissue, mouse 
cardiomyocytes 
AQP4 Coronary 
artery 
occlusion 
↓  (Rutkovskiy
, 
Stensløkke
n, et al., 
2012) 
 Mouse cardiac 
endothelial cells 
AQP1 Retrograde 
buffer-
perfused 
global 
ischemia 
↓  (Rutkovskiy 
et al., 
2013) 
 Rabbit heart AQP1 Coronary 
artery 
occlusion 
↑  (Ran et al., 
2010) 
 Mouse heart AQP1, 
4, 6 
Coronary 
artery 
occlusion 
↑  (Zhang, H. 
Z. et al., 
2013) 
 Rat pulmonary 
arterial smooth 
muscle cells 
AQP1 4 - 10% O2, 
Ca2+ 
channel 
blockers   
↑ Intracellular 
Ca2+ 
(Leggett et 
al., 2012) 
Musculo-
skeletal 
Rat NP cells AQP1, 
5 
1% O2, 
DMOG 
− Basal 
expression 
regulated by 
HIF-1α 
(Johnson 
et al., 
2015) 
Reproductive PC-3M prostate 
cancer cell line 
AQP1 5% O2, 
CoCl2 
↑ p38, PKC, 
Intracellular 
Ca2+ 
(Tie et al., 
2012) 
Respiratory Mouse lung AQP1 1% O2, 
DMOG 
↑ HIF-1α (Kawedia 
et al., 
2013) 
 Mouse lung AQP5 1% O2, 
DMOG 
↓ HIF-1α, 
proteasome 
(Kawedia 
et al., 
2013) 
Table 5.1. Regulation of AQP expression by O2 concentration. The expression of many 
AQP isoforms, across many tissue and cell types is upregulated (↑) or downregulated 
(↓) by O2 concentration. AQP expression may also be unaltered by changes in O2 
concentration (−). 
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 Tissue/cell 
type 
AQP Treatment Regulation Pathways References 
Adipose 3T3-L1 
adipocyte cell 
line 
AQP7 TNF-α ↓  (Fasshauer et 
al., 2003) 
Brain Rat primary 
astrocytes 
AQP4 IL-1β ↑ NF-κB (Ito et al., 
2006) 
 Rat brain 
tissue/ 
astrocytes 
AQP4 IL-1β, TNF-
α 
↑ NF-κB, 
p38 
(Ding et al., 
2013) 
 Rat cortical 
astrocytes 
AQP4 IL-1β ↑  (Chastre et 
al., 2010) 
 Rat 
hippocampus/ 
entorhinal 
cortex 
AQP4 TNF-α ↑ PKC (Zou, 
Vetreno and 
Crews, 2012) 
Digestive Gingival 
epithelial 
tissue 
AQP3 TNF-α ↑  (Tancharoen 
et al., 2008) 
 NS-SV-AC 
human salivary 
acinar cell line 
AQP5 TNF-α ↓  (Yamamura 
et al., 2012) 
Kidney Mouse kidney AQP2 IL-1β ↓  (Boesen, 
2013) 
Musculo-
skeletal 
Human 
synoviocytes 
AQP9 TNF-α ↑  (Nagahara et 
al., 2010) 
 Bovine NP cells AQP1 TNF-α ↓  (Maidhof et 
al., 2014) 
Respiratory Mouse lung 
epithelial cells 
AQP5 TNF-α ↓  (Krane et al., 
2001a) 
 Human 
bronchial 
epithelial cells 
AQP1, 
5 
TNF-α ↓  (Mezzasoma 
et al., 2013) 
 Rat nasal 
mucosa 
AQP5 IL-1β ↓ NF-κB (Wang and 
Zheng, 2011) 
Skin DJM-1 
keratinocyte 
cell line 
AQP3 TNF-α ↓  (Horie et al., 
2009) 
Table 5.2. Regulation of AQP expression by cytokines specific to IVD degeneration.  
The expression of many AQP isoforms, across many tissue and cell types is 
upregulated (↑) or downregulated (↓) by IL-1β or TNF-α.  
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 Tissue/cell 
type 
AQP Treatment Response Pathways Reference 
Kidney Rat kidney AQP6 NaCO3-
induced 
alkali 
loading 
↑  (Promeneur 
et al., 2000) 
 Rat Kidney AQP6 NH4-
induced 
acid 
loading 
↑ only 
with free 
access to 
drinking 
water 
 (Promeneur 
et al., 2000) 
 Rat kidney AQP2 NH4-
induced 
metabolic 
acidosis 
↑ AVP (Amlal, 
Sheriff and 
Soleimani, 
2004) 
Table 5.3. Regulation of AQP expression by pH alterations.  The expression of AQPs 
is upregulated (↑) by altered tissue pH.  
 
 The regulation of AQP expression by these conditions occurs across many cell 
and tissue types and regulation of expression is potentially specific to each type. 
Many of the AQPs expressed in NP tissue (Chapter 2) are regulated by conditions in 
many tissues that are also present during healthy and degenerate IVD physiology, 
highlighting AQPs may also be regulated in a similar manner in NP cells. The potential 
regulation of AQP expression by physiological conditions may be an indication of the 
potential roles specific AQPs contribute towards with the disc. 
 This study aimed to investigate if AQPs expressed in human NP tissue were 
expressed in extracted NP cells and whether expression was regulated by culture 
conditions, including 2D and 3D culture and stimulation by cytokines, hypoxia and 
pH. Furthermore, these conditions were then combined to mimic the conditions 
representative of the IVD environment and effects on AQP expression determined.  
  
208 
 
5.2 Materials and methods 
5.2.1 Experimental design 
 To determine that all AQPs expressed by native human NP tissue (AQP0-7 and 
9, Chapter 2) were expressed by human NP cells during culture; IHC was performed 
on cytospins of human NP cells taken from passage 0 - 2 and after 2w alginate bead 
culture which is utilised to re-differentiate cells to an NP like phenotype. How AQP 
expression in NP cells is regulated has not been previously established. Therefore, 
human NP cells, encapsulated in alginate beads to re-differentiate into an in vivo-like 
phenotype, were treated with cytokines (IL-1β, IL-6 and TNF-α), altered pH (pH7.4 - 
6.5) under 5% and 21% O2. Furthermore, combined treatments mimicking healthy 
and degenerate IVD conditions were investigated to determine if AQP gene 
expression within NP cells is regulated by conditions observed during IVD physiology. 
The experimental design is outlined in Figure 5.1. 
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Figure 5.1. Experimental design of methods used in this study. 
 
5.2.2 Human Tissue, NP cell extraction and culture 
 Human IVD tissue was obtained with ethical consent, NP cells extracted and 
monolayer cultured according to methods outlined in section 2.2. 
5.2.3 Cytospins 
 Human NP cells were taken at passage 0 (straight after isolation from NP 
tissue), at passage 1, passage 2 during splitting and after 2 week culture and isolation 
from alginate beads (section 3.2.6), and centrifuged at 300g for 5min. Supernatant 
was discarded and cell pellets resuspended in 10% neutral buffered formalin for 
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5min. Fixed cells were centrifuged at 300g for 5min and pellets resuspended in PBS 
at 1x106/mL. Cytospins, filter cards (Thermo Fisher, UK) and slides (Leica 
Microsystems) were assembled and 200μL of cell suspension was added to each 
cytospin and centrifuged at 300g for 5min to deposit a single layer of cells onto slides. 
Slides were stored at 4°C. IHC was performed (Section 2.2.7) to determine if the 
expression of AQPs in native human NP tissue (AQP0-7, 9) was retained in isolated 
human NP cells during culture duration and conditions used in experiments. 
5.2.4 Regulation of AQP gene expression under physiological IVD conditions 
 At passage 2, human NP cells were encapsulated into alginate beads as 
previously described (section 3.2.6). To assess catabolic cytokine regulation of AQP 
gene expression in human NP cells, alginate beads were treated with 0 (control), 1, 
10 and 100ng/mL recombinant human IL-1β (200-01B, Peprotech), recombinant 
human IL-6 (200-06, Peprotech) or recombinant human TNF-α (300-01A, Peprotech) 
for 48h. To determine the effect of physiological pH on the gene expression of AQPs, 
alginate beads were treated with standard culture media with altered pH: pH 7.4 
(media control), pH 7.1 (healthy IVD), pH 6.8 (moderate IVD degeneration) or pH 6.5 
(severe IVD degeneration) for 48h. The pH of standard culture media was adjusted 
using HCl and replaced every 12h to ensure treatment pH was constant and media 
remained unbuffered. All treatments were performed at 21% (v/v) O2 (to represent 
standard culture conditions) and 5% (v/v) O2 (to represent physioxia of the native 
IVD). All treatment conditions were combined to produce a set of treatments to 
represent the healthy and degenerate IVD niche (Table 5.4), which alginate beads 
were also treated with for 48h. 
211 
 
Treatment Standard culture 
control 
Healthy IVD  
niche 
Degenerate IVD 
niche 
Osmolality 
(mOsm/kg) 
325 425 325 
pH 
 
7.4 7.1 6.8 
Cytokines 
(1ng/mL) 
- - IL-1β, IL-6, TNF-α 
O2 concentration 
(% v/v) 
5, 21 5, 21 5, 21 
Table 5.4 Healthy and degenerate IVD niche treatment components. Combined 
treatments represent the healthy and degenerate extracellular environments within 
the IVD; standard culture conditions were included as an untreated control. Human 
NP cells encapsulated in alginate beads were subjected to 48h treatment in either 
control, healthy or degenerate IVD conditions, to assess the effect on AQP gene 
expression. 
 
 Following 48h treatment, NP cells were released from alginate beads and RNA 
extracted (section 3.2.6), cDNA synthesised and the gene expression of AQPs 
investigated using previously described methods (section 2.2.5). 
5.2.5 Statistical analysis 
 All experiments investigating AQP gene expression by physiological IVD 
conditions were performed on at least 3 patient-derived human NP cells in triplicate. 
Data was shown to be non-parametric, therefore, Kruskall-Wallis with Dwass-Steel-
Critchlow-Fligner post hoc analysis test was used to identify significant differences in 
in AQP gene expression after 48h treatment (p ≤ 0.05).   
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5.3 Results 
5.3.1 AQP expression during 2D and 3D culture of human NP cells 
 Throughout all culture conditions (passage 0 - 2 and 2w 3D culture in alginate 
beads) prior to experimental procedures, immunopositivity was seen for all AQPs 
which were expressed in native human NP tissue (Chapter 2) (Figure 5.2).  
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Figure 5.2 Expression of AQP proteins expressed by native human NP tissue, in cytospins of extracted and cultured human NP cells. Immunopositive 
cells are indicated by brown staining and nuclei are counterstained with Mayer's haematoxylin (blue). Scale bar 50μM.
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5.3.2 Regulation of AQPs by cytokines in human NP cells 
 The gene regulation of all AQPs expressed by human NP tissue (AQP0-7 and 
9) was investigated during all experiments, however, results only show AQPs that 
were detected by qRT-PCR, all other AQP family members were undetected. 
5.3.2.1 AQP1 
The relative gene expression of AQP1 was significantly down-regulated by 
48h treatment with 1 and 10ng/mL IL-1β in human NP cells encapsulated in alginate 
beads (p ≤ 0.05) (Figure 5.3A). The relative gene expression of AQP1 was up-regulated 
by 48h treatment with 10 and 100ng/mL IL-6 in human NP cells encapsulated in 
alginate beads (p ≤ 0.05) (Figure 5.3B). TNF-α treatment of human NP cells did not 
significantly regulate the expression of AQP1 (Figure 5.3C). 
5.3.2.2 AQP2 
IL-1β (Figure 5.4A) or IL-6 (Figure 5.4B) treatment of alginate bead 
encapsulated human NP cells did not significantly regulate the gene expression of 
AQP2. However, the relative gene expression of AQP2 was up regulated by 48h 
treatment with 1 and 10ng/mL TNF-α in human NP cells (p ≤ 0.05) (Figure 5.4C). 
5.3.2.3 AQP3 
The relative gene expression of AQP3, in human NP cells, was down-regulated 
by 48h treatment with 1ng/mL IL-1β (p ≤ 0.05) (Figure 5.5A) but was up-regulated by 
48h treatment with 10ng/mL IL-6 (p ≤ 0.05) (Figure 5.5B). Forty-eight-hour treatment 
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with 1ng/mL TNF-α also up-regulated the relative gene expression of AQP3 in human 
NP cells (p ≤ 0.05) (Figure 5.5C).  
5.3.2.4 AQP9 
The relative gene expression of AQP9 was up-regulated by 48h treatment 
with 1-100ng/mL IL-1β (p ≤ 0.05) (Figure 5.6A), 10 and 100ng/mL IL-6 (p ≤ 0.05) 
(Figure 5.6B) and 1-100ng/mL TNF-α (p ≤ 0.05) (Figure 5.6C), in human NP cells. 
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Figure 5.3 Regulation of AQP1 gene expression in 3D cultured human NP cells by catabolic cytokines. Alginate encapsulated human NP cells were 
treated with 0, 1, 10, and 100ng/mL IL-1β (A), IL-6 (B) and TNF-α (C) for 48h. Relative gene expression of AQP1 was determined by qRT-PCR and 
normalised to housekeeping genes (GAPDH and 18S) and untreated controls (0ng/mL). Statistical significance determined using Kruskal-Wallis test * = 
p ≤ 0.05
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Figure 5.4 Regulation of AQP2 gene expression in 3D cultured human NP cells by catabolic cytokines. Alginate encapsulated human NP cells were 
treated with 0, 1, 10, and 100ng/mL IL-1β (A), IL-6 (B) and TNF-α (C) for 48h. Relative gene expression of AQP2 was determined by qRT-PCR and 
normalised to housekeeping genes (GAPDH and 18S) and untreated controls (0ng/mL). Statistical significance determined using Kruskal-Wallis test * = 
p ≤ 0.05 
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Figure 5.5 Regulation of AQP3 gene expression in 3D cultured human NP cells by catabolic cytokines. Alginate encapsulated human NP cells were 
treated with 0, 1, 10, and 100ng/mL IL-1β (A), IL-6 (B) and TNF-α (C) for 48h. Relative gene expression of AQP3 was determined by qRT-PCR and 
normalised to housekeeping genes (GAPDH and 18S) and untreated controls (0ng/mL). Statistical significance determined using Kruskal-Wallis test * = 
p ≤ 0.05 
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Figure 5.6 Regulation of AQP9 gene expression in 3D cultured human NP cells by catabolic cytokines. Alginate encapsulated human NP cells were 
treated with 0, 1, 10, and 100ng/mL IL-1β (A), IL-6 (B) and TNF-α (C) for 48h. Relative gene expression of AQP9 was determined by qRT-PCR and 
normalised to housekeeping genes (GAPDH and 18S) and untreated controls (0ng/mL). Statistical significance determined using Kruskal-Wallis test * = 
p ≤ 0.05 
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5.3.3 Regulation of AQPs by pH in human NP cells 
The relative gene expression of AQP5 in alginate encapsulated human NP cells 
was not significantly regulated by physiological changes in extracellular pH (pH7.4 - 
6.5) for 48h at 21% O2 (Figure 5.7A) or 5% O2 (Figure 5.7B). Gene expression of AQP5 
was also unchanged in 5% O2 when compared to expression in 21% O2 after 48h 
treatment in standard culture media (pH7.4) (Figure 5.7C). However, the relative 
gene expression of AQP5 was significantly up-regulated by 48h culture at 5% O2, when 
compared to culture at 21% O2, when extracellular pH was altered to pH7.1 (p ≤ 0.05) 
(Figure 5.7D), pH6.8 (p ≤ 0.05) (Figure 5.7E) and pH6.5 (p ≤ 0.05) (Figure 5.7F) (NP cell 
viability during pH and O2 % treatments, Appendix XIII). 
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Figure 5.7 Regulation of AQP5 gene expression in 3D cultured human NP cells by pH 
and oxygen concentration. Alginate encapsulated human NP cells were treated with 
media control (pH7.4) or physiological pH (pH7.1, 6.8 and 6.5) at 21% (A) and 5% (B) 
O2 for 48h. Alginate encapsulated human NP cells were treated with 21% and 5% O2 
at pH7.4 (C), 7.1 (D), pH6.8 (E) and pH6.5 (F) for 48h. Relative gene expression of 
AQP5 was determined by qRT-PCR, and normalised to housekeeping genes (GAPDH 
and 18S) and untreated controls (A & B: pH7.4, C-F: 21% O2 concentration). Statistical 
significance determined using Kruskal-Wallis test * = p ≤ 0.05. 
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5.3.4 Regulation of AQPs by physiological IVD conditions 
 The relative gene expression of AQP1 and 2 was unaltered when 3D alginate-
cultured human NP cells were treated for 48h in healthy or degenerate conditions 
compared to standard culture controls, although an increase was seen in 5% O2 in 
degenerate conditions this did not reach significance (Figure 5.8A and 5.8B). AQP5 
gene expression was significantly upregulated in 3D-alginate-cultured human NP 
cells after 48h treatment with both healthy and degenerate conditions at 21% O2 
concentration compared to standard culture conditions, however no change was 
observed in these conditions under 5% O2 (p ≤ 0.05) (Figure 5.8C) (NP cell viability 
during healthy and degenerate treatments, Appendix XIV). 
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Figure 5.8 Regulation AQP gene expression in response to conditions mimicking 
healthy and degenerate IVD conditions. Alginate bead-encapsulated human NP cells 
were treated with control, healthy and degenerate conditions (Table 5.4), at 21% 
(grey) and 5% (magenta) O2 concentration, for 48h. The gene regulation of (A) AQP1, 
(B) AQP2 and (C) AQP5 was compared to standard media controls (21% O2). Statistical 
significance determined using Kruskal-Wallis test * = p ≤ 0.05. 
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5.4 Discussion 
 NP cells have adapted to a hypoxic, hyperosmotic, acidic and mechanically 
stimulated environment that also has low nutrient diffusion. This environment 
contributes to the overall function of NP cells to maintain the integrity of the tissue 
(Bibby et al., 2005; Tsai et al., 2006; Wuertz et al., 2007; Neidlinger-Wilke et al., 
2012). However, during degeneration the NP environment is drastically altered, 
causing numerous adverse cellular effects that lead to IVD degeneration. How AQPs 
function within NP cells is unknown, elucidating how AQPs are regulated in NP cells, 
possibly by environmental stimuli, may signify the specific functions of AQPs within 
the IVD. 
5.4.1 AQP expression during culture 
 All AQPs that were expressed in human NP tissue (AQP0-7 and 9, Chapter 2) 
were also expressed in extracted NP cells. AQP protein expression was present 
throughout all culture conditions utilised for experiments (passage 0-2, 2w alginate 
bead culture). This emphasises that AQP expression remained stable throughout 
standard culture conditions, so the potential regulation of expression by particular 
treatments was able to be investigated. However, the gene expression of only certain 
AQP isoforms was able to be detected during qRT-PCR experiments within this 
chapter (AQP1-3 and 9, cytokine regulation; AQP5, pH and O2 regulation; AQP 1, 2 
and 5, combined treatment). Gene expression of all other AQPs was investigated but 
remained undetected. Potentially, AQP protein expression is more stable than gene 
expression as it was detected across all culture conditions. AQP gene expression may 
be more transient; gene regulation was only investigated after 48h treatment but 
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may be regulated and detectable by qRT-PCR at earlier or later time points. Chapter 
3 identified that both AQP1 and 5 expression was upregulated by hyperosmotic 
treatment after 24h and also 72h. Even though the gene expression of many AQPs 
was undetected by qRT-PCR, their expression in human NP cells may be below 
detectable limits. Also, as patient-derived NP cells were used there may be variability 
in the AQPs that are expressed across different patients. This was also observed in 
Chapter 2 where AQP gene expression was investigated in patient-derived NP tissue; 
no AQP isoforms present were expressed in 100% of patients (102 patient samples), 
indicating biological variability. In contrast, AQP protein expression was observed in 
all patient-derived NP tissue used for IHC (Chapter 2, 30 patient samples), supporting 
the argument that protein expression may be more reliable when detecting AQP 
expression and regulation in NP cells. 
5.4.2 AQP gene regulation by cytokines 
 Cytokines, such as IL-1β, IL-6 and TNF-α, are upregulated and trigger IVD 
degeneration by altering the expression of many genes (Le Maitre, Freemont and 
Hoyland, 2005; Le Maitre et al., 2007; Le Maitre, Hoyland and Freemont, 2007a; 
Hoyland, Le Maitre and Freemont, 2008; Phillips et al., 2015). Potential regulation of 
AQPs by these cytokines in NP cells may indicate that they are also dysregulated 
during degeneration, either as a cause or consequence.  
 AQP1 and 3 were both significantly down-regulated by IL-1β and up-regulated 
by IL-6, potentially indicating shared mechanisms of cytokine regulation, yet as both 
cytokines are present during IVD degeneration it is unclear if the opposite effects of 
singular cytokine treatments actually mimic in vivo regulation. TNF-α did not 
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significantly alter AQP1 expression in NP cells, yet a previous study has shown that 
AQP1 expression in NP cells is down-regulated after 10ng/mL TNF-α treatment 
(Maidhof, Jacobsen, Papatheodorou and Chahine, Nadeen O., 2014). However, the 
Maidhof et al., 2014 study used juvenile bovine NP cells which may respond to TNF-
α treatment differently to mature human NP cells extracted from degenerate discs, 
and the down-regulation in AQP1 expression was observed after 24h TNF-α 
treatment, whereas human NP cells were treated for 48h, indicating responses may 
also be time dependent.  
 AQP9 gene regulation by cytokines provided the clearest results. AQP9 
expression was significantly up-regulated by all cytokine treatments, indicating that 
AQP9 expression may follow a similar pattern during in vivo degeneration, as all three 
cytokines contribute simultaneously. Whether the increase in AQP9 gene expression 
could be a potential cause of further degeneration or is a consequence of the cellular 
dysfunction observed during degeneration is unknown. However, results in Chapter 
2 identified that the in vivo AQP9 immunopositivity was unaltered during IVD 
degeneration, which may indicate that the in vitro AQP9 gene regulation by cytokines 
may be irrelevant during this process. Although, immunopositivity is only a measure 
of the number of cells within the tissue expressing the protein of interest, not the 
actual levels of expression, which potentially could be altered during degeneration, 
thus utilising western blotting or ELISA techniques would be important to investigate 
to investigate changes in AQP 9 protein expression both in vivo and in vitro. 
 
5.4.3 AQP gene regulation by pH 
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 As the IVD is an avascular and hypoxic tissue, NP cells favour anaerobic 
glycolysis as their main form of metabolism, producing an acidic environment (Bibby 
et al., 2005). NP cells have adapted several mechanisms to adapt to this environment 
(Silagi et al., 2018a; Silagi et al., 2018b), yet during degeneration the pH decreases 
further, as removal of waste products (lactic acid) is reduced.  There is limited 
evidence for pH regulation of AQP expression (Table 5.3), highlighting such regulation 
is only observed in tissues where pH balance is essential (or because no one has 
investigated this in other tissues), such as the kidney (Promeneur et al., 2000; Amlal, 
Sheriff and Soleimani, 2004) and possibly the IVD. 
 AQP5 gene expression was unchanged by altered pH in human NP cells 
cultured in 21% or 5% O2, indicating that AQP5 expression may not be sensitive to 
oxygen tension or pH. However, when NP cells were cultured in physiological pH 
(pH7.1 - 6.5) and physioxia (5% O2) AQP5 expression was up-regulated compared to 
21% O2 controls. This indicates that both physiological pH and oxygen tension may 
contribute to the correct regulation of AQP5 expression in NP cells, whereas 
individual treatment with either does not. This provides evidence highlighting that 
multiple environmental cues all provide NP cells with the correct (and incorrect, in 
the case of degeneration) stimuli to regulate expression and function accordingly, 
which will be the case in vivo. Hence NP cell treatment with combined treatments 
mimicking the healthy and degenerate IVD niche was investigated. 
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5.4.4 AQP gene regulation by combined healthy and degenerate IVD conditions 
 The regulation of AQP1, 2 and 5 gene expression by healthy and degenerate 
IVD conditions was unclear. The gene expression of these AQPs was largely 
unaffected by these conditions at 21% and 5% O2 when compared to standard culture 
conditions at 21% O2, indicating that AQPs may not be regulated within NP cells 
during degenerative processes and their functions may be independent of 
degeneration. However, only changes in oxygen tension, osmolality, pH and 
cytokines were used to 'mimic' the healthy and degenerate IVD niche, compared to 
standard culture media. This is a simplified environment and thus, full recapitulation 
of the degenerate and normal niche is needed to investigate this more accurately.  
 The pH of treatments was altered using HCl; this may be an ineffective way of 
altering media pH as desired alterations may be buffered out, an alternative which 
may be more physiologically relevant could be to use lactic acid. Furthermore, the 
addition of the appropriate amount of NaHCO3 to media (without NaHCO3), 
calculated using the Henderson-Hasselbalch equation, will enable the correct 
maintenance of the desired media pH (Esser, Thermo Scientific, 2010; Gilbert et al., 
2016).  
 The native environment of the NP is far more complicated than the 
treatments devised in these experiments. Treatments failed to address the 
mechanical forces (Neidlinger-Wilke et al., 2012), low nutrient diffusion (Urban et al., 
1977) and diurnal patterns (McMillan, Garbutt and Adams, 1996) that NP cells are 
exposed to in vivo. Also, an increased level of calcium deposition within the endplates 
and IVD has been observed during degeneration (Grant et al., 2016), indicating the 
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inclusion of increased calcium concentration may be important to mimic degenerate 
conditions as well. Therefore, without including all environmental factors that 
contribute to IVD health and degeneration, treatments aiming to mimic these 
complex systems will not be physiologically relevant and should be expanded on, to 
gain a more complete view of AQP regulation. Furthermore, these physiological 
conditions may affect AQPs at protein levels rather than gene expression levels, as 
many post-translational modifications (channel gating, phosphorylation, calcium 
binding cytoskeletal remodelling and protein interactions) (Yasui et al., 1999; Nicchia 
et al., 2008; Benfenati et al., 2011b; Conner, Bill and Conner, 2013; Jo et al., 2015; 
Kitchen et al., 2015; Kitchen, P. et al., 2015) all potentially play a significant role on 
the expression, regulation, trafficking and function of AQPs during IVD physiology, 
which should be explored further, particularly due to the issues experienced with 
gene expression analysis of AQPs within NP cells.   
5.4.5 Conclusion 
 AQPs within NP cells may be regulated by many environmental cues within 
NP cells, such as cytokines and pH (Figure 5.9), along with (the well documented) 
alterations in osmolality. Yet, to date the true regulation and function of AQPs within 
the IVD is relatively unknown (Figure 5.9). The in vivo conditions of the IVD must be 
replicated very specifically to gather the information required to unfold the potential 
roles AQPs, and all other genes and proteins, may play during IVD physiology. 
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Figure 5.9. Regulation of AQP gene expression in 3D alginate cultured human NP cells. Cytokines present during IVD degeneration upregulate and 
downregulate AQP gene expression, depending on the individual cytokine and AQP. AQP5 is upregulated by simultaneous physiological pH and O2 
tension treatment, indicating many microenvironmental factors may influence AQP expression in human NP cells, in unison. However, there are more 
factors that contribute to NP cell function in vivo than have been investigated in this study, such as nutrition and mechanical loading. To determine 
how AQP expression is truly regulated in the IVD, the in vivo conditions must be recapitulated very precisely.  
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Chapter 6: General discussion and future directions 
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IVD degeneration-associated LBP remains a debilitating condition with no 
treatments currently available that are directed towards halting and reversing the 
degenerative cascade at a cellular level. The lack of such treatments is in part due to 
incomplete knowledge of the molecular mechanisms that govern IVD function in 
health and degeneration. Due to the unique location and role of the IVD within the 
spine, many factors contribute to the microenvironment that cells reside within. The 
survival and function of cells has been irrefutably linked to their ability to adapt to 
the microenvironment in which they live. During IVD degeneration the 
microenvironment is altered which has a detrimental effect on cell behaviour and, in 
part, plays a role in the dysfunction that causes cells to display a catabolic phenotype, 
intensifying IVD degeneration. As such, increasing the understanding of normal 
cellular functions, and how the IVD microenvironment contributes to this, may help 
elucidate mechanisms that are altered during degenerative processes. Potentially 
revealing novel strategies and treatments to target the cellular causes of IVD 
degeneration. 
The overall aim of this thesis was to investigate the expression, regulation and 
function of AQP transmembrane water channels within the IVD and how they 
potentially contribute to the adaptation of cells to their environment. Chapter 2 
investigated the expression of AQPs in the IVD, specifically how expression may be 
altered during developmental and degenerative processes. Chapter 3 presented the 
regulation of AQP expression by hyperosmolality, physiological to the IVD and well 
known to regulate AQPs in other tissues, and the control of regulation by a 
transcription factor (TonEBP) implicated in NP cell function. Chapter 4 demonstrated 
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that AQPs contribute to fundamental cellular processes such as the control of cell 
volume in response to altered extracellular osmolality in NP cells, and that other 
transmembrane channels work in unison with AQPs to facilitate this. Chapter 5 set 
out to further characterise that AQP expression in NP cells was also regulated by 
other microenvironmental factors that contribute to IVD health and degeneration. A 
summary of key findings from this body of work is provided below. 
6.1 The expression of AQPs within the intervertebral disc 
 The IVD is an osmotically challenged tissue which is altered from 
development to maturation and further changes during degeneration. Therefore, NC 
and NP cells must employ several tightly regulated mechanisms to survive and 
function within their unique osmotic environment. Their function as transmembrane 
water channels, highlighted that many AQP isoforms may be expressed by these cells 
to enable their adaptation to the surrounding environment. In fact, results here did 
identify the expression of 9 different AQP isoforms (AQP0 – 7 and 9) within the 
developing and mature IVD, of which 5 had not previously been shown to be 
expressed (AQP0, 4, 6, 7 and 9). Results presented here imply that the expression of 
numerous AQP family members in the disc highlights the importance of maintaining 
intricate control over regulation of water and solute transport and cell volume in NP 
cells. The increased proportion of NP cells expressing AQP2 and AQP7 during 
degeneration may reflect consequences or potential repair mechanisms employed 
by the disc as NP cells lose their ability to adapt to the degenerate hypo-osmolar 
environment, which is identified by the loss of AQP1, AQP4 and AQP5 expression 
during degeneration.  The expression of numerous AQPs within the disc may 
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highlight the importance of controlling water and solute transport in relation to 
maintaining NC and NP cell function. As yet the actual roles of AQPs within disc 
maturation and degeneration are unknown; warranting further investigation into the 
identification of mechanisms of regulation and functions of AQPs (determined by 
later chapters), to elucidate the true action of these transmembrane channel 
proteins on the overall behaviour and health of the disc. 
6.2 The osmotic regulation of AQP1 and 5 in nucleus pulposus cells 
AQP1 and 5 expression is decreased during human IVD degeneration 
(Johnson et al., 2015). This study has identified that AQP1 and 5 are upregulated by 
hyperosmolality, mimicking the healthy NP, and may explain why expression is 
decreased during degeneration, when the osmolality is decreased. This suggests 
AQP1 and 5 may be part of the mechanisms that allow NP cells to adapt to their 
hyperosmotic environment. TonEBP has already been established as an integral part 
of those mechanisms; as the hyperosmotic upregulation of AQP1 and 5 is dependent 
on TonEBP, this implies they both participate in the osmoadaptation process and 
matrix synthesis. During IVD degeneration TonEBP function is uncoupled from the 
altered osmolality and catabolic genes are upregulated instead of the classical 
osmotic response genes, which may also include AQP1 and 5. As expression of these 
genes (and AQP1 and 5) is reduced, NP cells can no longer adapt to the altered 
environment and degeneration is exacerbated Therefore, AQPs may play a role in 
adapting NP cells to their environment and maintaining the function of NP tissue. 
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6.3 The regulation of cell volume and water permeability in nucleus pulposus cells 
Identifying how NP cells adapt to their osmotically challenging environment 
is key to understanding their fundamental functions, which in turn enables their 
adaptation. The activity of AQP4 and TRPV4, an osmotic and mechano-sensitive Ca2+ 
channel, were identified by this thesis to contribute to the fundamental functions of 
NP cells when physiological extracellular osmolality levels were changed. AQP4 and 
TRPV4 function may be linked in NP cells in order to control the rate of cell volume 
regulation, water permeability and Ca2+ influx, which may trigger downstream 
mechanisms enabling the adaptation of NP cells to their osmotic environment. 
During IVD degeneration, this thesis identified that AQP4 expression was decreased; 
as a result, NP cells will not be able to respond to the hypo-osmotic environment due 
to impaired cell volume regulation and Ca2+ influx. Due to the lack of osmotic 
response, downstream mechanisms may not be employed by NP cells to ensure their 
survival and function in the increasingly degenerate environment. Further study is 
warranted to determine what impact AQP4 and TRPV4 expression and function have 
on potential downstream mechanisms such as RVD, cell survival and matrix synthesis. 
6.4 Regulation of AQP expression by physiological conditions within the 
intervertebral disc 
 AQPs within NP cells may be regulated by many environmental cues within 
NP cells, such as cytokines and pH, along with alterations in osmolality. Yet, to date 
the true regulation and function of AQPs within the IVD is relatively unknown. 
Cytokines along with combined physiological pH and O2 concentration regulated AQP 
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expression in NP cells indicating that multiple conditions control AQP expression in 
the IVD, and that multiple conditions may work in tandem to finely tune AQP 
expression. However, AQP regulation by healthy and degenerate conditions was 
unclear, and other factors that contribute to the IVD microenvironment, such as 
nutrition and mechanical loading, were not investigated.  The in vivo conditions of 
the IVD must be replicated very specifically to gather the information required to 
unfold the potential roles AQPs, and all other genes/proteins, may play during IVD 
physiology. 
6.5 Future directions 
6.5.1 AQP membrane trafficking 
 The regulation of AQP expression at gene and protein level in NP cells has 
been investigated and linked to the potential roles AQPs play within the IVD, in this 
thesis. However, the function of AQPs as channels relies on their insertion into the 
cell membrane; which has been shown to be regulated by cellular trafficking 
mechanisms, such as protein kinase phosphorylation, calcium signalling and 
cytoskeletal rearrangement (Section 1.6).  
 In order to investigate if AQP (particularly 1, 4, and 5) membrane expression 
is regulated by physiological hyperosmolality in NP cells, the use of cell surface 
biotinylation can be used. This ELISA-based method biotinylates cell surface proteins 
after short (minutes) or longer-term (hours) osmotic treatments, and then 
immobilises them to avidin-coated wells. Proteins of interest can then be probed 
using antibodies and HRP-substrate absorbance changes detected to determine AQP 
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abundance at the cell membrane (Kitchen, P. et al., 2015). The mechanisms that 
control AQP trafficking can also be determined by introducing protein kinase 
inhibitors or transfection of AQP phosphorylation mutants (Kuwahara et al., 1995; 
Conner et al., 2010, 2012; Kitchen, P. et al., 2015), calcium inhibitors such as BAPTA-
AM (Kitchen, P. et al., 2015), and microtubule and actin inhibitors (Nicchia et al., 
2008; Conner et al., 2010). If the trafficking of AQPs was determined, this would 
identify another level of functional regulation and control of AQPs within NP cells 
that investigations which this thesis has not elucidated.   
6.5.2 AQP contribution to NP cell function 
 This thesis determined that AQP expression is altered during IVD 
development and degeneration, and that physiological conditions regulated their 
expression and function. However, it was not determined whether changes in 
expression were causes or consequences of the changing physiology of the IVD and 
what changes in AQP expression actually meant for the function of NP cells. 
 Performing AQP knockdown on NP cells by using siRNA or lentiviral vectors 
and transfection of AQP over-expression plasmids and determining the effects of 
AQP deletion and over-expression on matrix synthesis and cytokine, ADAMTS and 
MMP expression, will give an indication on how AQP expression (and changes during 
degeneration) may be linked to the functions of NP cells. 
 The effects of AQP3 expression on NP cell function has previously been 
investigated (Xie et al., 2016). It was determined that siRNA knockdown of AQP3 in 
NP cells was detrimental for matrix synthesis and proliferation and ADAMTS 
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expression was upregulated (Xie et al., 2016). This investigation shows promise that 
AQPs do contribute to the overall functions of NP cells and the integrity of the IVD, 
but as AQP3 expression is not altered during human IVD degeneration (Chapter 3), it 
remains to be determined what changes in AQP1, 2, 4, 5 and 7 (which showed altered 
expression during degeneration (Chapter 2)) actually correspond to with regards to 
IVD health. However, Xie et al., 2016 used commercial human NP cell lines in their 
studies, which are reported to remain differentiated up to 15 passages and are not 
properly characterised as actual NP cells; vimentin and fibronectin are reported as 
phenotypic markers (ScienCell Research Laboratories, San Diego, CA, USA) which are 
not NP markers (Section 1.2.3). To accurately determine AQP function in the IVD, it 
would be beneficial to use NP cells extracted from tissue and used at a low passage, 
such as the NP cells utilised in this thesis. 
6.5.3 AQP regulation by mechanical loading 
 Many environmental factors govern the function of NP cells. This thesis 
identified that physiological conditions regulate AQP expression and function in NP 
cells, however, not all physiological conditions were considered. Mechanical loading 
of the IVD, and how NP cells have adapted to this, is an essential part of how NP cells 
function. Yet, to date no studies have investigated how AQPs may contribute to this 
adaptation. 
 The regulation of AQP expression by mechanical loading in healthy and 
degenerate NP tissue explants could be investigated by using mechanical testing 
equipment such as the ElectroForce BioDynamic 5200 (TA Instruments) mechanical 
stimulation bioreactor. This system enables axial compression of tissue to simulate 
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the physiological loading of the IVD on ex vivo NP tissue explants, whilst media is 
perfused through a bioreactor chamber (also allowing the nutrient diffusion and 
osmolality to be controlled at the same time), to determine how this effects AQP 
expression. The potential underlying mechanisms that control AQP expression under 
load, could be investigated using Flexcell (Burlington, NC, USA) culture plates, for 
example limited studies have previously shown that AQP function may be linked to 
integrin-linked kinase and focal adhesion kinase (Cano-Peñalver et al., 2014; Meng et 
al., 2014; Mamuya et al., 2016; Hatem-Vaquero et al., 2017). This technology allows 
the application of loading, such as tension and compression, to cells in monolayer 
which will enable the use of function-modulating compounds to determine 
mechanisms that control AQP expression. Such experiments may be able to 
determine how AQPs contribute to NP cell adaptation to mechanical loading and how 
they may be involved in altered mechanotransduction during IVD degeneration (Le 
Maitre et al., 2009). 
6.6 Concluding remarks 
 The anatomy of the IVD and age-related changes has been well documented 
over the past few centuries. However, LBP still costs the UK £12 billion per year in 
the 21st century, with 40% of cases attributed to IVD degeneration. Much of the 
physiology contributing to the disc during health and degeneration has been 
elucidated in recent years. However, despite this, current treatment options only 
ameliorate symptoms; there are no treatments that target the underlying cellular 
causes to halt or reverse IVD degeneration. There is current research interest to 
develop therapies to combat IVD degeneration, but whether research findings will 
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translate into clinical use remains to be seen. It is clear however, that an increased 
understanding of the fundamental processes that control the physiology of the IVD 
is of great importance to enable the development of new therapies that take into 
consideration how IVD cells determine the fate of the tissue. 
 Together, the data presented in this thesis have contributed novel findings 
and increased knowledge in the field of IVD biology and spine-related research. 
Results have highlighted NP cells express many AQP water channels in vivo, whose 
expression may be altered between disc development and degeneration. AQP1 and 
5 were found to be upregulated by TonEBP in hyperosmotic conditions, mimicking 
the healthy IVD, which may implicate them in the adaptation of NP cells to their 
environment, which is no longer achievable when AQP1 and 5 are decreased during 
degeneration. The importance of AQP4 and TRPV4 function in the way NP cells adapt 
to their osmotically fluxing environment has also been determined. Additionally, this 
PhD project has raised new avenues of research for future study, which have the 
potential to unravel the roles of AQPs in the fundamental cellular processes of IVD 
biology.  
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Appendix I. Sheffield Research Ethics Committee approval letter 
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Reference Source Age IVD Level Intact IVD? Average 
Grade 
Classification DE IHC 
HD 1 Surgical 42 L4/L5 No 3 ND X   
HD 2 Surgical 40 L5/S1 Yes 3.9 I X   
HD 3 Surgical 25 L4/L5 Yes 4.8 MD X   
HD 5 Surgical 33 L5/S1 Yes 9 SD X   
HD 9 Surgical 32 L5/S1 Yes 5 MD X   
HD 16 Surgical       7 SD X   
HD 17 Surgical 45 L5/S1 Yes 4 ND X   
HD 23 Surgical       7.8 SD X   
HD 24 Surgical       2 ND X   
HD 25 Surgical 20 L4/L5 No 2 ND X   
HD 26 Surgical 40 L5/S1 No 5 MD X   
HD 31 PM 45 L3/L4 Yes 1 ND X   
HD 33 Surgical 48 L4/L5 No 8 SD X   
HD 34 Surgical 26 L5/S1 No 12 I X   
HD 36 Surgical 33 L5/S1 Yes 9 I X   
HD 40 PM 74 L2/L3 Yes 11 SD   X 
HD 44 Surgical 42 L5/S1 Yes 2 ND X   
HD 45 Surgical 36 L5/S1 Yes 8 SD X   
HD 53 Surgical 38 L5/S1 No 7 SD X   
HD 54 Surgical 28 L4/L5 Yes 6 MD X   
HD 56 Surgical 43 L5/S1 No 8 I X   
HD 57 Surgical 44 L5/S1 Yes 9 SD X   
HD 58 Surgical 28 L5/S1 No 8 SD X   
HD 59 Surgical 35 L5/S1 Yes 6 MD X   
HD 61 Surgical 43 L5/S1 No 7 SD X   
HD 63 Surgical 42 L5/S1 No 5 MD X   
HD 65 Surgical 43 L4/L5 No 10 I X X 
HD 66 Surgical 62 L3/L4 Yes 10 I X   
HD 71 Surgical 42 L5/S1 Yes 3 ND   X 
HD 75 Surgical 40 L3/L4 Yes 11 SD X   
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Reference Source Age IVD Level Intact IVD? Average 
Grade 
Classification DE IHC 
HD 79 Surgical 45 L4/L5 No 2.6 ND X   
HD 85 Surgical 85 L2/L3 No 8 I X   
HD 86 Surgical 40 L5/S1 No 9 I X   
HD 89 Surgical 21 L5/S1 No 4 ND   X 
HD 92 Surgical 38 L5/S1   7 SD X   
HD 93 Surgical 38 L5/S1   12 SD X   
HD 94 Surgical 66 L5/S1 Yes 10 SD X   
HD 97 Surgical 46 L5/S1 No 10 SD X   
HD 98 Surgical 65 L3/L4 Yes 11 SD X X 
HD 103 Surgical 45 C5/C6 No 9.5 SD   X 
HD 145 Surgical 38 L4/L5 No 11 I X X 
HD 146 Surgical 47 L5/S1   7 SD X   
HD 148 Surgical 70 C5/C6   8.5 SD X   
HD 151 Surgical 47 L5/S1   8.5 SD X   
HD 153 Surgical 30 L5/S1 No 5 MD X   
HD 154 Surgical 52 L4/L5 No 11 SD X X 
HD 156 Surgical 24 L4/L5 Yes 3 ND X   
HD 157 Surgical 31 L5/S1 No 5 I X   
HD 158 Surgical 38 L4/L5 No 7 I   X 
HD 159 Surgical 39 L4/L5 No 9 I X X 
HD 160 Surgical 26 C3/C5           
HD 166 Surgical 33 L4/L5 Yes 8 SD X   
HD 170 Surgical   L5/S1 No 10 SD X   
HD 174 Surgical 29 L5/S1 Yes 6 I X   
HD 175 Surgical 37 L5/S1 Yes 7 SD X   
HD 184 Surgical 49 L4/L5   5 I X   
HD 192 Surgical 29 L5/S1 No 8 SD X   
HD 194 Surgical 35 L4/L5 No 11 SD X   
HD 195 Surgical 38 C6/C7 No 9 SD X   
HD 197 Surgical 42 L4/L5 No 8 SD X   
HD 203 Surgical 45 L5/S1 Yes 4 ND   X 
HD 207 Surgical 38 L5/S1 No 8 SD X   
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Reference Source Age IVD Level Intact IVD? Average 
Grade 
Classification DE IHC 
HD 219 Surgical 54 L5/S1 No 11 I X X 
HD 225 Surgical 36 L5/S1 Yes 10 SD X   
HD 228 Surgical       7 I X   
HD 229 Surgical 56 L5 Yes 6 MD X X 
HD 231 Surgical 56 L4/L5 No 5 MD X   
HD 232 Surgical 58 L5/S1 No 8 SD X   
HD 233 Surgical 44 L5/S1 Yes 10 SD X X 
HD 234 Surgical 54 L5/S1 Yes 9 SD X X 
HD 243 Surgical 28 L4/L5 Yes 6 I X   
HD 246 Surgical 40 L5/S1 Yes 7 I X   
HD 253 Surgical 63 C5/C6 Yes 4 I X   
HD 254 Surgical 47 L4/L5 No 6 I X X 
HD 257 Surgical 46 L5/S1 No 3 I X X 
HD 264 Surgical 65 C3/C5 Yes 6 MD   X 
HD 266 Surgical 27 L5/S1 No 4 ND   X 
HD 270 Surgical 45 L5/S1 No 6 MD   X 
HD 276 Surgical 71 C5/C6   6 MD X   
HD 281 Surgical 27 L4/L5 Yes 3 ND X   
HD 282 Surgical 21 L5/S1 No 4 ND   X 
HD 287 Surgical 46 L5/S1 Yes 5 MD X   
HD 292 Surgical 23 L2/L3 Yes 4 ND X   
HD 309 Surgical 52 L2/L3 No 7 SD X   
HD 310 Surgical 37 L4/L5 Yes 5 I X X 
HD 319 Surgical 47 L5/S1 No 5 MD X X 
HD 320 Surgical 68 L4/L5 No 4 I X   
HD 321 Surgical 22 L4/L5 Yes 4 ND X   
HD 328 Surgical 38 L5/S1   6 I X   
HD 329 Surgical 48 L5/S1 Yes 5 I X   
HD 330 Surgical 32 L5/S1 Yes 5.5 MD   X 
HD 332 Surgical 24 L5/S1 No 10 I X   
HD 339 Surgical   L5/S1 No 7 SD X   
HD 342 Surgical 18 L4/L5 Yes 6 I X   
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Reference Source Age IVD Level Intact IVD? Average 
Grade 
Classification DE IHC 
HD 346 Surgical 46 C5/C6 Yes 6 MD   X 
HD 350 Surgical 38 L4/L5 Yes 9 SD X   
HD 352 Surgical 82 L4/L5 No 8 SD X   
HD 355 Surgical 33 L4/L5 No 5 I X   
HD 356 Surgical 26 L5/S1 Yes 4 ND X   
HD 357 Surgical 53 L4/L5 Yes 4 I X   
HD 359 Surgical 40 L5/S1 No 4 ND   X 
HD 360 Surgical 50 C6   5.5 MD   X 
HD 369 Surgical 50 L5/S1 Yes 7 SD X   
HD 370 Surgical 50 L5/S1 Yes 8 SD X X 
HD 372 Surgical 49 L4/L5 No 7 I X   
HD 374 Surgical 37 L4/L5 Yes 4 ND X   
HD 375 Surgical 41 L5/S1 No 6 MD   X 
HD 378 PM 33 L4/L5 Yes 2 ND X   
HD 379 PM 33 L3/L4 Yes 5 MD X   
HD 380 PM 33 L2/L3 Yes 4 ND X X 
HD 388 Surgical 54 C6/C7 Yes 6 MD X   
HD 396 Surgical 44 L4/L5 Yes 9 SD X   
HD 397 Surgical 20 L4/L5 No 3 ND X   
HD 480 Surgical   No 5 MD   
HD 482 Surgical   No 7 SD   
HD 521 Surgical 42 L5/S1 No 5 MD   
HD 538 Surgical 43 L3/L4 No 6 MD   
HD 540 Surgical 45 L4/L5 No 8 SD   
HD 545 Surgical 38 L4/L5 No 4 ND   
Appendix II. Human patient details. Samples were separated into different grades, 
0-4 (Non-degenerate, ND), 4.1-6.9 (Moderately-degenerate, MD) and 7-12 (severely-
degenerate, SD).  X indicates samples used for direct extraction (DE) of RNA and RT-
qPCR and immunohistochemistry (IHC). 
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Appendix III. Canine sample details. Non-chondrodystrophic (NC)=0. 
Chondrodystrophic (C)=1. Not determined (ND). 
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Appendix IV. IHC of (A) Rabbit and (B) mouse IgG controls of human NP tissue used 
in AQP protein expression experiments. Scale bar 50µm. 
 
Appendix V. IHC of rabbit IgG controls of (A) NP cells and (B) NC cell clusters in canine 
IVD tissue and (C) sections of NC cells in alginate beads used for IF. IHC of mouse IgG 
controls of (D) NP cells and (E) NC cell clusters in canine IVD tissue and (F) sections of 
NC cells in alginate beads used for IF. IHC scale bar 50µm. IF scale bar 20µm.  
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Appendix VI. NP cell viability in response to altered osmolality treatment. NP cells 
were treated with (A)225, (B) 325, (C) 425 or (D) 535mOsm/kg media for 0 – 72h and 
metabolic activity was measured using the resazurin reduction assay. Resazurin 
sodium salt (Sigma-Aldrich) stock solution (3mg/mL, prepared in DMEM) was diluted 
1:100 and was incubated on cells for 2h at 37°C 5% CO2 (v/v) before absorbance was 
read at excitation: 560nm, emission 590nm. Fluorescence values normalised to 
acellular controls. Significance determined by Kruskal-Wallis *p ≤ 0.05. 
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Appendix VII. (A) Rat NP cell fluorescent ICC and (B) mouse IVD IHC Secondary 
antibody only controls for AQP1. (C) Rat NP cell fluorescent ICC and (D) mouse IVD 
IHC Secondary antibody only controls for AQP5. ICC scale bar 20µm. IHC scale bar 
100µm.
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Appendix VIII. (A) Rabbit IgG control of human NP tissue from TonEBP IHC 
experiments. Scale bar 20µm. (B) Rabbit IgG control of human NP cells from TRPV4 
immunofluorescence experiments. Scale bar 20µm. 
 
 
Appendix IX. Calcein fluorescence and cell volume correlation with osmolality in 
human NP cells. (A) Relative fluorescence (F1/F0) of calcein depends linearly on 
extracellular osmolality. (B) NP cell volume is not linearly correlated to extracellular 
osmolality; therefore, cell volume cannot be deduced directly from calcein 
fluorescence. Similar findings were observed by Fenton et al., 2010 when developing 
this method. Average results for calcein F1/F0 and NP cell volume were plotted with 
standard deviation. Linear regression analysis was plotted as a red-dashed line. 
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Appendix X. Example of non-linear regression curve fitting to determine rate of cell volume change in response to extracellular osmolality 
changes. The change in intracellular calcein F1/F0 is plotted when NP cells are exposed to altered osmolality. To determine the rate of change in 
calcein F1/F0, plateau followed by one-phase association (increase in F1/F0) or decay (decrease in F1/F0) curves were fitted to data using GraphPad 
Prism v7.03 software. The average baseline value of Y (Y0) before experimental intervention (X0) was constrained to 1; X0 was constrained to 
0.05s (the first fluorescence reading after injection). 
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Appendix XI. (A) Fluorescent images of CFSE-labelled human NP cells exposed to altered extracellular osmolality used for ImageJ cell size determination. 
Scale bar 20µm. (B) Flow cytometry gating strategy to determine changes in forward scatter (FSC) of CFSE-labelled human NP cells in response to 
altered extracellular osmolality. 
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Appendix XII. NP cell viability in response to AQP4 and TRPV4 channel inhibition. NP 
cells were treated with (A) no treatment control (B) DMSO vehicle control (C) 300μM 
AQP4i or (D) 4.8μM TRPV4i for 1 − 3h and metabolic activity was measured using the 
resazurin reduction assay. Resazurin sodium salt (Sigma-Aldrich) stock solution 
(3mg/mL, prepared in DMEM) was diluted 1:100 and was incubated on cells for 2h (prior 
to treatment) at 37°C 5% CO2 (v/v) before absorbance was read at excitation: 560nm, 
emission 590nm. Fluorescence values normalised to acellular controls. Significance 
determined by Kruskal-Wallis *p ≤ 0.05. 
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Appendix XIII. NP cell viability in response to altered pH and O2 % treatment. NP cells 
(in alginate beads) were treated with altered pH (7.4 – 6.5) at (A) 21% O2 and (B) 5% 
O2 for 0 – 48h and metabolic activity was measured using the resazurin reduction 
assay. Resazurin sodium salt (Sigma-Aldrich) stock solution (3mg/mL, prepared in 
DMEM) was diluted 1:100 and was incubated on cells for 4h at 37°C 5% CO2 (v/v) 
before absorbance was read at excitation: 560nm, emission 590nm. Fluorescence 
values normalised to acellular controls. Significance determined by Kruskal-Wallis *p 
≤ 0.05. 
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Appendix XIV. NP cell viability in response to healthy and degenerate treatment. NP 
cells (in alginate beads) were treated with combined (A) healthy or (B) degenerate 
IVD conditions for 0 – 48h and metabolic activity was measured using the resazurin 
reduction assay. Resazurin sodium salt (Sigma-Aldrich) stock solution (3mg/mL, 
prepared in DMEM) was diluted 1:100 and was incubated on cells for 4h at 37°C 5% 
(v/v) before absorbance read at excitation: 560nm, emission 590nm. Fluorescence 
values normalised to acellular controls. Significance determined by Kruskal-Wallis *p 
≤ 0.05. 
